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SUMMARY
The economic impact of fasciolosis on livestock industries including those in
tropical countries such as Nigeria has prompted research into various aspects of the
host-parasite relationship in fasciolosis. An improved knowledge of this interaction
should contribute to the development of control measures for fasciolosis. The
excretions, secretions and surface components of a parasite are by their nature
centrally involved in the host/parasite interaction. Rats, like cattle, are capable of
developing resistance to fasciolosis after primary infection and are therefore
considered a suitable laboratory model for cattle. The objective of this study was to
characterise the excretory/secretory (ES) and surface components of Fasciola
hepatica as it develops in the rat, and to identify those components involved in the
host/parasite interaction that may have diagnostic and/or protective value.
In the first instance the available scientific literature on the immunochemical
nature of Fasciola spp. and on natural and experimentally induced resistance to F.
hepatica infection in various hosts was reviewed.
Three trials were conducted during the study in order to produce supplies of
rat antiserum which was protective against F. hepatica. Rats were infected with
either 10 (first trial) or 20 (second and third trials) F. hepatica metacercariae as
information from the literature indicated that these doses were adequate to stimulate
the production of protective antibody levels.
The rat sera from the three trials were checked for the presence of protective
antibodies by passive protection studies. Only in the latter two trials was the level of
protection conferred on recipient statistically significant. The probable causes for
the lack of significant protection in trial 1 are discussed.
The silver stained protein profiles of ES from newly excysted (DO) flukes
and one-day old (Dl) flukes were characteristic and were similar to each other. The
ES of parenchymal 14-day old (D14) and adult (D56) flukes were markedly
different from DO and Dl flukes but similar to each other. The silver stained total
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ES protein profiles of the developing flukes were very different from the total
biosynthetically (35S-methionine) radio-labelled ES protein profiles. Possible
reasons for this are discussed. However, as with the total silver stained ES protein
profiles there were clear changes in the profiles of the biosynthetically radio-
labelled ES as the flukes developed. It is suggested that these differences in the ES
products may reflect the changing environment and activities of the flukes. The
possible functions of the changing ES products are discussed.
Western blot studies of adult fluke ES using sera collected sequentially from
rats infected with F. hepatica in the three trials revealed a 25 kDa doublet (reduced)
and 26 and 27 kDa antigens (non-reduced). It is thought possible that these antigens
provoke a protective antibody response. The rat sera (I2) used for the second
protection trial contained more antibodies which reacted with these particular
antigens than the sera used in the other 2 trials and had a demonstrably greater
protective ability. The 25 kDa doublet was also identified in D14 ES but not in the
DO or D1 ES. In DO and D1 ES, however, an immunodominant reduction-sensitive
191kDa antigen was identified.
Western blot studies on DO, D14 and adult ES using sequential bleeds from
rats injected with the protective I2 serum prior to challenge infection revealed two
interesting points. Firstly, in rats that were completely protected from infection
antibody activity against the 25, 26 and 27 kDa antigens in D14 and adult fluke ES
and against the 191 kDa antigen in DO and D1 ES gradually declined as the
experiment progressed. Secondly, in partially protected rats although the response to
these antigens had also declined by D14 and D28, it then rose again by D42 and
D56. Thus, although these antigens may be involved in promoting a protective
immune response, the antibodies against them are also good indicators of infection.
Immune-coprecipitation of biosynthetically radio-labelled DO ES with sera
from infected rats in trial 2 revealed a 26 kDa antigen. It is suggested that this
antigen may be the same as the 25 kDa antigen detected in western blots ofD14 and
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adult fluke ES and that it was not detected in Western blots of DO and D1 ES due to
the limited assay sensitivity. A novel antigen of about 38kDa was strongly detected
by serum I2 containing protective antibody in immune-coprecipitation of
biosynthetically radio-labelled ES of parenchymal (D14, D28 and D42) flukes. It is
suggested that this antigen may also have protective and/or diagnostic properties.
The study thus indicated that the following F. hepatica antigens merit
further study; the 191kDa antigen in DO ES, the 25 kDa in D14 ES and the 25, 26
and 27 kDa antigens in adult ES, in order to further elucidate their role in the
host/parasite relationship. Similarly, the 26 kDa antigen detected in immuno-
coprecipitation of biosynthetically (35S-methionine) radio-labelled DO ES, and the
38 kDa antigen detected in D14, D28 and D42 ES deserve further investigation. The
fact that these antigens were being actively synthesized by the parasite at the time of
study suggests that it would be feasible to clone them.
In conclusion, the possible relevance of the above antigens for diagnosis and
protection in fasciolosis is discussed, as is the potential use of non-immunogenic
biosynthetically radio-labelled ES components in diagnostic assays designed to
detect parasite products. Some components of this nature were detected in the
course of this study.
Overall, the study has clearly identified antigenic components in the ES and
surface extracts of F. hepatica which are involved in the host/parasite interaction in
the rat model and, by implication, may also be of significance in bovine fasciolosis.
The antigens detected by western blotting and by immuno-coprecipitation of DO ES
(that is those of 191 and 26 kDa) as well as the 38 kDa antigen detected in the ES





Fasciolosis is caused by several species of digenetic trematodes belonging to
the genera Fasciola and Fascioloides (Soulsby, 1982).
The two known Fasciola spp. which are parasitic in domestic animals and
sometimes in man are F. hepatica (Linnaeus 1758) and F. gigantica (Cobbold,
1885) (cited in Soulsby, 1982). F. hepatica occurs in the temperate regions (Hunter
and Health, 1984; Lemma, Gabre and Telda, 1985; Sharma, Dhar, and Raina, 1989),
while F. gigantica occurs in the tropical regions particularly in Africa, Indian
subcontinent, parts of China, South East Asia, Philippines and Hawaii (Boray, 1969;
Mzembe and Chaudhry, 1980; Soulsby, 1982; Lemma, et al., 1985; Sharma et al.,
1989). Overlapping infection with both species occur in some parts of Africa and
the Indian subcontinent (Kendall, 1954; Guralp, Ozcan and Simms, 1964; Boray,
1969).
The major hosts of these parasites are sheep, goats, cattle and buffalo. The
horse, donkey, mule and camel are less susceptible but epidemiologically important
while the domestic pig is naturally resistant to infection (Soulsby, 1982; Boray,
1969). Wild mammals may also contract fasciolosis and some of these act as
reservoir hosts (Hammond, 1972).
Estimates of the prevalence rates of fasciolosis in tropical livestock are
largely conjectural, although available figures suggest prevalence rates of between
30% and 90% are common in the highly endemic areas of East, West and Central
Africa (Ogambo-Ongoma, 1972; Diaw, Seya and Sarr, 1988; Babalola and
Schillhorn, 1976). The situation appears to be similar in tropical Asia, particularly
in some parts of Bangladesh (Rahman, Ali and Rahman, 1972) and India (Sharma,
et al., 1989).
The economic losses caused by fasciolosis can be very serious, particularly
in areas where the local environmental conditions are favourable to the intermediate
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hosts, so that the final hosts are exposed to a high rate of infection which may lead
to acute fasciolosis with both high morbidity and mortality (Sewell, 1976).
In such areas susceptible animals are often exposed to large doses of
infection resulting in acute form of the disease, which is often associated with
traumatic hepatitis inflicted by migrating immature flukes in the parenchyma
(Soulsby, 1982). This acute form of the disease is often associated with high
mortalities particularly in small ruminants (Henderson, 1936; Gretillat, 1961;
Schillhorn Van Veen, 1979; Karib, 1962).
The chronic form of the disease, which commences when the fluke enters the
bile duct, is responsible for heavy direct and indirect losses, especially in cattle
(Chick, 1979). This is probably why Fabiyi (1986) described fasciolosis as the most
important single helminth infection of cattle. The direct loss is brought about by
liver condemnation (Fabiyi and Adeleye, 1982) while the indirect loss is caused by
the reduced growth rate arising from increased protein catabolism coupled with
reduced feed intake (Sewell, 1966; Dargie, Berry and Parkins, 1979) and lower feed
conversion efficiency (Chick, Coverdale and Jackson, 1980). These losses are
aggravated when only a low plane of nutrition is available for the animal as often
occurs during the hot dry season in the tropics (Webster and Wilson, 1980) and in
the autumn in temperate countries (Roseby, 1970; Reid, Doyle Armour and
Jennings, 1972). Other indirect losses during the chronic phase of fasciolosis include
a reduction in the yield and quality of milk (Froyd, 1978), a decrease in the number
and activity of spermatozoites (Ramaniuk, 1978) and reduced wool growth in sheep
(Hawkins and Morris, 1978).
The control of fasciolosis involves management procedures and the use of
anthelmintics and molluscicides. These are expensive and not often available. For
example pasture management or controlled grazing procedures, which may be used
as control measures against Fasciola infection, do require additional labour and
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fencing (Sewell, 1976) while the repeated use of anthelmintic or molluscicides is
expensive.
Some hosts such as rats (Hayes, Bailer and Mitrovic, 1972, 1974a; Haroun,
Hammond and Sewell, 1980a) and cattle (Ross, 1966; Doyle, 1971) develop
significant resistance to fasciolosis following a primary infection. Several workers
(Armour and Dargie, 1974; Hayes, Bailer and Mitrovic, 1974b; Haroun, Hammond
and Sewell, 1981; Chapman and Mitchell, 1982a) have demonstrated that this
resistance can also be passively transferred in sera from infected hosts. Most reports
agree that the injection of metabolic products of immature flukes confers significant
resistance to recipients, as does the implantation of these flukes into recipients
(Lang, 1976; Lang and Hall, 1977; Rajasekariah, Mitchell, Chapman and Montague,
1979). Only a few workers (Ericksen and Flagstad, 1974; Anderson, Hughes and
Harness, 1975) have reported that the implantation of the adult fluke will confer
similar protection on recipients. It could be inferred that protective serum antibodies
are directed against some components of the parasite's excretory/secretory products.
If defined, such components will be useful targets for vaccination and/or diagnosis.
This study was therefore designed to characterize Fasciola hepatica at the molecular
level, with the aim of identifying parasite components that might be involved in





2.1 THE PARASITE AND ITS LIFE CYCLE
The definitive hosts of parasitic trematodes of Fasciola spp. are mammals
where they inhabit the liver bile ducts. Their eggs are passed into the bile and
voided with the faeces of an infected host.
The life span of the miracidium is only about 24 hours, during which it must
find and penetrate an intermediate host (Smyth, 1962). The most common
intermediate host for F. hepatica is Lymnea truncatula, an amphibious snail while
L. natalensis is the most common intermediate host for F. gigantica.
The life cycle of Fasciola spp. is fully described by Reinhard (1957) but,
briefly, the miracidia undergo mitosis inside the snail and develop into a sporocyst.
By repeated divisions, each germinal cell within the sporocyst becomes a germinal
ball which then becomes a redia. Germinal cells within the rediae also develop into
germinal balls, each of which gives rise to a second generation of rediae. The
germinal cells of these second generation of rediae develop into cercariae. The tailed
cercariae swim out of the snail and encyst on the surface of blades of grass and other
objects, losing their tails in the process, to become metacercariae. The metacercaria
is the infective form for susceptible mammalian hosts.
When metacercariae are ingested by a susceptible host, the outer cyst wall is
digested off by the host's gastro-intestinal enzymes and the activity of the young
fluke releases it through a pore in the inner wall. The newly excysted juvenile fluke
penetrates the intestinal wall and passes via the peritoneal cavity (Schumacher,
1938) to the liver, into which it penetrates. These invading flukes migrate and grow
for several weeks in the liver parenchyma, later entering into the bile ducts where
they mature into egg-laying adults (Gorgi and Theodorides, 1980). The prepatent
period for F. hepatica is about six weeks in the rat (Kendall, 1967), eight weeks in
the sheep (Sinclair, 1962; Boray, 1969) and nine weeks in the cattle (Kendall,






















Scanning electron microscopy ofD14 F. hepatica (x 625).
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(Ogunrinade, 1983) and 13 weeks in sheep and goats (Ogunrinade, 1984, Ajanusi,
Ogunsusi, Njoku and Gyang, 1988).
2.2 RESISTANCE TO FASCIOLA INFECTION
Throughout this discussion the levels of protection are the results of
comparison with animals which had not received the specified treatment but were
otherwise alike in all aspects and had received the same dose of the same batch of
metacercariae.
2.2.1 Resistance Following Natural Infection
2.2.1.1 Rats
The presence of immunity in rats with an existing infection derived from
normal metacercariae was first demonstrated by Hayes et al. (1972), who observed
that infection of rats with an existing infection of F. hepatica resulted in the
recovery of 92.5% fewer flukes. This observation was confirmed by the same
authors in 1973 when they found that 76% fewer flukes developed from a challenge
infection in rats previously infected with one metacercaria of F. hepatica and that
rats that had first been exposed to a primary infection of 10 metacercariae were able
to completely resist a challenge infection. This resistance persisted even in chronic
infections (Hayes et al., 1974a), but the age of the primary infection at the time of
challenge influenced the degree of resistance as rats challenged 28 or 48 weeks after
a primary exposure yielded 66 or 50% less flukes respectively from challenge
infection. Hayes and Mitrovic (1977) considered that the immunity is expressed in
the rat within 24 hours of challenge. The number of flukes recovered 24 to 48 hours
after challenge were 84 to 99% fewer. Doy, Hughes and Harness (1978) also
reported that a 3-week-old primary infection of 30 metacercariae per rat initiated a
high degree of resistance within 48 hours after challenge with 200 metacercariae.
Anthelmintic removal of the immunizing infection before challenge did not interfere
with the ability of the rats to develop resistance to the challenge infection. Goose
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and MacGregor, (1973) demonstrated that a single sensitizing infection of rats with
30 metacercariae engendered resistance to a challenge infection given 63 or 98 days
later as an oral metacercarial challenge or intraperitoneally transplanted adult flukes
and that removal of the immunising infection by anthelmintic treatment 6 days
before challenge did not interfere with the resistance. The effect of oral sensitization
upon intraperitoneal challenge was also investigated by Hughes, Anderson and
Harness (1976). They found that 71% of the implanted flukes were killed in rats
which had been sensitized by oral infection with metacercariae 10 weeks before
being challenged by intraperitoneal implantation of adult flukes. In contrast, in rats
sensitized by subcutaneous implantation of adult flukes prior to challenge, only 23%
of the challenge flukes were killed. Histological evidence suggested immunological
killing of the challenge flukes. Therefore these authors concluded that oral infection
of rats causes sensitization of the host against all stages of the parasite and that this
is necessary for the development of protection against an adult fluke challenge. The
work of later investigators (Rajasekariah and Howell, 1977, 1978; Haroun et al.,
1980b; Doy and Hughes, 1982) lends credence to this ability of rats to develop
resistance after a primary infection.
Doy and Hughes (1982) observed that previously infected athymic nude
Rnu/rnu rats and their heterozygous hairy (rnu/+) counterparts showed a high degree
of resistance to oral challenge but that only the rnu/+ rats showed a high degree of
resistance to an intraperitoneal challenge with newly excysted juveniles. In addition,
they observed that serum from infected rnu/+ and PVG rats readily induced in vitro
adherence of peritoneal cells of infected or naive PVG rats to newly excysted
juveniles while serum from infected rnu/rnu rats failed to elicit adherence. They
therefore postulated the existence of two distinct mechanisms of resistance, one a T-
independent system effective at the gut wall and the second, a T-dependent system
effective in the body cavity and the liver parenchyma.
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2.2.1.2 Mice
Lang (1967) observed that mice immunized by two stimulating infections
before challenge harboured significantly fewer flukes. There was earlier migration
by the challenge flukes to the bile ducts. On the basis of the nature and timing of
lymphocyte infiltration, and the histopathology of the liver, he suggested that
delayed (cellular) hypersensitivity may play a prominent role in the earlier
migration of the challenge flukes. Lang (1968) gave mice two immunizing
infections of 2 metacercariae 60 days apart, followed by challenge 40 days later. At
post mortem examination 25 and 40 days after challenge there was a significant
decrease in worm burdens. As the author had been unable to demonstrate a
significant decrease in the worm burdens in previously infected mice 20 days after
challenge in a previous experiment, he concluded that the factors responsible for the
immunity are manifested between 20 and 25 days. Lang's work was criticised by
Dawes and Hughes (1970) on the grounds that he did not include the results
obtained from all the mice which had received the two immunizing infections before
challenge. However, Lang and Dronen (1972) again observed significant immunity
in mice harbouring natural infection prior to challenge. Harness, Doy and Hughes
(1977) did not find any significant decrease in the worm burdens of mice that had
received a 3-week sensitizing oral infection of 2 metacercariae which was
terminated by an anthelmintic prior to challenge. However, they did observe that
significantly more flukes reached the liver 2 days after challenge in the sensitized
mice.
2.2.1.3 Rabbits
Healy (1955) reported that in rabbits that had been infected with 50
metacercariae 60 days prior to an oral challenge there were no decrease in fluke
burdens, although there were reduction in the size of challenge flukes recovered.
However, Ross (1966) observed that in 4 rabbits that were each challenged with 50
metacercariae 24 weeks after a primary infection of 75 metacercariae, there was a
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reduction in the number and size of challenge flukes recovered. However, there was
much individual variation.
The effect of a primary infection on a subsequent challenge infection in
rabbits was also investigated by Kendall, Hebert, Partiff and Pierce (1967). They
observed that fewer flukes were recovered from a challenge infection of 20
metacercariae in rabbits with a 12-week-old primary infection of 10 metacercariae.
However, these authors derived their conclusion from consideration of the number
of flukes recovered when the primary and challenge infections were given
separately.
Kendall and Sinclair (1971) confirmed that a primary infection did not
engender resistance to a challenge infection in rabbits, but that termination of the
primary infection with an anthelmintic 2 days before challenge resulted in a
significant decrease in challenge fluke recovery. They attributed this decrease to the
effect of the anthelmintic. Conversely, Bolbol, Hammond and Sewell (1978) found
no reduction in the number of flukes recovered from rabbits challenged with 100
metacercariae 4 weeks after the removal of a primary infection of either 100 or 500
metacercariae. However, a significant decrease was obtained in rabbits that had two
similar previous infections and treatments before challenge.
Fortmeyer (1973) found that rabbits that had each received an oral
sensitizing dose of 50 metacercariae 28-263 days before an oral challenge of 50-150
metacercariae showed considerable reduction in challenge fluke burden. Fortmeyer
(1974) again demonstrated that intraperitoneal infection of rabbits with 20 to 30
metacercariae 42 days before an oral challenge of 50 metacercariae did not result in
immunity but that a marked immunity was produced when the interval between
infection and challenge was increased to 94-155 days.
2.2.1.4Sheep
Sinclair (1962) found that a group of sheep given four doses of
metacercariae developed more severe anaemia, showed a lower rate of liveweight
10
gain but had similar fluke burden as a comparable group given the same number of
metacercariae in a single dose. The findings of Boray (1967) also demonstrated that
a 12-week-old primary infection of 200 metacercariae in sheep did not cause any
decrease in fluke burdens from a challenge infection of 200 or 4000 metacercariae
given 12 weeks later.
Sinclair (1970) studied the pathogenicity of F. hepatica after reinfection
with 500 metacercariae in two groups of lambs, one of which had received daily
injections of corticosteroid during the initial infection. Evidence of acquired
resistance to reinfection was demonstrated in both groups by the recovery of fewer
but larger flukes. However, there was considerable individual variation which
precluded the demonstration of any statistical significance.
The role of the developmental stages in the resistance of sheep to reinfection
was investigated by Sinclair (1971a). Comparing the development and pathogenicity
of F. hepatica in previously uninfected sheep and in sheep in which a four-week-old
infection of 300 metacercariae had been terminated by anthelmintic treatment 5
weeks prior to challenge, he observed a delayed onset of anaemia and later
appearance of haemorrhagic lesions in livers of reinfected sheep. He concluded that
the flukes remained longer in the livers of the reinfected sheep than in controls and
that this retardation was a measure of resistance even though fluke recoveries were
similar in both groups.
Sinclair (1973) confirmed these results in a study in which he again
compared the development and pathogenicity of F. hepatica in three groups of
sheep. Temporary retardation of development of flukes derived from the challenge
infection was seen in the group that had been treated to eliminate a nine-week-old
primary infection and in the group that had previously received five one-week long
drug-abbreviated infections. However, the total recovery of flukes from both of
these groups were similar to controls.
11
The results of Sinclair (1971a, 1973) were also supported by Rushton (1977)
who did not observe any reduction in the worm burdens derived from challenge
infections in sheep that already harboured an 11-week-old primary infection or in
sheep in which a 10-week-old primary infection was removed before challenge.
However, the reinfecting flukes had temporary retardation of growth.
Sinclair (1975) further studied the resistance to pathophysiological effects of
a challenge infection in 3 groups of sheep, one previously unexposed, one exposed
to a 15-week drug abbreviated infection of 1000 metacercariae, and the third
exposed to five one-week drug abbreviated infections of 200 metacercariae. He
found no evidence that previous infection conferred resistance to the
pathophysiological effects of a challenge infection as both challenge groups showed
earlier and greater peaks of eosinophils and a more gradual but persistent rise in
glutamate dehydrogenase. In addition, there were no differences in fluke burdens of
the three groups. Sinclair considered that this showed that the immune response in
repeatedly infected sheep is ineffective in protecting them from challenge.
Sandeman and Howell (1981) were also unable to demonstrate resistance to
reinfection in sheep.
2.2.1.5 Cattle
The ability of cattle to acquire resistance to reinfection has been
demonstrated by many workers (Ross, 1966; Boray, 1969; Doyle, 1971). However,
Ross (1967) found that 3-month-old calves given an infection of 200 metacercariae
three weeks before challenge with 300 metacercariae had no significant reduction in
the total numbers of flukes recovered. However, a significant reduction in total
fluke burden was obtained when the challenge infection was given 18 weeks after
the primary infection. Elimination of a primary infection with anthelmintic does not
interfere with the ability of cattle to acquire resistance to reinfection as Boray
(1967) reported that eliminating a primary infection 3 weeks before challenge still
resulted in a reduction of about 78% in fluke burden in previously infected steers.
Previously infected steers also showed fewer clinical signs, lower faecal egg output
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and a short patency in the challenge infections. Armour, Dargie, Doyle, Murray,
Robinson and Rushton (1974) and Kendall, Sinclair, Everett and Partiff (1978) were
also of the opinion that resistance in cattle persists after the elimination of a primary
infection. Doyle (1973) found a relationship between the duration of the primary
infection and the subsequent development of the acquired immunity. He observed a
significant resistance in calves challenged after 12 but not in others challenged after
7 weeks of a primary infection of 750 metacercariae. He excluded the possibility of
the resistance being due to physical factors such as the degree of fibrosis or
chollangitis. Doy and Hughes (1984) also agreed that the duration of the primary
infection influences the degree of acquired resistance but contrary to the opinion of
Doyle (1973), these authors believed that physical barriers in the livers of infected
cattle could not be ruled out as a mechanism of resistance to reinfection.
2.2.2 Stimulation of Resistance by Implanting Flukes
Protective immunity has generally been found to be best stimulated by living
parasites and it is thought that the antigens responsible for this immunity are
released by the parasites during their development in the host (Rickard and Bell,
1971a, b, c). Many attempts have been made to stimulate immunity to infection with
various helminths by implanting the particular parasite in a site different from its
normal predilection site in the host so that they can release antigenic metabolic
products without causing significant pathological changes. Rickard and Bell
(1971b, c) explained that when activated embryos of Taenia taeniaformis and
Taenia ovis contained in membrane diffusion chambers were intraperitoneally
implanted into rats and lambs respectively, the "diffusible functional antigens" thus
produced stimulated a high degree of resistance to subsequent challenge.
Eriksen and Flagstad (1974) reported that there was a 50% reduction in the
fluke burden in rats that received subcutaneous implantation of four adult flukes 3
weeks before an oral challenge. In addition, the percentage of liver necrosis was
approximately 50% lower in the implanted rats. Similarly, Anderson, et al. (1975)
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observed a 34% reduction in the challenge fluke burdens of rats that were sensitized
by subcutaneous implantation of one adult fluke before oral challenge. Hughes,
Anderson and Harness (1976) observed that sensitization of rats by subcutaneous
implantation of one adult fluke 14 days prior to intraperitoneal challenge with one
adult fluke resulted in the deaths of 23% of the challenge flukes while stimulation
by oral infection resulted in the deaths of 71% of adult flukes intraperitoneally
implanted as a challenge. Hughes, Harness and Doy (1981) reported that
intraperitoneal sensitization of rats with 10 newly excysted juveniles, six or 8 14-
day-old flukes 3 weeks before intraperitoneal challenge with adult flukes led to the
death of almost all the challenge flukes. The study of Rajasekariah and Howell
(1978) lends credence to the ability of young flukes to confer protection. These
authors revealed that there was a significant protection in rats that had received
subcutaneous implantation of 40 metacercariae or four 4-week-old F. hepatica two
weeks before an oral challenge. However, they did not find any protection in rats
sensitized by implantation with two adult flukes. In contrast, Haroun et al. (1980a)
did find significant protection in rats that had received subcutaneous or
intraperitoneal implantation of 2 adult flukes 2 weeks before an oral challenge. This
protection was maintained even when the immunising flukes were removed by
treatment before challenge. In addition, the immunised rats showed only little
evidence of liver damage.
Lang (1974a) implanted 12, 14, 16, 18, 20 and 24 day-old F. hepatica
intraperitoneally into groups of mice. The implanted mice were challenged orally
when the transferred flukes had a total age of 40 days. A significant reduction in the
fluke burdens was obtained in mice immunized with 12, 14, 16, and 18 day-old
worms and in mice harbouring a natural infection before challenge. The author
presumed that flukes older than 20 days do not arouse immunity or that the duration
of the fluke's migration in the liver had an effect on it's ability to stimulate
immunity. Lang and Dronen (1972) had earlier demonstrated protective immunity in
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mice that had received an intraperitoneal implantation of 8 or 16 day-old flukes and
challenged when the implanted flukes had a total age of 40 days.
Ross (1967) implanted 6-week-old flukes into the gluteal muscles of 6
rabbits, a lamb and a calf which had already received 5 subcutaneous injections of
whole fluke homogenate. When these animals together with a group of animals that
had received the whole fluke homogenate but not the implant and a control group
which had received neither the homogenate nor the implant were concurrently
challenged, there was no significant difference in the numbers of flukes recovered
from the vaccinated and non-vaccinated groups although the vaccinated group
(which had received the homogenate and the implant) had fewer flukes. A group of
sheep in which 6-week-old flukes were similarly implanted in the intercostal
muscles preceding challenge was also not protected.
2.2.3 Transfer of Immunity by Vaccination With Irradiated
Metacercariae
Thorpe and Broome (1962) reported that in rats that were orally vaccinated
with metacercariae irradiated at 2.5 kilo-roentgens 7 or 11 weeks before an oral
challenge there was evidence of a significant immunity with a reduction of
approximately 50% in worm burden. Although this result was criticised by Dawes
and Hughes (1964) on the basis that the authors measured the degree of immunity
by comparing their results to a "theoretical control group fluke burden", the findings
nonetheless gained support from the work of Corba, Armour, Roberts and Urquhart
(1971) and Armour and Dargie (1974). The former authors reported significant
protection of 80% against oral infection in rats vaccinated with 3 weekly doses of
metacercariae irradiated at 2.5 Kr but the latter authors obtained a much lower
protection level (56%) in rats vaccinated with metacercariae that had been irradiated
at 3 Kr. Hughes, Hanna and Symonds (1981) observed that sensitization of rats with
a single oral dose of F. hepatica metacercariae irradiated at 3-8 Kr did not give
significant protection against an intraperitoneal challenge with 3 adult flukes.
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Hughes, Doy, Burden and Oldham (1982) demonstrated that rats sensitized for 3
weeks by a single oral dose of F. hepatica metacercariae irradiated at 3 Kr were
significantly protected as demonstrated by a significant decrease in the fluke
burdens recovered 48 hours after challenge. Sensitization using metacercariae
irradiated at 4 Kr did not give significant protection against challenge.
Mice sensitized with F. hepatica metacercariae irradiated at 2-4 Kr (Hughes,
1962) or 3 Kr (Dawes, 1964) did not develop any significant resistance to a
subsequent oral challenge. However, Harness, Hughes and Doy (1976) found that
sensitization of mice for 3 weeks by one dose of F. hepatica metacercariae
irradiated at 3.8 Kr led to significant (40%) decrease in the worm burden recovered
48 hours after challenge. In contrast, in a similar experiment, Harness et al. (1977)
did not find a significant decrease in the fluke burdens of sensitized mice examined
12 or 14 days after challenge. They considered that the juvenile flukes resulting
from the challenge infection migrated more quickly from the peritoneal cavity of
previously sensitized mice and that this quicker migration may be due to the host's
immune response in the peritoneal cavity or to "substances" leaking from the liver
tissue already damaged by the sensitizing infection.
Sheep vaccinated with three doses F. hepatica metacercariae irradiated at 20
Kr were not significantly protected from a challenge infection (Dargie, Armour,
Rushton and Murray, 1974). A similar observation was made by Campbell, Gregg,
Kelly, Dineen (1978). However, Agadir, Haroun and Gameel (1986) reported
significant protection against challenge in sheep sensitized 8 weeks before challenge
with metacercariae of F. gigantica that had been irradiated at 3 Kr.
Boray (1967) reported that cattle immunized with 3 doses of F. hepatica
metacercariae irradiated at 20 Kr 3 weeks before an oral challenge of 5000
metacercariae were not significantly protected although they showed fewer
pathological changes in the liver. However, Armour et al. (1974) found a reduction
of 30% in the fluke burdens in a group of cattle challenged 4 weeks after
vaccination with two doses of metacercariae of F. hepatica irradiated at 3.5 Kr. A
reduction of 70% was found in the group challenged 8 weeks after immunization.
Nansen (1975) reported that in calves that had been vaccinated with two doses of
1500 F. hepatica metacercariae irradiated at 3 Kr prior to their exposure to natural
infection, there was a decrease of 71% in the fluke burden. Significant levels of
protection (65-98%) have also been reported in calves that had received one or two
doses of F. gigantica metacercariae irradiated at 3 Kr (Bitakaramire, 1973) or 2 Kr
(Younis, Yagi, Haroun, Gameel and Taylor, 1986) 8 to 14 weeks before challenge.
In calves challenged 4 weeks after sensitization only 18% protection was seen
(Younis et ah, 1986).
2.2.4 Stimulation of Immunity by Somatic Fluke Extracts
The use of fluke extracts or fractions of such preparation for vaccination
against fasciolosis have yielded conflicting results in different hosts. In most cases
the results of such vaccination mirrors the natural ability of the host to develop
resistance.
Hughes et al. (1981) did not find any protection in rats that had received two
intramuscular injections of 0.2 ml of adult fluke somatic antigen three weeks before
receiving an intraperitoneal challenge with 2 adult flukes. Similarly, Burden,
Harness and Hammet (1982) were unable to demonstrate resistance in rats that had
received a subcutaneous injection of 500 pg fluke protein from 14, 16 or 17 days
old flukes. Although Oldham and Hughes (1982) did not find resistance in rats
sensitized with adult fluke extract in Freund's adjuvant by the subcutaneous and
intramuscular routes, rats sensitized with the antigen by the intraperitoneal route had
significantly lower fluke burdens whether the extract was presented in Freund's
incomplete adjuvant alone or in Freund's incomplete adjuvant with Bordetella
pertusis (Oldham, 1983). However, Yoshihara, Nakagawa and Suda (1985) reported
a 74% reduction in the number of flukes recovered from the liver of rats that were
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given two doses (intramuscular and subcutaneous) of a metacercarial extract
containing 400 fag of protein two weeks before an oral challenge. Rats immunized
with the same doses of adult extract had a 40% reduction in fluke burdens.
Lang (1976) was unable to confer resistance to infection in mice following
intraperitoneal injection of a homogenate of 16-day-old flukes. However, Lang and
Hall (1977) did appear to stimulate resistance in mice that had received one or two
intraperitoneal injections containing 500 pg of a somatic preparation obtained by
sonic disruption of freshly collected 16-day-old flukes. These vaccinations resulted
in 86 and 82% reduction in worm burdens respectively. In contrast to these results,
Chapman and Mitchell (1982a) found no significant resistance in mice that had been
sensitized with 3 subcutaneous doses of sonicated newly excysted juvenile or 2
doses of sonicated 16-day-old flukes before challenge although the vaccination did
lead to lower mortality rates. Hillyer (1985) vaccinated mice with the
FasciolatSchistosoma cross reactive antigen, so called Fhsm(lll) isolated from
adult F. hepatica. The immunization conferred 69-78% protection. Immunization
using crude adult F. hepatica extract conferred a protection of 15-31% on recipient
mice.
Kerr and Petkovich (1935) immunized 7 rabbits with nine 1 ml doses of
intraperitoneal injections of a 1% suspension of adult flukes five weeks before an
oral challenge with 13 metacercariae. The mean number of flukes recovered from
the immunized group was 2.1 as compared to a mean of 8.3 recovered from the non-
immunized controls. However, Urquhart, Mulligan and Jennings (1954) questioned
the significance of these results on the basis of the small number of animals used.
These latter authors were unable to find resistance in rabbits immunized with three
intramuscular doses of alum-precipitated protein extract prepared from a crude adult
fluke homogenate, apart from evidence of retarded development of the flukes
recovered from the immunized rabbits. As in the results of Urquhart et al. (1954),
Healy (1955) found no evidence of resistance against reinfection in rabbits
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vaccinated with whole fluke extracts containing large amounts of polysaccharides
but no proteins or lipids. Ross (1967) found no resistance in rabbits sensitized by
two subcutaneous injections of homogenate of 6-week-old flukes three weeks before
challenge. However, the findings of Sinclair and Joyner (1974) were similar to those
of Kerr and Petkovich (1935). They reported that in rabbits sensitized by both an
oral primary infection and intravenous injection of an adult fluke extract there was
50 to 75% reduction in the fluke burdens which developed from a challenge
infection. This significant protection was not achieved when rabbits were sensitized
only with the fluke extract.
Ershov (1959) reported that only 10-25% of sheep vaccinated with a fluke-
antigen complex containing 60% polysaccharide and 30 to 40% albumen developed
a solid resistance, while the rest only showed reduced susceptibility. However, this
immunity was short-lived as no resistance was found in any vaccinated sheep
infected 45 days after vaccination. Absence of resistance was also reported by Ross
(1967) in a lamb and a calf vaccinated with 5 subcutaneous injections of whole
fluke homogenate, but Hall and Lang (1978) reported protection of 90.6, 98 and
99% in calves sensitized by a single subcutaneous dose of sonicated 16-day-old
flukes for 38, 100 and 200 days respectively. Hillyer, Haroun, Hernandez and Soler
De Galanes (1987) also achieved a 55% reduction in fluke burdens in cattle that
were each immunized with 1 mg of a FasciolatSchistosoma cross reactive antigen 7
weeks prior to an oral challenge.
2.2.5 Stimulation of Resistance by Metabolic Products
The metabolic products of helminths cultured or maintained in vitro have
often been used in attempts to stimulate immunity against these parasites (Soulsby,
1957, Urquhart, Jarrett and Mulligan, 1962).
Rats have been successfully vaccinated using the immune complex formed
by culturing metacercariae in immune or hyperimmune homologous serum (Howell,
1979; Howell and Sandeman, 1979) but not by culture products obtained from 48-
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hour or 14-day in vitro cultivation of newly excysted juvenile (Davies, Rickard,^md
Hughes, 1979). Rajasekariah et al. (1979) reported that a degree of resistance
comparable to that seen following a low-dose oral infection could be induced in rats
by subcutaneous injection of ES products (1.6 mg) harvested from 4-week-old but
not from 8-week-old F. hepatica. Burden and Hammet (1980) did not observe any
resistance in rats sensitized on days 0 and 12 by subcutaneous injection of
unembryonated or macerated F. hepatica eggs or ES products from adult flukes 2
days before an oral challenge. However, the flukes recovered from the rats
vaccinated with ES products were smaller than those from the controls. Analogous
results were obtained by Burden et al. (1982). These authors injected 500 pg of ES
proteins from 16-day-old flukes subcutaneously and intraperitoneally into rats 3
weeks before an oral challenge of 20 metacercariae and were unable to demonstrate
any significant protection. The authors also revealed that subcutaneous injection of
rats on days 0 and 14 with concentrated incubation medium (containing 1.6 mg
protein) from 10 or 13-day-old flukes caused slight but insignificant reduction in
fluke burdens resulting from an oral challenge given two weeks after the last
immunising dose.
Lang (1976) used metabolic products from 16-day-old F. hepatica
maintained in medium 199 for various periods of time as a vaccine against F.
hepatica in mice. A single intraperitoneal injection of medium in which 40 16-day-
old flukes had been maintained (at 150 pi of medium per fluke) for 4 hours and
which contained 160 pg of protein, failed to stimulate resistance in recipient mice,
although host mortality was significantly lowered. On the other hand, four
sequential vaccinations (total dose of 1920 pg per mouse) using worm incubate
produced over a 24-hour period protected 75% of the mice from challenge and
reduced the worm burden by 83.3%. Lang and Hall (1977) vaccinated groups of
mice with incubation media produced over various periods of time and found that
the highest resistance was shown by the group vaccinated with medium collected
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between 12 and 24 hours after incubation commenced. As the injection of medium
collected at 24 hours produced only marginally significant immunity, the authors
suggested that qualitatively different antigens were produced between 12 and 24
hours. Contrary to the results of Lang (1976) and Lang and Hall (1977), Lehner and
Sewell (1979) found that vaccination of mice with incubation medium from 16-day-
old flukes (375 pi ofmedium/fluke) did not result in protection. Rajasekariah et al.
(1979) were also unable to demonstrate protection in mice that had been sensitized
intraperitoneally or intramuscularly with ES products from 4-week-old F. hepatica
14 days before challenge.
Healy (1955) attempted to vaccinate rabbits against fasciolosis using pooled
regurgitated caecal contents of adult flukes. No resistance was found in the
vaccinated rabbits 60 days after challenge. However, some of the flukes recovered
from the vaccinated rabbits showed retarded development and produced abnormal
eggs. Similarly, Lehner and Sewell (1979) did not observe resistance in rabbits
sensitized four times with varying doses of metabolic products from immature and
mature adult F. hepatica maintained in a recirculating system for 7 days. They did
observe however that flukes recovered from the vaccinated rabbits were slightly
smaller in size.
2.2.6 Passive Transfer of Immunity by Serum Injection
2.2.6.1 Rats
Corba et al. (1971) reported that intraperitoneal injection of naive rats with 4
ml of homologous serum obtained from rats 8-10 weeks after infection of 10 F.
hepatica metacercariae did not protect against challenge. However, Armour and
Dargie (1974) later demonstrated the ability of homologous and heterologous serum
to confer protection on recipient rats. They found that naive rats intraperitoneally
injected on the day of challenge and again two days later with 10 ml of serum
obtained from infected rat, had an overall reduction of 71% in their fluke burdens
while those injected with similar volumes of serum from sheep or cattle with 12-14-
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week-old primary infection of 1000 metacercariae had reductions of 79 and 66%
respectively. The authors demonstrated that the volume of serum influenced the
degree of protection. Thus, the mean number of flukes recovered from rats given 0,
5, 10 or 20 ml of serum were 3.6, 2.0, 1.4 and 0.6 respectively. Hayes et al. (1974c)
did not obtain a similar relationship in their studies. They found all groups of rats
that received 1, 2.5 or 5 ml of homologous antiserum at the time they were
challenged had significant reductions in their fluke burdens. This protective effect
was removed by heat treatment and adsorption with live flukes. Howell, Sandeman
and Rajasekariah (1977) demonstrated that a significant protection was conferred on
naive recipients by serum from donor rats that had received primary and challenge
infections of F. hepatica metacercariae. In addition, the authors observed that
exposure of newly excysted juveniles to immune rat serum resulted in complete loss
of viability. Rajasekariah and Howell (1979) observed that, while serum from rats
that had experienced 10-15 weeks of infection with 5 metacercariae did not protect
recipient rats from challenge, serum from similar rats with a secondary infection of
30 metacercariae conferred significant protection to the recipients. The ability of
serum from infected rats to confer protection on recipients is also supported by the
results ofHaroun et al. (1981) and Pfister, Turner and Wedrychowicz (1984/85).
There is a relationship between the ability of immune homologous serum to
confer protection and the time at which the serum is administered to recipient rats.
Hayes et al. (1974c) observed that antiserum given 2, 4, 6 or 8 days after challenge
did not result in significant resistance, although there appeared to be a slight
protective effect following transfer 2 or 4 days after infection. Similarly, Chapman
and Mitchell (1982a) observed that no protection was conferred when the serum was
given 14 days after infection. Antiserum collected from rats with chronic infections
had no protective effects on recipients (Howell et al., 1977).
Chapman and Mitchell (1982a) established that heated immune rat serum
was as effective as unheated serum. The authors deduced that the heat-labile serum
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components such as IgE and complement were not responsible for serum-mediated
transfer of protection in rats. This observation on the effect of heat on immune
serum was a direct contrast to that made earlier by Hayes et al. (1974c).
Immune ovine serum has been shown to confer significant protection on
recipient rats. Armour and Dargie (1974) obtained a significant reduction (66%) in
the fluke burdens of rats that had received antiserum obtained from sheep infected
12 to 14 weeks previously with 350 F. hepatica metacercariae. The ability of ovine
antiserum to confer protection in recipient rats was also demonstrated by Mitchell,
Armour, Ross and Halliday (1981) and Sandeman and Howell (1981). The latter
authors reported that significantly fewer flukes were recovered from rats into which
juvenile flukes were injected after they had been cultured in immune serum obtained
from sheep 10 weeks after a primary infection. Serum obtained 12 weeks after
infection had no effect on juvenile flukes.
Rats have also been protected by serum obtained from infected rabbits
(Haroun et al., 1981) and cattle (Corba et al., 1971; Haroun et al., 1981) but not
mice (Chapman and Mitchell, 1982a).
Armour and Dargie (1973), demonstrated that IgG fraction was involved in
the transfer of this passive immunity. Rats that were injected with this fraction had
significant (55%) protection. Such protection was not found when IgM was
transferred. Dargie, Armour and Urquhart (1973) also described transfer
experiments using fractions of immune serum from rats and cattle and indicated that
IgG was a pre-requisite for successful protection.
2.2.6.2 Rabbit
Baalawy (1975) transferred 1 to 10 ml of concentrated homologous immune
serum to rabbits at the time of challenge and 2 days later. The immunization
conferred a protection of 25 to 40% against an oral challenge with F. gigantica. The
protection conferred by the serum was directly related to the infecting dose of
metacercariae given to the donor rabbits. Thus, the highest protection (40%) was
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obtained in rabbits which received 10 ml of serum obtained from rabbits infected
with 30 metacercariae. The same dose of concentrated immune serum from goats
infected with 250 metacercariae also conferred the highest (78%) resistance. This
author concluded that for immune serum to be effective, it must be given in high
concentration, in a sufficiently high dose and it must be collected while the young
flukes are still in their migratory phase. This author did not indicate how
"concentrated" the serum should be to be effective. Haroun et al. (1981) observed
significant protection in rabbits that had received heterologous rat or bovine
antiserum but not homologous antiserum at the time of challenge.
2.2.6.3 Mice
Lang (1974b) found that when 12, 16, 18, 20 or 24-day-old flukes were
incubated in homologous immune serum and intraperitoneally transferred to
recipients mice, there was a significant reduction in the worm burden which resulted
from a subsequent oral challenge when compared with that from mice implanted
with flukes incubated in heat-inactivated immune serum, normal serum, medium
199 or buffered saline. In contrast to the result of Chapman and Mitchell (1982a)
this author observed that effect of immune serum was significantly decreased by
heat inactivation at 56°C for 30 minutes, and suggested that complement was
necessary for the antigen-antibody reaction involved in this type of protection. The
significant reduction in the length of flukes recovered from mice implanted with
flukes incubated in inactivated immune serum led the author to suggest that the
effect is not only due to IgG, as had been suggested by Dargie et al. (1973) but also
to IgM. The IgM, they suggested, may combine with a cell membrane antigen,
activating complement to produce immune lysis of cells and death of flukes.
Lang (1976) incubated 16-day-old F. hepatica in immune serum from mice
which had been injected with ES products from 16-day-old flukes or in immune
serum from mice with 25-day-old infections prior to intraperitoneal transfer to
recipient mice. At necropsy, it was found that in both cases the immune serum had a
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protective effect, shown by a significant decrease in both fluke recovery and host
mortality. Serum from mice which had been injected with a somatic antigenic
preparation or from those with 100-day old infections had no such effects. Hence,
the author suggested that those ES antigen(s) which stimulate the production of
antibodies harmful to the flukes are produced only by immature flukes. Following
the observation that incubation of young flukes in antiserum from mice with a
mature infection resulted in earlier migration after transfer, the author suggested that
mature flukes also produce the antigen concerned but that their location in the bile
ducts does not allow these antigens to have sufficient contact with the host to
maintain immunogenic levels. However, Chapman and Mitchell (1982a) indicated
that serum from infected mice did not protect homologous recipients against an oral
challenge.
2.2.6.4 Sheep and cattle
Although sheep are naturally unable to develop resistance to reinfection,
serum from infected sheep has been shown to confer protection in some recipient
hosts. Serum transfer experiments using homologous immune ovine serum are rare.
Armour and Dargie (1973) reported that sheep could be protected against F.
hepatica if large volumes of immune serum are used. They found that 400 ml of
immune serum injected intraperitoneally resulted in 80% protection against a
challenge of 750 metacerciae.
In an experiment involving the transfer of 2400 ml of hyperimmune serum
from a donor calf with a mature F hepatica infection into the peritoneal cavity of
recipient calves simultaneously challenged with 1000 metacerciae, Corba et al.
(1971) did not find significant protection. However, Armour and Dargie (1973)
reported that cattle could be protected if larger volumes of serum were given. They
reported that immune serum administered intraperitoneally to cattle at 3.6L/250 Kg
body weight resulted in 99% protection against an oral challenge of 1000
metacercariae.
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Transfer of immunity by serum is traditionally taken as evidence of antibody
involvement (Jones, Edwards and Ogilvie, 1970). The mechanism for this protective
effect are not entirely known. Doy et al. (1978) and Doy and Hughes (1982)
observed immune adherence of peritoneal cells onto newly excysted F. hepatica in
vitro in the presence of immune serum but this did not affect their viability when
subsequently transferred into naive rats. By contrast, Davies and Goose (1981)
observed that newly excysted juvenile F. hepatica injected into previously
sensitized rats were rapidly coated with peritoneal cells, which were releasing
peroxidase and other lysosomal enzymes onto the worms, which were eventually
killed. Furthermore, Eckblad, Woodard and Ogilvie (1981) detected, in vitro,
structural damage to the tegument of juvenile (16-day-old) flukes caused by serum
antibodies from a fluke-infected calf. Moloney and Denham (1979) observed that
new born larvae of T. spiralis exposed to immune serum before infection of mice
had significant decrease in infectivity, while new born larvae exposed to adsorbed
immune serum were unaffected. They suggested that exposure to immune serum in
vitro makes the larvae chemotactic to some type of "killer cell" and that this cell
prevents them from infecting the muscle.
2.2.7 Transfer of Resistance by Sensitized Cells
Lang, Larsh, Weatherly and Goulson (1967) demonstrated protective
immunity to F. hepatica in mice that had received intraperitoneal injections
containing peritoneal exudate cells obtained from mice harbouring 35-week-old
infections. Significantly fewer flukes developed following a challenge infection of
the vaccinated mice, and they had a more rapid cellular (polymorphonuclear)
response. The authors suggested that a delayed sensitivity reaction had taken place,
resulting in allergic inflammation, rapid migration of the young flukes and death of
some of the flukes.
Intraperitoneal transfer of lymphoid cells from infected rats to syngeneic
recipients has been shown by several authors to give significant protection against
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an oral challenge infection (Corba, et al., 1971; Armour and Dargie, 1974;
Rajasekariah and Howell, 1979). However, Pfister et al. 1984/85) did not observe
any protection in rats given lymphoid cells obtained from rats infected with F.
hepatica for six weeks. Rajasekariah and Howell (1979) found that lymphoid cells
obtained from splenic, mesenteric and hepatic lymph nodes from immune and
hyperimmune donor rats conferred protection on recipients examined at 4 weeks but
not at 8 weeks after challenge although they did not mention the number of cells
transferred. The authors agreed that this was a conflicting result and suggested it
might have arisen due to small numbers of experimental animals. Mitchell et al.
(1981) obtained a 55.6% reduction in the fluke burdens in rats that had been
intraperitoneally injected with leucocyte lysates obtained from infected rats although
they did not mention the number of cells in the lysate.
Baalawy (1975) obtained a 53.5% protection against oral challenge in rabbits
immunized with 2 x 109 lymphocytes from infected homologous donors.
Homogenates of lymph nodes and spleen from donor sheep infected with F.
hepatica for 8 weeks did not reduce the number of flukes which developed after
challenge although some retardation in fluke development was observed in the
recipient sheep (Sinclair, 1971b).
Corba et al. (1971) obtained significant protection in a calf that had received
lymphoid cells obtained from its infected monozygous twin.
The basis of transfer of resistance by sensitized cells is not well understood.
Eosinophils (Doy et al., 1978; Milbourne and Howell, 1990), neutrophils and
macrophages (Bennett, Hughes and Harness, 1980) have all been implicated as
effector cells in resistance to F. hepatica in sensitized rats.
Eosinophilia, is a major hallmark of many helminth infections (Butterworth,
1984), especially of those with tissue-invasive stages (Befus and Bienenstock,
1982). Milborne and Howell (1990) demonstrated that rats and mice infected with
F. hepatica or injected with ES products of adult fluke showed a rapid increase in
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peripheral eosinophil as well as increase in the percentage of bone marrow
proeosinophil cells. In rats infested with intestinal worms, localized accumulation of
eosinophils in the lamina propria and submucosa may arise from chemotactic factors
released following mast cell/IgE-worm antigen interaction, localized T-cell-
mediated eosinophilopoesis and chemoattractants released from the worms
themselves (Moqbel and MacDonald, 1990).
Lang (1967; 1968) suggested that sensitized lymphocytes may be attracted to
sites of antigen deposition, where they initiate a delayed-type hypersensitivity
reaction which renders the environment unsuitable for the young flukes. During a
primary infection in rats, Keegan and Trudgett, (1992) observed pronounced
eosinophilia in peripheral blood and massive eosinophil infiltration and
degranulation in sections of the infected liver. In addition, peroxidase was present at
the site occupied by the parasite and also on the fluke's tegument. Peroxidase
catalyses oxidation of many substances by hydrogen peroxide and oxidation,
coupled with the participation of halides, markedly potentiates the killing of
metazoan parasites by phagocytes (Letonja and Hammerberg, 1987). The study by
Keegan and Trudgett (1992) also revealed acid phosphatase staining in liver from
rats that had been infected with F. hepatica for 3 weeks, which the authors said was
an indication of the presence of large numbers of activated phagocytes.
Chapman and Mitchell (1982b) showed that immature F. hepatica releases a
papain or cathepsin B-like thiol protease which cleaves mouse, rat, rabbit or sheep
immunoglobulins in vitro. They suggested that this cleavage of immunoglobulin
could render one of the major host defence systems ineffective in the vicinity of the
parasite. Such an evasion mechanism has been postulated for the non-parasitic
Taenia pysiformis (Eisen and Tallan, 1977) and S. mansoni shistosomula (Auriault,
Ouiassi, Torpier, Eisen and Capron, 1980). Auriault et al. (1980) also indicated that
in addition to rendering IgG non-functional, the peptides released by IgG cleavage
inactivate rat macrophages, thus paralysing another host defence system.
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2.3 ANTIGENS OF HELMINTH PARASITES
The variety of different antigens to which the host is exposed during
helminth infections has been classified into four major levels. These are the parasite
stage, the antigenic compartment within the stage, the antigenic components within
the compartment and antigenic epitopes of each particular antigen. The antigens in
any given stage of a parasite can be classified in three compartments, surface,
secretory and somatic (Parkhouse and Harrison, 1989).
The antigens in the first two compartments play important role in the host-
parasite relationship since they form the interphase between the living parasite and
the host's immune response. In particular, antigens in the surface compartment are
the direct target of the host immune responses and components within this
compartment could be important in parasite protection. Thus, purified surface
antigens of the infective larvae of the nematode Trichinella spiralis have been
shown to be protective in mice (Silberstein and Despommier, 1984,1985; Gamble,
1985.). A monoclonal antibody produced against newborn larvae of this parasite has
also been demonstrated to confer passive protection against infection (Ortega-
Pierres, MacKenzie and Parkhouse, 1984). Monoclonal antibodies directed against
determinants on the surface of hatched-activated Taenia saginata onchospheres have
been used successfully in passive protection of cattle against experimental oral
infection (Harrison and Parkhouse, 1986).
The term excretory/secretory product is used to describe material collected
from helminths in vitro and shown to be produced or assumed to be produced in
vivo and an extensive review on the subject was given by Lightlowers and Rickard
(1988). There are various sources of excretory/secretory products. These include
excretory glands and oesophageal glands of several nematode species (Edwards,
Burt and Ogilvie, 1971; Ogilvie, Rothwell, Bremner, Schnitzerling, Nolan and
Keith, 1973), stichocyte cells surrounding the oesophagus in members of the
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superfamily Trichuroidea (Despommier and Muller, 1976; Jenkins and Wakelin,
1977), apical and lateral glands in schistosome miracidia (Hang, Warren and Boros,
1974), scolex of taeniid parasites (Heath, Lawrence, Glennie and Twaalhoven,
1985; Jenkins and Rickard, 1986a,b). In addition, molecules derived from the
tegument or cuticle may make a substantial contribution to the contents of ES
products of parasites maintained in vitro and are probably shed in vivo (Kusel,
MacKenzie and McLaren, 1975; Wilson and Barnes, 1977).
A variety of functions, some of which are apparently protective to the
parasite, have been associated with ES products of helminths. Species of some
nematodes are known to secrete enzymes with acetylcholinesterase activity in vitro
(Edwards et al., 1971; Ogilvie et al., 1973; Bremner, Ogilvie, Keith and Berrie,
1973). The secreted enzymes suppress local peristalsis, thereby allowing the worms
to remain at their predilection sites. In addition the enzyme may also interfere with
or delay worm expulsion by controlling acetylcholine-induced secretion of mucus
goblet cells in the gut. ES products may also have a suppressive effect on
lymphocyte function. For instance, Taenia taeniaformis ES products have inhibitory
effects on lymphocyte function in vitro through induction of suppressor cell
populations (Burger, Rikihisa and Lin, 1986). Similarly, the caecal content of adult
F. hepatica have been shown to be toxic for rat splenic lymphocytes and to inhibit
the binding of rat peritoneal cells to the parasite (Goose, 1978). The transformation
of Schistosoma mansoni cercariae into schistosomula is associated with the release
of certain factors which have been shown to exert inhibitory effects on peripheral
blood mononuclear cell proliferative responses to phytomitogens (Vierra,
Gazzinelli, Kusel, De Souza and Colley, 1986).
The gut associated ES products of adult schistosomes are significant
components of the circulating immune complexes which are known to cause
blockading of antibody-dependent cytotoxicity of eosinophils for S. mansoni
schistosomula. The ES products of T. spiralis has been shown to contain the enzyme
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superoxide dismutase (Rhoads, 1983) and marked differences in variation in
susceptibility of different life-cycle stages of this parasite to in vitro killing by
granulocytes and oxidant-mediated damage are reflected in their superoxide
dimutase content (Kazura and Meshnick, 1984). Co-incubation of the highly
susceptible newborn larvae with oxidant-resistant adult worms resulted in partial
protection of the susceptible newborn larvae.
Ironically, parasite products may sometime have detrimental effects against
the parasite. When surface molecules are released into ES products, it may stimulate
immune responses against the parasite surface. Such potential is suggested by the
demonstration that a monoclonal antibody raised against a 64 kDa antigen present
on the surface of, and released in vitro by, newborn larvae of Trichinella spiralis,
mediates eosinophil killing of larvae in vitro and reduces the infectivity of antibody-
treated larvae in vivo (Ortega-Pierres, et al., 1984).
2.4 "ANTIGENS" OF FASCIOLA SPP
An understanding of the antigenic composition of the various stages in the
life cycle of F. hepatica is of importance to understudy host/parasite interactions
and development of diagnostic assays. A defined sequence in the development of
these antigens seems to occur as the fluke develops. (Sewell, 1964; Sinclair and
Kendall, 1969; Gundlach, 1971).
On its way to the bile ducts, the migrating fluke undergoes both
morphological and physiological changes to its outer tegument or glycocalyx, which
comprises an anucleate surface syncitium bound apically and basally by tubules to
the underlying perikarya or tegumental cells (Threadgold, 1967; 1976). The newly
excysted juvenile has only one type of tegumental cell (Bennett and Threadgold,
1973) referred to as the Type 0 cell. These cells are filled with a single type of
secretory granule, a very dense and thick biconcave disc, 0.22 pm in diameter which
is unlike either of the secretory bodies of the adult cell types and is therefore
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designated as TO granule. The cell also contain occasional masses of crystalline
spine-like material. Between 5 days and 3 weeks the synthesis of TO granules in the
Type 0 tegumental cells gradually declines (Bennett and Threadgold, 1975). The
tegument of the adult fluke is known to be composed of two types of cells, Type 1
and Type 2, both of which lay below the peripheral musculature and are connected
to the surface syncitium. The Type 1 cell metamorphose from the TO cell after
arrival in the liver while the Type 2 cell metamorphose from the embryonic cells in
the parenchyma (Bennett and Threadgold, 1975). The T1 bodies produced by the
T1 cell are spheroidal and electron dense 0.12 pm in diameter, while the T2 bodies
are flattened biconcave disks, 0.20 pm in diameter, with electron lucid contents. The
T1 bodies are thought to serve to replace the surface glycocalyx of F. hepatica as it
becomes complexed with host antibodies during the parenchymal stages of
development (Hanna, 1980a). The synthesis and transportation of T1 bodies has
been investigated by Hanna (1980b). When slices of adult flukes were incubated in
[3H]leucine the T1 tegumental cells showed labelling over the cytoplasm and after
lh incubation labelled T1 bodies were seen free in the cytoplasm of the T1 cells and
in the connecting tubules leading to the surface syncitium. Carbohydrate moities
were added to the proteins in the golgi fields to form the future secretory product
(Hanna, 1976) and the resulting glycoprotein is concentrated and packaged into
spheroidal electron dense bodies known as T1 bodies (Threadgold, 1976). The T2
cell synthesize the T2 bodies, which are flattened biconcave disks, 0, 20 pm in
diameter with electron-lucid contents which are also glycoproteins.
2.4.1 "Antigens" of Newly Excysted Juvenile Fluke (DO)
DO flukes express stage-specific antigens as well as some which are shared
with later developmental stages (Reddington, Wes Leid and Wescott, 1984). Davies
et al., (1979) revealed that infected rats synthesized antibodies against an antigen
derived from DO F. hepatica maintained in vitro. These in vitro culture antigens
were thought to be at least partially stage-specific because, under the cultivation
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conditions used, the flukes did not switch over to the production of adult tegumental
and caecal granules. This line of thought was confirmed by in vivo studies (Hanna,
1979; 1980a) involving monitoring the antibody developing on the surface of
developing flukes. Antisera from sheep and rats that had been infected for 6-7
weeks with F. hepatica reacted strongly with the tegument of young flukes but gave
progressively weaker reactions with older flukes, while antisera from animals
infected for longer than 6 weeks gave strong reactions with adult antigens and
weaker reactions with antigens from young flukes. Yoshihara, Taira and Suzuki
(1981) used immunodiffusion to study the reaction between metacercarial extracts
and antisera from rabbits infected with F. hepatica. They reported two precipitins,
one of which was also detected in extracts of immature and adult flukes. Using this
same technique, Sandeman and Howell (1981) found that at least two juvenile
"antigens" were present in the precipitates formed around juvenile flukes cultured in
immune rat serum. Bennett, Joshua and Hughes (1982) immunized rabbits with
soluble metacercarial extracts and adsorbed the resultant antisera by adult fluke
extracts. By an immunofluorescent technique, they showed the presence of at least
two unique, juvenile-specific antigens in the adsorbed antisera. One of these
antigens was present up to day 4 after infection while the other persisted until 7 days
after infection.
Bennett (1978), however, had been unable to detect any immunofluorescent
labelling on the tegument of DO flukes using antiserum raised in rabbits against a
soluble extract of adult fluke even though reactions were detected on the surface of
other juvenile stages.
Using I25-I lactoperoxidase surface labelling, Reddington and Leid
(unpublished result cited by Reddington, Leid and Wescott, 1984) showed that sera
from infected cattle and goats recognised a minimum of 13 surface antigens in DO
flukes although the values of these antigens were not stated. Lammas and Duffus
(1985) mentioned that iodogen labelling of DO flukes revealed components with
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molecular weights of 10.5, 13, 13.5, 26, 30, 45.5 and 78 kDa as the major
components. Dalton and Joyce (1987) reported the identification, by surface (125I
and galactose oxidase/tritiated sodium borohydride) radio-labelling, that
glycoproteins with weights of about 75, 90, 180 and 200 kDa were specific to DO
flukes (Table 2.1).
2.4.2 "Antigens" of Immature Stages
Thorpe (1965) was the first to show that sections of immature and mature
flukes treated with fluoresceinated globulins from infected rats showed strong
immunofluorescence in the caecal lining, excretory ducts and the cuticle. Moore and
Halton (1976) found that carboxylesterase, acetylcholinesterase, and alkaline
phosphatase were similar in both immature and mature flukes. Antiserum raised in
rabbits against a soluble extract of adult fluke reacted with all but the earliest forms
of the immature fluke. The reaction was strongest with migrating flukes while the
tegument of newly excysted juveniles or of stages recovered 1 and 2 days after
infection from murine livers were not labelled (Bennett , 1978). Sandeman and
Howell (1981) identified two antigens by gel diffusion of an extract prepared from
immature fluke reacted against serum from infected sheep.
Of the seven surface-labelled components that were identified on newly
excysted juvenile (Lammas and Duffus, 1985) that of 13 kDa was not present in 7-
day-old flukes and in 14-day-old flukes there was additional loss of the 26, 30 and
78 kDa components and the appearance of a 32 kDa component (Table 2.1)
Dalton and Joyce (1987) reported that surface-radio-labelled glycoproteins
of 180 and 200 kDa present in DO flukes were not detected in D21 flukes but that
the latter contained four specific components of 70, 85, 94 and 110 kDa (Table 2.1).
Dalton, Tom and Strand (1985) noted that immature (28-day-old) F.
hepatica synthesized more than 30 biosynthetically (35S-methionine) radio-labelled
immunoreactive glycoproteins, of which the major ones released into the culture
medium had molecular sizes of 25-38 kDa. These were reactive with sera obtained
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from rabbits 3 or 9 weeks after infection with F. hepatica. Another major
immunoreactive glycoprotein (260 kDa) released into the culture medium was only
reactive with sera from rabbits with a 3-week-old infection. In contrast, several
synthesized glycoproteins in the molecular size range of 45 to 74 kDa which were
not released into the medium were reactive only with sera obtained 9 weeks after
infection. Irving and Howell (1982) stated that the total excretory/secretory products
of D21 F. hepatica biosynthetically radio-labelled using [14C]leucine,
[14C]isoleucine or [35S]methionine contained three major polypeptides with
apparent molecular weights of 24, 26 and 27 kDa and a less prominent one of 23
kDa. In 14C-leucine and 35S-methionine labelled ES, the 23 kDa band was more
pronounced and the 27 kDa band was less intensively labelled. The three major
proteins were immunoprecipitated by sera from rabbits and sheep immunised with
somatic and ES products respectively (Table 2.1).
Sera from infected rats as well as a monoclonal antibody produced from rats
that had been infected with F. hepatica detected antigens of 30, 32, 41, 58, 70, 91-
94 and 200 kDa in somatic extracts of 3-week-old flukes. Majority of these antigens
contained both phosphorylcholine and non-phosphorylcholine epitopes (Sloan,
Dooge and Joyce, 1991).
2.4.3 "Antigens" of Adult Fluke
The entire mature stage of liver flukes or extracts derived from them, have
been the focal point of many immunological studies. This is most likely due to the
ease of recovery of this stage from infected animals.
2.4.3.1 Surface and somatic "antigens" ofadultflukes
Hillyer (1980) isolated tegumental antigens of adult F. hepatica which gave
a positive immunodiffusion reaction with sera from rabbits and humans infected
with F. hepatica. Fractionation of this antigen by precipitation with ammonium
sulphate resulted in a soluble aqueous phase which detected infection in an ELISA
or Enzyme linked Immunosorbent Assay in rabbits at 2 weeks after infection
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(Hillyer and Serrano, 1986). De Weil, Hillyer and Pacheco (1984) eluted antigens
that resulted from reacting tegument extracts of adult F. hepatica with a CNBr-
sepharose 4B column coupled with IgG from rabbits with a 6-8 week old infection
of F. hepatica. Fractionation of this eluate on sepharyl S 200 column resulted in
three major peaks. Only rabbits immunized with peak 2 (25 kDa) showed strong
precipitin lines when reacted against somatic and surface extracts of adult fluke by
immunodiffusion and immunoelectrophoresis.
Pfister, Daveau and Ambroise-Thomas (1984) fractionated a homogenate of
adult F. hepatica on sephadex G200 and observed that the third (Fhsl) peak showed
the highest ELISA activity. This fraction detected F. hepatica infection in rabbits
after 19 days. However, the authors did not give the molecular weight of this
fraction. Santiago and Hillyer (1986) fractionated a similar homogenate on
sephacryl S-200 and tested sera from infected rabbits, cattle, and humans by western
blots against peaks 3 and 4, which included polypeptides in the 14-45 kDa range.
Antigens with molecular weights of about 11-14, 18-23, 27-28 and 31-33 kDa were
recognised by each of the test sera. The 18-23 kDa antigens were strongly identified
by sera from infected cows but only faintly identified by sera from infected humans
and rabbits. By use of western blotting, Santiago and Hillyer (1988) found that sera
obtained from sheep and cattle 4-6 weeks after infection recognised major
polypeptides with molecular weights of 30-38 kDa in somatic extracts of adult F.
hepatica. Four to five polypeptides with molecular weights ranging from 20 to 25
kDa were detected by sera from infected sheep but only faintly, if at all, by sera
from infected bovids. Three clusters of polypeptides with approximate weights of
56, 64, and 69 kDa were recognised by the bovine sera early in infection but were
not recognised by the ovine sera. Sloan et al. (1991), who probed immunoblots of
somatic extracts of adult F. hepatica with polyclonal (rat) and monoclonal
antibodies, identified antigens with apparent molecular weights of 31, 32, 41, 58,
and 160 kDa.
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2.4.3.2Antigens in the ES products ofadultfluke
Immunodiffusion reactions between a whole metabolic (ES) antigenic
preparation of adult F. hepatica with sera from infected sheep, rabbits and rats gave
three, one and two precipitin lines respectively (Lehner and Sewell, 1980).
Metabolic antigens which had been completely adsorbed with sera from any of the
three infected hosts still gave precipitins reaction with sera from the other two host
species. Following fractionation of the antigenic preparation, sera from all three
species reacted with antigens fractions within 10-25 kDa. Sandeman and Howell
(1981) found that antiserum collected from sheep after 8 or 12 weeks of infection
formed 5 and 6 precipitin lines respectively in immunodiffusion reactions with ES
products from adult flukes.
Sepharyl S200 separation of ES from adult F. hepatica resolved four peaks
(40, 70, 202 and 376 kDa) while sepharose 6 separation resolved 9 peaks with
apparent molecular weights of 2, 3.6, 5.4, 12, 24, 59, 81, 217 and 362 kDa)
respectively. Fractions with molecular weights of 24, 40, 59 and 70 kDa were dot-
ELISA positive (Zimmerman and Clark, 1986). Rivera-Marrero, Santiago and
Hillyer (1988) separated adult fluke ES by gel filtration and eluted two main peaks
containing polypeptides with weights of 12-14, 25-48, 150-160 kDa respectively.
Santiago, Hillyer, Garcia-Rosa and Morales (1986) detected by western
blotting that sera from rabbits infected with F. hepatica for 5-6 weeks identified a
cluster of 7 polypeptides with weights of 23-28 kDa in ES from the adult fluke. Five
additional polypeptides (39, 52, 58, 84 and 120 kDa) were recognised by sera taken
after 6 to 52 weeks of infection. Using this same technique, Hillyer and Soler De
Galanes (1988) showed that sera collected from humans, calves, sheep and rabbits
infected with Fasciola hepatica recognised two antigenic polypeptides of 17 and 63
kDa in the ES of adult fluke. In addition, sera from infected sheep and calves
















































































































































































































































































































































































































Solano, Ridley and Minocha (1991) probed ES from adult F. hepatica with
four monoclonal antibodies produced against adult fluke ES. These monoclonal
antibodies detected antigens of 50 and 53; 160 and 180; 66-93; and 29, 32, 45, 50
and 53 kDa respectively.
Poitou, Baeza and Boulard (1992) reported that antigens with molecular
weights of about 22.5 and 115 kDa were recognised by immunoblotting of antisera
collected at week two from infected rats with ES of adult flukes. They also stated
that antigens of about 37.5, 42.5 and 50 kDa were recognised by sera collected from
four weeks of infection while antigens with molecular weights of about 33 and 60
were recognised by sera collected from week 5 of infection.
Sexton, Millner and Campbell (1991) biosynthetically radio-labelled ES of
adult F. hepatica and reported that the dominant molecules had molecular weights
of between 29-31 kDa. Immunocoprecipitation revealed that a 29-43 kDa antigen
was identified by sera taken from sheep at week 4 after infection. Santiago et al.,
(1986) revealed that immunocoprecipitation using sera from rabbits 3-5 weeks after
F. hepatica infection detected antigens of about 33 and 62 kDa in 35S-methionine-
labelled ES products of adult F. hepatica while sera taken 9 weeks after infection
recognised antigens of 38, 40, and 44 kDa.
CONCLUSION
There is abundant evidence on the ability of some hosts, notably the rat and
cattle, to develop resistance to challenge following a primary infection. The ability
of antiserum from these animals to transfer passive immunity to experimental
animals is suggestive of involvement of humoral antibodies in protection. Sera from
hosts such as sheep which are incapable of developing resistance after a primary
infection have also been shown to confer some degree of protection in passive
transfer experiments. However, the nature of this protection has not been
characterized at the molecular level.
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In addition, the results of several workers have demonstrated that
experimental immunization of animals with ES products of various stages or ages of
this parasite confers significant protection upon recipients. This suggests that
protective serum antibodies may possibly be directed at some ES components. It can
be implied therefore that changes in the ES products of the parasite might have
important implication in its host/pararite relationship. As of now there is no
available report on the sequential study of biosynthetically radio-labelled ES
products of F. hepatica. Yet, molecular characterization of the parasite's ES
products is an important and necessary step towards the identification of possible
protective and or diagnostic components.
The study of Poitou, Baeza and Boulard (1992) involved only the unlabelled
ES products of the adult fluke. The study by Lammas and Duffus (1985)
concentrated mainly on the surface antigens of DO, D7, D14 and adult flukes.
Biosynthetic labelling, unlike surface labelling, affords the opportunity to
study proteins which are actively produced in vitro by a parasite. Any radio-isotope-
labelled components can then be cloned using the mRNA of the particular stage.
The only available reports on biosynthetic labelling of Fasciola hepatica proteins
were those of Santiago et al. (1986) and Sexton et al. (1991), both of which were
done on adult fluke.
This study was therefore designed to characterize ES products of Fasciola
hepatica as it develops in the rat and to characterise components that might be





All experiments were conducted on male Wistar rats purchased as specific
pathogen (helminth) free animals from Bantin and Kingsman. They were aged five
to six weeks at the start of each experiment.
3.1.1 Management
The rats were kept paired in cages with a polypropylene body and stainless
steel top, measuring 380 x 220 x 190 mm. The cages contained a mixture of fresh
wood shavings (BS&S Ltd, Edinburgh) and Okaite spill-dry (Okaite, Edinburgh) as
dessicant. Water and rat and mouse maintenance diet (Labsure) were supplied ad
libitum and the animals were kept at a temperature of between 21°C and 23°C. The
litter was changed three times a week and the lids of the boxes were cleaned every
two weeks.
3.1.2 Infection of Rats With Metacercariae
The required numbers of metacercariae were gently scrapped off the
polythene bag on which they had encysted using a mounted needle. They were then
transferred onto a watch glass containing a few drops of a 1% solution of gum
tragacanth (Boots) using a pipette pre-treated with silicone (ReplecoteR, Hopkin &
Williams, England). A silicone-treated plastic tube fitted onto a 2-ml syringe was
used to administer the metacercariae directly into the stomach of the rat under light
ether (Anaesthetic B.P; May and Baker) anaesthesia.
Three trials were conducted to produce antiserum following the protocol
described in Table 3.1.
40 uninfected control rats were included in each trial to obtain normal rat
serum.
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Table 3.1 Experimental protocol for rats infected to produce antiserum in
the three trials
Metacercariae
Trial No of Dose per Length of







3.1.3 Blood Sampling From Rats
Infected rats were bled on days 0, 14, 28, 42 and were exsanguinated at 56
days after infection. Rats that were used for passive protection trials 2 and 3 were
bled at days 1 and 3 as well.
A small incision was made at the tail of each rat and blood was collected into
vials without anticoagulants.
At the end of each experiment rats were exsanguinated. First they were
deeply anaesthetized with ether and laid in dorsal recumbency. They were then
exsanguinated by external cardiac puncture using a 14G needle. The blood was
placed in sterile Universal bottles.
3.1.4 Preparation of Sera
Vials and Universal bottles containing blood were incubated at 37°C for 1
hour to allow formation of the clot. They were then left overnight at 4°C, followed
by a 30 min centrifugation at 3000 g and 4°C. The serum from each bottle was
carefully decanted into labelled sterile Bijoux bottles, avoiding inclusion of blood
clots, while serum in vials were carefully pipetted off into labelled sterile vials.
3.2 HAEMATOLOGY
3.2.1 Packed Red Cell Volume
Blood was collected from the rats' tails into disposable heparinized capillary
tubes (Camlab Ltd). The tubes were two-thirds filled and sealed at one end with
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Cristaseal (Hawkley, England). The percentage packed red cell volume (PCV) was
determined using a microhaematocrit centrifuge (Haemofuge A, Heraeus Sepatech)
and reader, the tubes being centrifuged for five minutes at 17,000 g.
3.2.2 Differential Leucocyte Counts
Thin blood smears were made on clean microscope slides (Chance Propper
Ltd, England) and air-dried. They were fixed for two minutes in methanol and then
stained for 30 minutes in Giemsa's stain (BDH) diluted 1:10 with distilled water.
The slides were washed with Giemsa's buffer (BDH) pH 7.2 and allowed to air-dry.
Differential leucocyte count were performed on the stained slides by
differentiating a total of 100 cells in successive microscope fields using the xlOOO
magnification on a Leitz Dialux 22 microscope (Leica UK Ltd)
3.3 SHEEP
Two female cross Suffolk sheep were each infected orally with 500
metacercariae of F. hepatica at the age of 18 months (on the 6th of September
1989).
They are maintained in conditions that precluded any accidental infections
with other helminth parasites and fed routinely on hay and commercial concentrates
consisting of sheep nuts and crushed oats (Seafield mill).
3.4 LABORATORY MAINTENANCE OF F. HEPATICA
3.4.1 Culture of Green Algae (Oscillatoria obscura)
Top soil containing as few stones as possible was collected. It was passed
through a 4 mm mesh to remove stones and other debris before being sterilized by
autoclaving at 1 kg/cm2 for 30 min. After cooling, the soil was mixed with 500 ml
of a mineral solution (see Appendix 1) described by Sewell (1973).
The mixture was then smoothed into the bottom of a 104 x 178 mm plastic
box (Stewart Plastic Products) to a depth of about 15 mm, to give a flat surface on
which algae could grow. A small amount of algae from a feeder culture was placed
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in the middle of the box and the whole surface gently sprayed with distilled water.
The boxes were placed in a warm room at 23°C, about 60 mm beneath three 38W
white fluorescent light bulbs (Gro-Lux, Sylvania, Germany). The algal cultures
were gently sprayed with water daily.
3.4.2 Culture of Young Snails
Egg masses from adult Lymnea truncatula were placed onto a fresh algal
culture and kept in the warm room to hatch. After hatching and eventual depletion
of the algae, the young snails were carefully collected using tissue forceps and
transferred onto a fresh algal culture.
3.4.3 Obtaining Miracidia of F. hepatica
Faecal samples were collected by gloved hands directly from the rectum of
the two F. hepatica-infected sheep. A suspension of the faeces in tap water was
made in a clean plastic bowl. The suspension was passed through a nylon coffee
strainer having a pore size of 1 mm and then through a sieve of 106 pm aperture
into one of 53 pm aperture. The eggs retained in the latter sieve were transferred
into 50 ml flasks (Nunclon, Gibco code 1-63371A) and incubated for five days at
23°C; being washed daily with distilled water. The bottles were wrapped in
aluminium foil and kept in the dark for nine days. Miracidia were obtained by
decanting the embryonated eggs in the flasks into a petri-dish and exposing the eggs
to light.
3.4.4 Infection of Snails with Miracidia
Infection of Lymnea truncatula was done as described by Haroun (1979).
The snails were infected when they were 2 to 5 mm in length. Seven to ten
miracidia were pipetted into each of 50 wells of a flat-bottomed polystyrene
microwell plate (Gibco, code 2-62162A) containing 96 (317 pi) wells. The snails
were then placed individually into each of the 50 wells. The plates were then
covered and left for 4 hours at room temperature, after which the infected snails
were transferred onto a fresh algal culture. The infected snails were maintained at
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23°C, being transferred to fresh algal plates as the need arose. Five weeks after
infection the snails were examined under a stereomicroscope to determine if they
contained F. hepatica rediae. Snails that did not contain rediae were separated and
re-examined after two weeks and those showing no evidence of infection at that
time were kept as egg-laying adults.
3.4.5 Shedding of Cercariae and Storage ofMetacercariae
50 snails harbouring mature (6-week or more) F. hepatica infections were
placed in small (120 x 75 mm) polythene bag containing 40 ml of cold (4°C)
distilled water. The polythene bag was placed in a bottle and left at room
temperature. The cercariae were shed as the water warmed up to room temperature.
The snails were removed from the water after about 4 hours and placed on a new
algal plate. The bag containing the cercariae was left at room temperature for 3
days, after which the water was poured off, leaving a few drops in the bag. The bag
was kept in the fridge at 4°C for a maximum period of 3 months until needed. The
discarded water was autoclaved in order to kill any metacercariae that may be
present.
Metacercariae were also purchased from the Central Veterinary Laboratory
(Weybridge) and from Compton Paddock Laboratory (Newsbury, Berks).
3.5 RECOVERY AND STORAGE OF F. HEPATICA FROM INFECTED
RATS
3.5.1 Newly Excysted Juveniles (DO)
Metacercariae were excysted using the method described by Lehner (1977).
On each occassion 1000 metacercariae were gently scraped off the cellophane bag
on which they had encysted. They were pipetted into a sterile petri dish and 25 ml of
a solution of 0.8% w/v NaCl, 0.5% w/v pepsin in 0.05N HC1 was added. This was
followed by incubation for 2 hours at 37°C, after which an equal volume of an
aqueous solution containing 1.0% w/v NaHC03, 0.8% w/v NaCl, 0.4% w/v trypsin
and 20% v/v ox bile was added; this being followed by a further 3 hour incubation
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at 37°C. At the end of the incubation period the petri dish was examined under a
stereomicroscope and, the excysted flukes were pipetted into sterile Universal
bottles containing phosphate buffered saline pH 7.4 (PBS, Sigma, code P 4417).
The bottles were kept in a water bath at 37°C for 20 min to allow the flukes to
sediment. The supernatant was decanted, leaving about 2 ml of fluid which was then
transferred into Eppendorf tubes. The tubes were centrifuged at 22 g for 1 min, after
which the supernatant was pipetted off, leaving the flukes in about 100 pi of sterile
phosphate buffered saline.
3.5.2 Invasive Stages (D1 flukes)
To recover this stage, three rats were each orally infected with 500
metacercariae. The rats were killed 24 hours after infection and invading flukes
were recovered using the method described by Davies and Goose (1981). Ten ml of
warm (37°C) sterile phosphate buffered saline (PBS) was injected into the
peritoneal cavity. A mid-line longitudinal incision was made on the skin from the
promontory of the pelvis to the thoracic inlet. Another incision was made
horizontally along the long axis of the last rib and a third incision was made along
the brim of the pelvis, so that skin flaps were formed. The fascia, muscle and
peritoneum were then cut to expose the viscera. The fluid in the peritoneal cavity
was aspirated into sterile Universal bottles with sterile syringes. The flukes were
then concentrated by sedimentation.
3.5.3 Parenchymal or Migratory Stages (DI4, D28 and D42).
These stages were recovered from the liver using the method described by
Harness, Doy and Hughes (1977). Three rats were each orally infected with 150
metacercariae. They were killed 14, 28 or 42 days after infection and their viscera
exposed as described above. The liver was freed of all its adhesions and was
transferred into a petri-dish containing sterile phosphate buffered saline (PBS,
Sigma, code P 4417) at 37°C. It was then broken up into small (10 mm) pieces by
applying slight pressure with a gloved thumb. The liver suspension was then
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incubated at 37°C for 4 to 6 hours, with periodic examination under a
stereomicroscope for emerging flukes. When a fluke was observed it was pipetted
into a Universal bottle containing warm (37°C) sterile Phosphate buffered saline
(PBS, Sigma code P4417) and kept in a waterbath at 37°C. After the 6 hour
incubation by which time about 80 flukes would have been recovered, the flukes
were washed several times with sterile Phosphate Buffered saline (PBS) under a
sterile hood.
3.5.4 Adult Flukes
Rats were each orally infected with 10 or 20 metacercariae and at D56 of
infection they were deeply anaethetized with ether and exsanguinated. The liver was
exposed as described above. The common bile duct was located, clamped with
artery forceps at its junction with the duodenum and severed. The liver was lifted
and the flukes were then gently expressed from the bile ducts.
Flukes that were not needed for immediate use were washed six times in
phosphate buffered saline, packed into 1 ml cryovials (BDH, 215/0880/02) and
preserved in liquid nitrogen at -196°C .
3.6 HISTOLOGY
3.6.1 Preparation of Histological Section
Sections of liver were fixed in 10% v/v formalin immediately after removal
from the animal. The fixed samples were trimmed, embedded in paraffin wax and
cut into thin 4 pm sections with a microtome by standard methods. Paraffin sections
were stained with haematoxylin and eosin (H&E) stain (Bancroft and Stevens,
1977)
Sections to be differentially stained for eosinophils were washed in water for
30 min and then for 1 min in Harris haematoxylin (Sigma, HHS-16). They were
again washed in Scott's tap water substrate (170 mM MgS04 and 40 mM NaHC03
in distilled water) and then stained for 10 min in Carbol-Chromatrope (10 mM
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Carbol Chromatrope 2R and 100 mM Phenol in distilled water), after which they
were dehydrated in alcohol, cleared in xylene and mounted in synthetic resin
medium (Neil Maclntyre, personal communication).
3.6.2 Scanning Electron Microscopy
Scanning electron microscopy were done by the EM Unit of the Faculty.
Flukes were fixed in 3% glutaraldehyde in 0.1M sodium cacodylate buffer
pH 7.3 for 2lA h at 4°C. They were then washed in three changes (20 min each) of
0.1M sodium cacodylate buffer followed by fixation for 45 min in the buffer, after
which the samples were washed (3 x 20 min) in distilled water. They were
dehydrated through a series ascending concentration (50, 70, 90 and 100%) of
acetone, each step lasting for 20 min and dried in C02 using the critical drying
apparatus (series 3000, Polaron, Hertfordshire).
The dried samples were then mounted on aluminium stub using Liet-C
conductive carbon cement (Neubauer, Germany), dried in an oven for 1-2 hours
before being sputter coated in an EMscope sputter coater SC 500 with 20 nm
gold/palladium mixture. The coated samples were then viewed and photographed on
SEM 505 Electron microscope using an FP4 black and white 35 mm (Ilford) film
(Stephen Mitchell, EM Unit, personal communication).
3.7 PASSIVE PROTECTION TRIALS
Three groups of rats were used in each trial and the experimental protocol is
as described in the Table 3.2. A total of 24 rats were used in the first trial while a
total of 30 rats were used in the two later trials. The rats were bled before infection
and then at fortnightly intervals but in trials 2 and 3 rats were also bled at D1 and
D3 of infection. The rats were exsanguinated at D56 for determination of fluke
burdens. Fluke burdens of groups were compared using Mann-Whitney test.
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1 10 ml of antiserum given IP 20
at challenge and 48h after
2 10 ml of normal rat serum IP 20
at challenge and 48h after
3 No serum given 20
3.8 PREPARATION OF PARASITE EXTRACTS
3.8.1 Somatic Extracts
One ml of packed adult F. hepatica was removed from storage in liquid
nitrogen and pulverized into a powder using a pestle and mortar on dry ice. The
powder was transferred into 4 ml of a solution of PBS containing protease inhibitors
(PBS-PI, see Appendix 2). The mixture was left on ice for 15 min with occasional
shaking, after which it was transferred to sterile Eppendorf tubes and centrifuged for
20 min at 14000 g at 4°C. The supernatant was pooled and its protein content was
determined as described by Warburg and Christian (1941). This extract was
aliquoted in 200 pi volumes and stored at -70°C until needed.
3.8.2 Cetyltrimethyl-ammoniumbromide (CTAB) and N-octyl
Glucopyranoside (NOG) Extraction
Freshly collected adult flukes were washed were washed six times in sterile
PBS. Eight flukes were transferred to Bijoux bottle containing 2 ml of 0.25% w/v
solution of CTAB or 1% w/v solution ofNOG in PBS-PI and left on ice for 30 min
with occasional shaking.
The extracts were transferred to dialysis tube (Sigma) and dialysed overnight
against sterile PBS so that the resultant concentration of the detergent was 0.03%
w/v. The protein content of the extracts were determined before storage at -70°C in
150 pi aliquots.
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3.9 COLLECTION OF TOTAL EXCRETORY/SECRETORY PRODUCTS
3.9.1 From DO and DI Flukes
After recovery, about 200 newly excysted juvenile flukes contained in
100 (j.1 of phosphate buffered saline in an Eppendorf tube, were transferred into a
sterile Universal bottle containing 25 ml ofwarm (37°C) RPMI 1640 (Gibco Ltd) in
a 37°C water bath. They were allowed to sediment for 10 min, after which they
were gently pipetted into another Universal bottle containing 25 ml of RPMI 1640
for another wash. Using this procedure, the flukes were given two more washes in
the complete culture medium (see Appendix 2). After the last wash, they were
pipetted into a sterile Eppendorf tube and centrifuged at 22 g for 1 min at room
temperature. The supernatant was carefully pipetted off, leaving the flukes in about
100 pi of culture medium. They were then pipetted into one well of a 24-well tissue
culture plate (Nunclon, Gibco) containing 400 pi of complete culture medium. They
were incubated for 24 hour at 37°C in an atmosphere of 5% v/v CO2 in air. The
culture supernatant was collected and centrifuged at 358 g for 10 min. The
supernatant obtained was again centrifuged for 30 minutes at 12000 g and 4°C. The
protein content of the culture supernatant was determined (as described by Warburg
and Christian, 1941), as was the protein content of the complete culture medium.
The difference between these two values was taken to be the amount of the protein
in the preparation derived from the parasites' excretory/secretory products. The ES
from newly excysted juvenile (ES0) or one-day-old flukes (ES j) was then stored in
150 pi aliquots at -70°C until needed for silver staining or western blot analysis.
3.9.2 From Parenchymal Flukes (D14).
After recovery the 14-day-old flukes were washed six times with sterile
(37°C) Phosphate buffered saline (PBS), followed by six washes in pre-warmed
(37°C) RPMI 1640 (GIBCO) and a further six washes in the pre-warmed (37°C)
complete culture medium in a sterile hood. The cleaned flukes were then transferred
into a sterile petri dish (Nunclon, Gibco, 1-68381 A) containing 20 ml of warm
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(37°C) complete culture medium. Using a sterile glass pipette, 75 flukes were
transferred into one well of a 24-well tissue culture plate (Nunclon, Gibco code 1-
43983A) containing 2 ml of complete culture medium. The surrounding wells were
each filled with 1 ml of RPMI 1640 to reduce evaporation. The plate was incubated
at 37°C for 24 hours, after which the culture supernatant was collected and
centrifuged at 14000 g for 30 min. The protein content was determined as described
by Warburg and Christian (1941) and the ES (ES14) stored at -70°C.
3.9.3 From Adult Flukes
After recovery from the bile ducts, the flukes were washed six times in
sterile phosphate buffered saline, followed by six washes in pre-warmed RPMI 1640
(Gibco) and a further six washes in complete culture medium.
Active undamaged flukes were identified, and one fluke each was transferred
into 8 adjacent wells of a 24-well tissue culture plate (Nunclon, Gibco), each of
which contained 1 ml of complete culture medium. One ml of RPMI 1640 was
pipetted into each of the unused wells surrounding the fluke-containing wells to
reduce evaporation. The plate was then covered and incubated for 24 hours in an
atmosphere of 5% v/v C02 in air at 37°C. The culture supernatants from the fluke-
containing wells were then pooled, aliquoted into Eppendorf tubes and centrifuged
at 1000 g for 5 min at 4°C. The supernatants were again pooled and centrifuged at
14000 g for 30 min at 4°C. The protein content was determined as described above.
3.10 BIOSYNTHETIC RADIO-LABELLING OF F. HEPATICA
3.10.1 Radio-Labelling of Parasites and Collection of Radio-labelled
Parasite Products
This procedure was performed as described by Joshua, Harrison and Sewell
(1988)
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DO and D1 Flukes
About 200 newly excysted juveniles (recovered as described in 3.5.1.) or
day-old flukes (obtained as in Section 3.5.2) contained in 100 pi of sterile phosphate
buffered saline were washed once in complete culture medium and once in
methionine-free medium (Selectamine, Gibco) prepared as instructed by the
manufacturers. The flukes contained in about 100 pi of methionine-free medium
were then transferred to a well of a 24-well (3.14 ml well volume) tissue culture
plate (Nunclon, Gibco) containing 2 ml of the methionine-free medium. 7.4MBq of
35S-methionine (1000 ci/mMol, Amersham code SJ 1015) was pipetted into the
well. The plate was labelled, covered and placed on a box of charcoal (to absorb any
radioactivity) and cultured for 24 hours at 37°C in an atmosphere of 5% v/v C02 in
air.
At 24 hours, the culture supernatant containing any radio-labelled parasite
excretory/secretory products was collected into a sterile Bijoux bottle on ice. Non¬
radioactive L-methionine (50 pg/ml) (Sigma, code M9625) was added to the
supernatant, after which it was centrifuged for 5 minutes at 1000 g and 4°C. The
resulting supernatant was again centrifuged for 30 minutes at 14000 g and 4°C. The
supernatant was collected into sterile Bijoux bottles and desalted.
D14, D28 and D42 Flukes
About 70-80 D14, 40 D28 or D42 flukes recovered as described in 3.5.3
were, under a hood, washed in 30 ml of complete culture medium contained in 144
x 21 mm sterile polystyrene petri dish (Nunclon, Gibco code 1-68381A). The flukes
were transferred into, and washed in 30 ml of methionine-free medium contained in
a similar petri dish. The flukes were then transferred into 2 ml of methionine-free
medium (Selectamine, Gibco) in a well of a 24-well tissue culture plate (Nunclon,
Gibco). One ml of complete culture medium was pipetted into the surrounding wells
to reduce evaporation. 7.4MBq of 35S-methionine (1000 ci/mMol, Amersham code
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SJ 1015) was pipetted into the fluke-containing well. The plate was placed on a box
of charcoal to absorb any radioactivity and then cultured for 24 h at 37°C in an
atmosphere of 5% v/v C02 in air. After 24 h, the culture supernatant was collected
and treated as already described while the flukes were washed in phosphate buffered
saline containing protease inhibitors before storage in liquid nitrogen.
Adult Flukes
Recovered adult flukes (3.5.4) were kept for 1 hour in an incubator at 37°C
to allow them regurgitate their caecal contents. Under a hood, the flukes were given
six washes in sterile phosphate bufferred saline, followed by six washes each in
RPMI 1640 (Gibco), complete culture medium and methionine-free medium
respectively.
Active undamaged flukes were identified and one of such flukes was
transferred to each of six wells of a 24-well tissue culture plate (Nunclon, Gibco)
containing 1 ml of methionine-free medium (Selectamine, Gibco). 1 ml of culture
medium was pipetted into each of the adjacent wells. 1.85MBq of 35S-methionine
(activity 1000 ci/mMol, Amersham, code SJ 1015) was added to each of the fluke-
containing wells. The plate was then covered, placed on a box of charcoal and
incubated for 24 hours at 37°C in an atmosphere of 5% v/v C02 in air. After
incubation, the labelled flukes were washed in phosphate bufferred saline containing
protease inhibitors and stored in liquid nitrogen. The culture supernatant in all the
fluke-containing wells was collected, pooled and centrifuged for 10 minutes at 500
g and 4°C. The resulting supernatant was again pooled and centrifuged for 30
minutes at 14000 g and 4°C, after which the supernatant was pooled and desalted.
3.10.2 Preparation of Somatic Extracts of Flukes
Somatic extracts of flukes were prepared as described by Joshua et al.
(1988).
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The flukes were recovered from liquid nitrogen and homogenised on dry ice
in sterile mortar and pestle. The powder was transferred to an Eppendorf tube
containing 0.95 ml of PBS-PI, and 50 pi of Nonidet P40 was added to the
homogenate, which was then held on ice for 30 minutes. The homogenate was then
centrifuged at 14,000 g for 3 minutes at room temperature after which the
supernatant was desalted.
3.10.3 Desalting the Supernatant
For every 2 ml of supernatant to be desalted 20-ml bed volume of Sephadex
G25 was prepared. The approximate weight of fine sephadex G25 (Pharmacia)
required to give the desired volume was swollen in phosphate buffered saline
overnight.
The gel was poured into Bio-Rad columns, and packed down with PBS-PI-
Methionine (PBS-PI containing 0.67 mM L-methionine [Sigma, m9625]) to the
20-ml mark, ensuring that the surface of the gel was uniformly flat.
Each column was washed once with PBS-PI-Methionine. The PBS-PI-
Methionine was drained down to the top of the column and 2 ml of the radio-
labelled ES product was immediately added and run into the column. The ES was
then eluted with PBS-PI-Methionine. Two 2-ml fractions and 34 0.5-ml fractions
were collected from each column into pre-labelled tubes.
Thirty six scintillation vials were numbered and serially arranged in racks.
Then, 4 ml of scintillation fluid was dispensed into each. Starting from the first
fraction, 10 pi from each eluate was sequentially added to the respective vials. The
vials were covered and the activity in each was counted on a scintillation counter
(Parkard) using the programme for 35Sulphur. The fractions containing the radio-
labelled parasite excretory/secretory products (i.e, peak 1) were pooled.
3.10.4 Trichloroacetic Acid Precipitation
From the pooled fractions 10 pi was pipetted into each of four test tubes.
Then 190 pi of 0.15M NaOH was added to tubes 1 and 2.
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190 pi of normal rabbit serum diluted 1:10 in normal saline was added to
tubes 3 and 4. These two tubes were filled with 10% solution of trichloroacetic acid
and centrifuged for 5 min at 2500 g at 4°C. The precipitate in each tube was
resuspended in 200 pi of 0.15M NaOH. The tubes were again filled with 10%
trichloroacetic acid and centrifuged. The supernatant was gently decanted and each
precipitate was resuspended in 200 pi of 0.15M NaOH.
The 200 pi from each tube was pipetted onto a vial containing 4 ml of
scintillation fluid. The four vials were counted along with four blank vials
containing only scintillation fluid.
The trichloroacetic acid precipitable counts per minute per pi were
calculated using this formula:
[(s/tx 100)xt]/10
where,
t - The total count represented by the mean of tubes 1 and 2 after
subtraction of the mean of the blank tubes (5-8).
s = the mean precipitable count represented by the mean of tubes 3 and 4
after subtration of the mean of the blank tubes.
All counts were expressed as TCA precipitable counts per pl/minute.
3.11 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)
General Protocol
ELISA assays were performed as described by Voller, Bidwell and Barlett
(1979) to monitor antibody responses of rats to infection. Flat bottom (96-well)
polystyrene microELISA plates (Immunolon, Dynatech Laboratories Inc. Virginia)
were coated with 50 pl/well of Excretory/Secretory or somatic antigens of adult
fluke, each antigen having been diluted to the optimal dilution of 1 pg/ml in Borate
Buffered saline (99.95 mM boric acid, 47.42 mM disodium tetraborate and
74.95 mM sodium chloride, pH 8.2). The plates were wrapped with cling film to
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prevent evaporation and incubated overnight at 4°C. The plates were washed twice
with a solution of 0.15M NaCl containing 0.02% w/v Tween 20 (Sigma code P
1379), allowing each wash to stand for 3 min then dried by shaking onto a pad of
paper towels. Then, 100 pi of diluent made of 4% v/v normal goat serum (NGS,
Gibco) in PBS containing 0.02% v/v of Tween 20 (NGS/PBS/Tween) was added to
each of the well and the plates were left for one hour at room temperature to block
any non-specific reaction sites. After shaking out the diluent and washing each plate
three times, 50 pi of test serum sample appropriately (1:200) diluted was added to
each well. Each test serum was run in duplicate. Samples of similarly diluted sera
from known infected and non-infected rats were each included as controls in five
wells of each plate.
The plates were covered with cling film and incubated for 1 hour at 37°C.
Following the wash procedure as described above, 50 pi of enzyme
conjugate (Goat anti-rat (heavy and light chain) IgG/Peroxidase [GAR/PO] whole
molecule, Nordic Immunological Laboratories, The Netherlands) diluted to the
optimal concentration of 1:1000 in the diluent, was added to each well. The plate
was then incubated for a further 1 hour at 37°C, then washed.
Substrate at 50 pl/well containing 0.42 mM N,N,N',N'-Tetramethylbenzidine
(Sigma code T 5513) in (dimethylsulphoxide ,Sigma) diluted in 100 mM sodium
acetate/citric acid buffer (pH 8.0) containing 0.13 mM urea hydrogen peroxide
(Sigma code U 1753) was added at room temperature. The colour reaction was
stopped after 10 to 15 minutes by the addition of 50 pi of 0.02M H2S04 (Aristar,
BDH) to each well and the optical density of the reaction product was measured at
450 nm using a Titertek Multiscan (Labsystems).
Corrected absorbance was calculated:-[(PpN^/^-NJ] x Tn
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where, P mean of five replicates of control positive serum
assayed on day 1 in plate 1.
N mean of five replicates of control negative serum
assayed on day 1 in plate 1.
P,n mean of five replicates of control positive serum
assayed on day n in plate n.
N,n mean of five replicates of control negative serum
assayed on day n in plate n.
T,n mean of one duplicate of test serum assayed on day n
in plate n.
3.12. SODIUM DODECYL SULPHATE POLYACRYLAMIDE GEL
ELECTROPHORESIS (SDS-PAGE)
Electrophoresis was conducted using the discontinous system described by
Laemmli, 1970.
3.12.1 Large Gels
Electrophoresis of large gels were carried out using the Gel Electrophoresis
apparatus GE-2/4 LS (Pharmacia) and following the manufacturers' instruction.
The stock solutions (Appendix 2) were mixed to prepare the required
gradient gel solutions, 10 - 20% in most cases. Samples were solubilized in reducing
or non-reducing buffers (Appendix 2) in a 2:1 ratio and heated for 5 minutes at
100°C. Samples intended for western blots were loaded at 0.595 pg/cm2 of gel
while samples intended for silver staining were loaded at 10 pg per track. The
samples, along with prestained molecular weight markers (Sigma, code PI677) were
then electrophoresed at 150V and 0.6A using the power pack model 1000/500 (Bio-
Rad) as source of electricity. After the samples had entered the resolving gel,
electrophoresis was continued for 3-4 hours, during which the system was cooled by
the Multitemp LKB apparatus set at 8°C. At the completion of electrophoresis the
gels were removed as instructed in the Pharmacia manual.
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3.12.2 Minigels
These were also run using the discontinous buffer system (Laemmli, 1970).
Samples were electrophoresed in the Mini-ProteanR II Dual Slab Cell
apparatus (Bio-rad) following the manufacturer's instructions.
A 12% homogenous gel solution was prepared (Appendix 2) and the
solubilized samples along with prestained markers were electrophoresed for 45
minutes at 200V and 45 mA using the 200/0.2 power supply (Bio-rad). Samples for
western blotting were loaded at 0.272 pg (ESD0) and 0.15 pg (ESD1) per cm2 of gel
respectively.
3.13 SILVER STAINING OF GELS
Silver staining of gels was done as described by Morrisey (1981).
After electrophoresis, gels were placed individually in suitable clean glass
pyrex trays and fixed for 30 min on an orbital shaker (KL2 Edmund Buhler
Tubingen) in a solution of 50% v/v methanol and 10% v/v glacial acetic acid in
distilled water. After 30 min this solution was replaced by a solution containing 5%
v/v methanol and 7% v/v glacial acetic acid. Then after a further 30 min by a
solution containing 10% v/v glutaraldehyde using 6 ml per gel. The gels were then
soaked in distilled water overnight, and then soaked for 30 minutes in a solution
(5 pg per ml of water) of dithiothreitol using 12 ml per gel. The gels were then
exposed to a solution of 0.1% w/v silver nitrate for 30 min. The staining solution
was poured off and the gels were rinsed with the developer, a 3% w/v solution of
sodium carbonate to which was added 50 pi of formaldehyde. The gels were then
left in 100 ml of fresh developer solution until the staining was optimal, after which
the reaction was stopped by the addition of 10 ml of 2.3 M citric acid. After a





Dot blots were performed using Bio-Dot Microfiltration Apparatus (Bio-
Rad) following the manufacturers instruction.
3.14.2 Western Blotting
3.14.2.1 Electrophoretic transfer ofproteins
The procedure was performed following the description of Towbin,
Staehelin and Gordon (1979).
Following separation of proteins on gradient gel as described in 3.12, the
gels were soaked in Bjerrum and Schafer-Nielsen transfer buffer (see Appendix 2)
The proteins were transferred onto nitrocellulose membrane with a pore size
of 45 |xm (Schleicher and Schuell, W. Germany) using the Trans-BlotR SD Semi-
Dry Electrophoretic Transfer Cell (Bio-rad) and following the instructions of the
manufacturers. Large gels were transferred for 45 minutes at 10V and a current limit
of 0.76A per gel, while minigels were transferred at the same voltage but a current
limit of 0.22A per gel.
After transfer, the NC was then placed in a blocking buffer (50 mM Tris,
150 mM NaCl, 1 mM EDTA, 0.05% Nonidet P40 and 0.25% gelatin in distilled
water (see Appendix 2) overnight. It was given three washes of ten min each in
30 ml of 0.15M NaCl/0.02% (w/v) Tween 20, following which it was dried between
two filter papers. The well-forming comb was used to indicate the position of the
sample tracks and of the markers on the NC membrane. Both ends of the part of the
NC membrane containing the blotted proteins were marked at 5 mm intervals with a
ball-point pen and the NC membrane was cut into 5 mm vertical strips.
3.14.2.2 Reaction ofstrips with sera
NC membrane strips which were to be reacted with test sera were incubated
overnight in a solution of 4% v/v NGS in blocking buffer. Next day they were given
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3x10 min washes in 0.15M NaCl/0.02% (w/v) Tween 20 (saline/Tween 20) on an
orbital shaker. The strips were then placed in slotted trays (Bio-rad western blot
tray) and 5 ml of appropriate test serum diluted 1:200 in 4% NGS (v/v)/blocking
buffer was pipetted into the corresponding slots, noteing each strip's number and the
type of serum being tested in it. The tray was rocked for 30 min at 37°C in an
incubator (Lab-therm, Adolf Kuhner AG Schweiz), after which the strips were
given three ten-min washes in saline/Tween 20. They were incubated for 30 min in
25 ml of biotinylated goat-anti-rat IgG conjugate (Sigma) diluted to the optimum
concentration in 4% NGS (v/v)/blocking buffer and then washed three times in
saline/Tween 20. The strips were again incubated for 30 min in 25 ml of
streptavidin alkaline phosphatase conjugate (Amersham) diluted to optimal
concentration in 4% NGS/blocking buffer. After further washing, colour
development was achieved by incubating the strips in the substrate, 0.1 M
diethanolamine containing 5 mM Mg£l, 0.4 mM nitroblue tetrazolium (in 70%
dimethylformamide) and 0.44 mM bromo-chloro-indolyl-phosphate (see Appendix
2). When colour development was judged to be optimal, the developing solution
was poured off and the strips were either photographed or dried between filter
papers and kept in a dark place until they were photographed.
3.15 IMMUNO-COPRECIPITATION
This procedure was carried out as described in laboratory notes of
helminthology section (CTVM).
Normal rat serum, goat-anti-rat gamma globulin and co-precipitation diluent
(20 mM Tris-HCl buffer pH 8.0, containing 50 mM NaCl and (0.2% v/v) Nonidet
P40) were mixed in a ratio of 1:20:50 and left overnight at 4°C. The volume of
radio-labelled ES required for the test sera (at 50,000-100,000 cpm/ per sample) was
added to an equal volume of the overnight precipitate. The mixture was left on ice
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for 5 min and centrifuged at 15,000 g for 5 min at 4°C. The supernatant was gently
pipetted off and added to an equal volume of diluent.
The volume of this antigen required for immuno-coprecipitation with test
sera was calculated using this formula :
[(mt/v)/P] x n
where,
P = cpm/pl required for each test serum,
m = volume of radio-labelled ES added in the first instance,
t = TCA precipitable count of the radio-labelled ES
v = the final volume in which the labelled antigen was contained,
n = number of test sera to be used.
3.15.1 Immuno-coprecipitation with Test Sera
This was done as described by Joshua et al. (1988).
After pipetting 5 pi of relevant serum into two labelled test tubes, the required
volume of the prepared antigen was added to each test tube, mixed then left for 1 h
at 4°C. Goat-anti-rat gamma globulin (which had earlier been titrated to determine
the minimum volume required to give visible precipitate when reacted with 5 pi of
serum and 1 ml of diluent) was diluted in co-precipitation diluent and an excess of
this (400 pi) was added to each tube. The mixture was then incubated overnight at
4°C and 1000 pi of ice-cold diluent was added to the precipitate in each tube. The
mixture was vortexed and centrifuged for 10 min at 800 g at 4°C. The supernatant in
each tube was aspirated off without disturbing the precipitate. The precipitate was
vortexed in 2 drops of diluent and the washing process repeated twice. After the
final washing, each precipitate was suspended in 25 pi of diluent.
From the suspension in each tube, 5 pi was pipetted into a scintillation vial
containing 4 ml of scintillation fluid for counting of radioactivity of the precipitates.
Pairs of tubes containing the same serum samples were solubilized in
reducing and non-reducing sample buffers (see Appendix 2), and heated for 5 min at
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100°C. The samples were then subjected to the SDS-PAGE electrophoresis. I4C
rainbow molecular weight markers (Amersham) were electrophoresed along with
the samples.
Fluorography
This procedure was performed as described by Hames and Rickwood (1990).
After separation of the labelled proteins by SDS-PAGE, the gels were fixed
for 30 min in 10% methanol and 5% acetic acid. They were then given two 30 min
washes in pure dimethylsulfoxide (Sigma). This was followed by a three-hour
washing in a 27.5% w/v solution of 2,5-diphenyloxazole scintran (PPO, BDH) in
dimethylsulfoxide (Sigma). The gel was rinsed in cold tap water and left overnight
in tap water, before it was dried.
Gel Drying
The gel was soaked for 30 min in 1% v/v glycerol and 10% v/v acetic acid in
distilled water.
The methanol trap of the gel slab dryer (Elnor) was half-filled with
methanol, which was cooled by the addition of dry ice until the methanol was
saturated.
An 18 x 34 cm cellophane membrane backing (Bio-rad) was soaked in
distilled water in a tray. The pre-soaked gel was placed on the membrane and the
excess membrane was cut off. The gel and the membrane were placed on the gel
dryer, and the gel was covered with cling film (Fisions scientific equipment). The
mylar sheet was placed on top of the gel and covered with the silicon flap.
The vacuum pump was switched on, holding the silicon flap down until a
good seal was produced. The gel dryer timer/heater was set at 45 min. When drying
was completed, the vacuum was released slowly. The gel was removed and taped
onto a filter paper which has been pre-cut to the size of an autoradiography cassette.
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Autoradiography
This procedure was performed as described by Hames and Rickwood (1990).
Aluminium plates used as autoradiography cassettes were made by the
workshop unit of the Veterinary Field Station. The 24 xl8 cm plates were taped in
pairs with an intensifying screen fastened to the inner side of one of the plates.
Working in a dark room, the dried gel on the filter paper was placed between the
aluminium plates with the gel facing the intensifying screen. An 18 by 24 cm X-ray
film (Agfa Curix, Agfa Gevaert N.V. B-2640, Belgium) was placed between the gel
and the intensifying screen, with a mark on the film to show the orientation of the
gel. The two plates were then taped together, wrapped in a black bag, sealed, placed
in a padded envelope and kept at -70°C until it was judged from experience to be
ready for development.
Developing the Autoradiographs
The envelope was removed from the freezer and allowed to warm up to
room temperature in the dark room. The film was removed from the cassette and
developed in a solution of D-19 developer (Sigma code P 5670). The tray was
gently but continuously agitated during the development. After 4 min the film was
removed and immersed for 4 min in a fixative (H.A. West (X-Ray) Ltd). After
fixing, the film was washed in cold tap water for 2 hours, after which it was air-
dried and photographed.
3.16 PHOTOGRAPHY
Photography was done using a Polaroid MP 4 Land camera (Polaroid Corp.,
U. S. A) and type 55 polaroid film as recommended by the manufacturers.
Different types of samples were photographed using various settings (Bob
Munro, Personal communication) as indicated in the following table.
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16.5 72 11 5 45
Silvers
(large)
67.2 23 11 7-8 45
Dot-blot 54.8 20.4 22 2 11
W/blots
(mini)
18 65 22 1 16
W/blots
(large)
60.5 16 16 2 23
Autorads 75 15.5 16 5 61
3.17 STATISTICS
Non-parametric analysis (Fowler and Cohen, 1990) was used to analyse data
sets with small sizes. Analysis of data sets with large sizes was carried out with




4.1 PATHOLOGICAL CHANGES IN INFECTED RATS
Pathological changes induced by infection was monitored by visual
assessment of pathology in the livers of rats that were infected to obtain Dl, D14,
D28 and D42 flukes. Changes at day 56 of infection were studied by observations
on rats used for producing antisera as well as challenge control rats in the passive
protection trials which terminated at D56.
4.1.1 Gross Pathology
No liver lesions were observable at day 1 of infection. By D14; however, all
the 9 livers examined were markedly friable and enlarged. Seven of these had
widespread necrotic tracts as well as fibrinous adhesions to adjacent organs (Figure
4.1). The three livers examined at D28 were all enlarged and had the necrotic
lesions seen at D14. The three livers examined at D42 were fibrotic and two had
necrotic foci which were confined to one lobe of the liver. In addition, the livers all
had fibrinous adhesions to the adjacent organs. A total of 136 livers were examined
at D56. All of these appeared fibrotic. There were marked distension of the bile duct
wall (Figure 4.2) and gall bladder in all the livers in which flukes were recovered.
Apart from this fibrosis, 13 (9.5%) of the livers appeared grossly normal, while a
total of 123 (90.4%) showed varying degrees of necrotic lesions. These lesions were
only slight in 58 (47%) of the rats, in which the necrotic foci were very few and
confined to just one lobe. The lesions were moderately severe and more widespread
in 49 (39%) of the rats but very severe in the remaining 16 (13%) rats. In this latter
group of rats the bile was very viscous.
4.1.2 Histopathological Changes
All the 9 livers examined at D14 as well as the three livers examined at D28
showed cellular infiltration of the parenchyma (Figure 4.3a), the main cell involved
in this reaction being eosinophils (Figure 4.3b). Hepatocytes in all the sections
examined showed degeneration with cloudy swelling. The three liver sections from
rats with 28-day-old infection also had mild interlobular fibrosis.
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Figure 4.1.
Necrotic tracts on liver recovered at D14 from a rat infected with 20 F. hepatica
metacercariae.
Figure 4.2
Liver recovered at D56 from a rat infected with 20 F. hepatica metacercariae showing
enlargement of the bile duct.
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Figure 4.3a.
Transverse histological section of liver recovered at D14 from a rat infected with
20 F. hepatica metacercariae, stained with hematoxylin/eosin, showing multiple
large necrotic foci packed with inflammatory cells.
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Figure 4.3b.
Transverse histological section of liver recovered from a rat infected with 20 F.
hepatica metacercariae, stained with carbol chromatrope, showing eosinophilic
infiltration.
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The livers examined at D42 all showed less granulocytic reaction but there
were increased interlobular fibrosis, hepatocyte degeneration and evidence of early
fibroplasia. All the 13 rats that had no gross liver lesions at D56 had slight
interlobular fibrosis. All the livers that had gross lesions showed varying degrees of
parenchymal fibrosis, proliferation of bile ductules (Figure 4.4) and presence of
pigment-laden macrophages (Figure 4.5).
4.2 PRODUCTION OF ANTISERA AGAINST F. HEPA TICA
The mean fluke burdens from rats infected with metacercariae to produce
antisera against F. hepatica in the three trials were 1.88 + .273, 1.83 + .274 and 4.29
+ .497 respectively (Figure 4.6). The mean percentage takes in the three trials were
18.1 + 2.73, 9.3 + 1.3 and 21 + 2.48 respectively. The mean percentage takes in
trials 1 and 3 were significantly higher than in trial 2 (U = 474, P = 0.015; U = 241,
P > 0.0001) but the difference between the mean percentage takes in trials 3 and 1
was only marginally significant (U = 481, P = 0.09).
The distribution in fluke burden were similar for trials 1 and 2, at 0-7 and 0-
6 respectively. Trial 3 differed in the pattern of distribution and the fluke burden
ranged from 1-14 (Figure 4.7 and Appendix 1, Table A4.2).
The percent mortalities in the three trials were 7.5, 5 and 12.5 respectively.
Varying degrees of liver pathology as assessed by visual observation
occurred in the infected rats (Figure 4.8). The extent and severity of observed
pathology varied in each trial. Rats in trial 1 had less liver pathology compared to
rats in the two subsequent trials. Of the rats that had flukes in this trial, 67% had
slight liver lesions while 33% had moderate lesions. In trial 2, 13% of rats with
flukes had no apparent liver lesion, while 26, 39 and 22% respectively had light,
moderate and severe lesions. In trial 3, 6% of the rats had no apparent lesion, 35, 50
and 9% of the rats had light, moderate and severe lesions respectively. Pooled
results from the three trials showed that in rats that had between 1 and 5 flukes, the
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Figure 4.4.
Transverse histological section of a liver recovered at D56 from a rat infected with
20 F. hepatica metacercariae, stained with haematoxylin/eosin, showing bile duct
proliferation and parenchymal fibrosis.
Figure 4.5.
Transverse histological section of liver recovered at D56 from a rat infected with
20 F. hepatica metacercariae, stained with haematoxylin/eosin, showing hepatic
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Figure 4.7
Distribution of numbers of F. hepatica recovered from rats 56 days after oral



















Visually assessed liver pathology in rats infected with 10 (trial 1) or 20 (trials 2 and■i) t. hepatica metacercariae.
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severity of liver lesion tended to increase with the number of flukes harboured. The
overall relationship between fluke burden and the degree of liver pathology is
presented in Table 4.1. Some of the rats without flukes in trials 1 and 2 also had
apparent liver pathology.
The sera obtained from the last bleeding of rats that had flukes and
discernible liver pathology in the three trials were pooled and designated as Ij, I2
and I3 respectively. Sera from uninfected control rats were similarly pooled and
designated Nls N2 and N3 (Table 4.2). These sera were stored at -70°C for use in
passive protection studies.
4.3 PASSIVE PROTECTION AGAINST F. HEPATICA
There was a higher percentage take in the first trial than in the two
subsequent ones (Figures 4.9 and 4.10). The mean fluke burden of rats given
antiserum in the first trial was lower than the mean for normal serum and challenge
control rats. However, this was not significantly different from those of either the
normal serum control (U = 21, P > 0.05) or the challenge control (U = 18.5, P >
0.05) rats. The mean recoveries from the two latter groups were not significantly
different from each other (U = 42.5, P > 0.05). The same pattern of fluke burdens
was observed in trials 2 and 3 but here the mean fluke burdens of rats injected with
antiserum was significantly lower than that in either the normal serum control (U =
8, P > 0.05; U = 15, P > 0.05) or the challenge control groups (U = 23, P > 0.05; U
= 9, P > 0.05). Once again, the mean fluke recoveries from normal rat serum and
challenge control rats were not significantly different from each other in trials 2 (U
= 42; P > 0.05) or 3 (U = 37; P > 0.05).
The range of fluke recovered from challenge control rats in trial 1 was
similar to that of normal rat serum control rats. Either of these values was much
higher than the range in rats that received rat antiserum in this trial. In trial 2, a
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Mean (±SEM) fluke burdens recovered from rats given antiserum (■), normal rat
serum (a), and challenge control (0) rats in passive protection trials 1(a), 2(b) and
(c).
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Figure 4.10.
Fluke burdens of rats given antiserum (■), normal rat serum ((□), and challenge
control rats (^) in passive protection trials 1(a), 2 (b) and 3 (c).
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much higher than that of normal serum control rats. The range in this latter group
was similar to that in rats that received antiserum. The range in rats used for trial 3
was similar to that of trial 1. Thus, in the three trials the range of flukes recovered
from rats that received rat antiserum were generally smaller than those of the two
other groups of rats. The distribution of flukes in normal rat serum and challenge
infection control rats in trials 1 and 2 followed a pattern similar to those observed in
trials 1 and 2 to produce antiserum. However, this pattern was not observed in these
groups of rats in passive protection trial 3 (Figure 4.10 and Appendix 1, Table
A4.3).
Generally, rats that received antiserum at challenge had less liver pathology
than those that received normal rat serum or challenge control rats. (Figures 4.11,
4.12 and 4.13). This difference was more marked in trials 2 and 3 (Figure 4.12 and
4.13) than in trial 1. Normal serum control rats in trial 2 had fewer discernable liver
lesions than the challenge control rats (Figure 4.12b and c) but such a difference
was not apparent in trial 3 (Figure 4.13b and c).
There were no significant differences in the mean sizes of flukes recovered
from the three groups of rats in the three trials (Table 4.3 and Appendix 1, Table
A4.3).
4.4 ANTIBODY RESPONSE TO INFECTION IN RATS
4.4.1 Titration of Parasite Extracts, Serum and Conjugate
Following titration of excretory/secretory and somatic extracts (in PBS-PI)
of adult flukes against 1:100 dilutions of known positive and negative sera and
1:1000 dilutions of conjugate (Goat anti-mouse peroxidase) a concentration of 1 pg
protein/ml was selected as the standard concentration for each of the extracts




Visually assessed liver pathology of rats given antiserum (a), normal rat serum (b)
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Figure 4.12.
Visually assessed liver pathology of rats given antiserum (a), normal rat serum (b)
and challenge control rats (c) in passive protection trial 2.
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Figure 4.13.
Visually assessed liver pathology of rats given antiserum (a), normal rat serum (b)
and challenge control rats (c) in passive protection trial 3.
80
Table 4.3 Mean measurements (mm) of flukes recovered from passive
protection trials
Treatment given to rats
+IRS +NRS No serum Trial















The results of ELISA titrations performed using known positive antisera (□,•)
against F. hepatica and known negative serum (■) to determine the optimum (a)









































The results of ELISA titrations performed using known positive antisera (□,•)
against F. hepatica and known negative serum (■) to determine the optimum (a)
concentration of somatic antigenic proteins (b) serum dilution and (c) enzyme
conjugate (goat-anti-mouse peroxidase) dilution.
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1:200. This was the optimal dilution in the titrations with ES products. The optimal
serum dilution for use in ELISA with somatic fluke extract was 1:100 but this
dilution was not used in order to conserve serum samples (Figures 4.14b and 4.15b).
Titration of enzyme conjugate against adult fluke excretory/secretory and
somatic extracts (1 pg/ml) and 1:200 dilutions of positive and negative serum
samples revealed the optimal conjugate dilution to be 1:1000 (Figures 4.14c and
4.15c).
4.4.2 Antibody Response to Primary Infection (Trials 1, 2 and 3)
Serum samples from sequential bleeds taken from the different categories of
rats were screened by ELISA using ES and somatic extracts of adult fluke as
antigens (Figures 4.16 and 4.17).
The response of infected rats to both parasite extracts followed similar
patterns. All rats with flukes and varying degrees of liver pathology showed an
antibody response within 14 days of infection. The antibody level remained high
until all the trials were terminated at day 56 of infection.
Interestingly, infected rats in which no flukes were found at post mortem
also showed an antibody response within 14 days of infection. In rats with no flukes
but liver pathology this response peaked at day 42 of infection but persisted
throughout the course of infection. In infected rats without liver pathology the
antibody response plateaued after 14 or 21 days of infection.
The antibody response of uninfected control rats was negative when
monitored at both the beginning and the end of trial. All the OD values for these
ELISA studies are presented in Appendix 1.
4.4.3 Antibody Response of Rats used in Passive Protection Trials
The antibodies detected in the sera of rats used in the three passive





The antibody response of rats that had 1-3 flukes (□,), >4 flukes (•), no flukes but
liver pathology (■) and neither fluke nor liver pathology (♦) at necropsy in trials
1(a), 2(b) and 3(c) to ES products of adult F. hepatica.
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The antibody response of rats that had 1-3 flukes (□,), >4 flukes (•), no flukes but
liver pathology (■) and neither fluke nor liver pathology (♦) at necropsy in trials
1(a), 2(b) and 3(c) to somatic extracts of adult F. hepatica.
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The antibody response of rats given antiserum (□), normal rat serum (•) and
challence control (■) in passive protection trials 1(a), 2(b) and 3(c) to ES products




The antibody response of rats given antiserum (□), normal rat serum (•) and
challenge control (■) in passive protection trials 1(a), 2(b) and 3(c) to somatic
extracts of adult F. hepatica.
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In trial 1 antibodies were first detected by day 14 as these rats were not bled
at days 1 and 3 of infection. The antibody remained high until the trial was
terminated at 56 days after infection. The antibody levels of rats that received
immune serum was significantly higher at days 14 (U = 0.0, P = 0.0003; U = 0.0, P
= 0.0002) and 28 (U = 9, P = 0.0289; U = 3, P = 0.0011) of infection than the levels
in the normal rat serum and challenge control rats.
The serum from rats that received immune serum in the second and third
trials contained a very significant antibody content on days 1 (U = 0.0, P = 0.0002;
U = 11, P = 0.0037) and 3 (U = 0.0, P = 0.0002; U = 10, P = 0.0029) of infection.
By day 14 of infection there had been a significant (U = 4, P = 0.0006; U = 1, P =
0.0029) decline in the antibody level. In trial 2 this decline continued until the
termination of the trial. In trial 3 an insignificant (U = 29.5, P = 0.131) increase was
noticed by day 42 of infection. These patterns of response were markedly different
from that seen in rats that received immune serum in the first trial. The normal
serum and challenge control rats showed a similar pattern of response to that of
similar group in the first passive protection trial.
4.5 HAEMATOLOGY
4.5.1 Changes in Packed Cell Volume
The packed cell volume of rats in the three groups did not appear to be
affected by the infection. In rats that received immune serum and normal rat serum,
the preinfection PCV values were significantly lower than the PCV values at the
termination of the trial (U = 17.5, P = 0.015; U = 19.5, P = 0.07), but in challenge
control rats these values were not significantly different from each other (U = 31.5,
P = 0.45) (Figure 4.21 and Appendix 1, Table A4.5.1a)).
4.5.2 Cellular Responses to Infection
In trial 3, an increase in the percentage of circulating eosinophils was first
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Figure 4.20.
The mean (± SEM) percentage eosinophil counts of rats that received antiserum (□
), normal rat serum (•) and challenge control rats (■) in passive protection trial 3.
Days after infection
Figure 4.21.
The mean Packed Cell Volume of rats that received antiserum (□), normal rat
serum (•) and challenge control rats (■) in passive protection trial 3.
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groups peaked and became significant relative to their preinfection levels (U = 19.5,
P = 0.0225; U = 6.5, P = 0.0031; U - 1.5, P - 0.0007) by day 28 of infection, at
which time the numbers in the challenge control rats were significantly higher (11 =
20, P = 0.046) than those in the rats that were injected with antiserum at challenge
(Figure 4.20).
No marked changes were detected in the percentages of other leucocytes.
The values are presented in Appendix 1.
4.6 WESTERN BLOTTING
4.6.1 Protein Concentration in Parasite ES Products and Somatic
Preparations
The protein concentration of the ES products of DO, Dl, D14 and adult
flukes were 54.4, 30, 909.9 and 4000 pg/ml respectively while the protein content
of PBS (somatic), N-Octyl-glucopyranoside and cetyltrimethyl-ammonium bromide
detergent surface extracts of adult flukes were 4.0, 4.55 and 0.75 mg/ml
respectively.
4.6.2 Silver Staining of Parasite Excretory/Secretory Products and
Extracts
Silver stained gel profiles of the proteins found in the complete culture
medium, ES products of various stages of F. hepatica as well as in the somatic and
detergent extracts of adult fluke are presented in Figures 4.22a and b.
Silver staining of the complete culture medium revealed a major protein of
about 69 kDa when the gels were run under reducing or non-reducing conditions.
Components analogous to this were detected in the profiles of all ages.
There were similarities but also variations in the components of ES as the
flukes developed. The ES of DO (ES0) and Dl (ESj) were quite similar. Both
contained a major component (63-76 and 54-76) which were possibly analogous to
the 69 kDa component in the complete culture medium. The four other components
revealed in the ES0 (reduced) were also present in ES,. ES] had three additional
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Figure 4.22a.
Silver stain of complete culture medium (track 1), and ES products of DO (track
2), D1 (track 3), D14 (track 4) and adult (track 5) F. hepatica (at 15, 0.9, 1.09,
15 and 15 pg per track respectively). Gels were run under either reducing (a) or
non-reducing (b) conditions.
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1 2 3
Figure 4.22b.
Silver stain of PBS-PI (track 1), NoG (track 2) and CTAB (track 3) extracts
of adult F. hepatica (at 15jag of protein per track). Gels were run under
either reducing (a) or non-reducing (b) conditions.
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minor components of about 25, 180 and 200 kDa which were not detected in ES0.
Components with apparent weights of about 180 and 200 kDa which were detected
in D1 ES were not present in ES14. However, ES14 revealed new major components
of about 48, 75, and 103 kDa as well minor components with molecular weights of
about 15 19, 28, 42 and 124 kDa. The ES of adult flukes was quite similar to D14
ES but a few differences were noticeable. The 103 and 124 kDa components of D14
flukes were not seen in adult ES.
Changes were again observed in the profiles when the samples were run non-
reduced. Analogues of the 69 kDa component in the complete culture medium were
detected in the ES of all ages of flukes. ES0 and ES[ were again quite similar.
Proteins with apparent molecular weights of 113-144 kDa was more prominent in
ESj. A component of about 26 kDa in ESj was not seen in ES0. There were obvious
differences between ES] and ESI4. Components with apparent weights of 176->200
kDa detected in D1 ES might possibly be analogous to the 182-222 kDa component
in ES14. A major component with weight of about 113-144 kDa and a minor one of
about 25 kDa detected in ES] were both absent in ES14. Conversely, three
components with apparent weights of about 19, 42 and 117 kDa as well as a cluster
of components with molecular weight of <15 kDa present in ES14 were not seen in
ES]. The non-reduced form of adult ES was again similar to that of ES[4 but with
few differences. A component with molecular weight of about 42 kDa in ES)4 was
not present in ESA. A summary of all components detected in ES of various ages of
flukes is presented in Table 4.4a anb b).
The somatic (PBS-PI) and NoG extracts contained more components than
the CTAB extract. In the reduced state, a component of about 25 kDa was common
to the three extracts although there were slight differences in the relative mobility of
this component in the three extracts. A component with apparent weight of about
65-68 kDa was common to the somatic and NoG extracts. Several components that
appeared quite prominent in the NoG extract were absent in the other two extracts.
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Table 4.4a Proteins identified in the silver stained complete culture medium
and ES products of F. hepatica run under reducing conditions




































Table 4.4b Proteins identified in the silver stained complete culture medium
and ES products of F. hepatica run under non-reducing
conditions
























These include components with apparent weights of about 94, 75, 62-44 and
32 kDa. In the non-reduced state, there were also similarities and variations in the
profiles of the three extracts. Components with apparent weights of >240, 60 and
16-19 kDa were common to the profiles of the somatic and NoG extracts.
Components with weights of about 96 and 72 kDa were also common to the profiles
of the NoG and CTAB extracts. A component with molecular weight of about
18 kDa was common in the non-reduced somatic and CTAB extracts. In addition,
the components of 32 and 27 kDa in the former could be the analogues of the 37 and
28 kDa components in the latter. The approximate molecular weights of the main
components are presented in Table 4.5.
4.6.3 Titration of Antigens, Serum, Conjugate and Biotinylated
Second Antibody
Titrations of ES products and somatic extracts of flukes against known
positive and negative serum, conjugate (goat anti-rat IgG) and biotinylated second
antibody (streptavidin alkaline phosphatase) using dot-blots (Bio-Rad) indicated that
optimal results were achieved when the dilutions of antigen, serum, conjugate and
second antibody were 3.5 pg/dot, 1:200, 1:1000 and 1:3000 respectively. These
were therefore the dilutions that were used in Western blot studies (Figure 4.23).
4.6.4 Probing of Antigens
Sera collected from sequential and final bleeds of rats used in the three trials
for raising antiserum as well as those from rats used for passive protection were
used to probe the ES and extracts of flukes. In addition, sera collected from rats that
had flukes and pathology in trial 2 was used to probe the complete culture medium.
4.6.4.1 Probing of ES of adult fluke with sera obtained from rats used to
produce antiserum in trial 1 (non protective)
Serum obtained from the final bleeding of rats with fluke and liver
pathology in this trial did not confer significant protection upon recepient rats. This
serum as well as sera from all the sequential bleeds from these rats were used to
probe ES of adult flukes. Sera similarly obtained from rats that had no flukes and
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Table 4.5 Proteins in silver-stained somatic and detergent extracts of adult
F. hepatica
Reduced state Non-reduced state
Somatic NoG CTAB Somatic NoG CTAB
>240 240
- 226-240 - - 117 -
205-240 - - - - 110
109 - - - - 101
- 102 - 101 - -
- 94 - - 96 96
- - 88 85 - -
- 75 - - - 72
- 68 - - 70 -
65-68 65 - - 60 -
- 62 - 58 - -
- - 55 - - 51
- - 48 - - 43
43 - - 37 - -
- - 41 - - 32
- 32 - 28 - -
28 - - - - 27
- - 27 25 - -
- - 26 - - 18
25 - - 17 - -
- 22-25 - - 16-21 -












Dot-blot titration of ES products of adult F. hepatica using DO (row 2). D14 (row 3),
D28 (row 4), D42 (row 5) and D56 (row 6) sera from rats with fluke and pathology
(Column a - d), no flukes but pathology ((column e - g) and neither flukes nor
pathology (column i -1) in trial 1.
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with or without liver pathology in this trial was also used to probe the adult fluke
ES.
Probing with Sera from Rats with Flukes and Pathology
DO and D14 sera did not recognise any antigens in adult ES run under
reducing conditions. D28 sera faintly recognised an antigen of about 25 kDa. This
antigen was more strongly recognised by D42 and D56 sera. When used to probe the
non-reduced form of ESA, DO, D14 and D28 sera did not recognise any antigens but
D42 sera again recognised an antigen of about 27 kDa. This antigen was also more
strongly recognised by D56 sera. D56 sera recognised two additional antigens of
about 75 and 26 kDa (Figure 4.24).
Probing With Sera From Rats With No Fluke But Pathology
DO, D14 and D28 sera recognised no antigens in the reduced form of adult
ES but D42 and D56 sera recognised the 25 kDa antigen. This recognition was very
weak. In the non-reduced form of adult ES, DO, D14 and D28 sera again did not
recognise any antigens but D42 and D56 sera recognised the 27 kDa antigen. In
addition, a doublet of about 19 kDa was recognised by both sera while an additional
antigen of about 75 kDa was recognised by D56 sera (Figure 4.25).
Probing With Sera From Rats With Neither Fluke Nor Pathology
Sera obtained from sequential and final bleeds of these rats did not recognise
any antigens in ESA whether reduced or non-reduced (Figure 4.26).
4.6.4.2 Probing of various fluke extracts with sera obtained from
sequential bleeds in trial 2 to produce (protective) antiserum
Excretory/Secretory Products of DO, Dl, D14 and Adults
DO, D14 and other sera collected subsequently from rats that had fluke and
liver pathology did not detect any antigens in complete culture medium run under





Western blots of ES products of adult F. hepatica probed with DO (track 1),
D14 (track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats
with flukes and liver pathology in trial 1. Gels were run under either reducing





Western blots of ES products of adult F. hepatica probed with DO (track 1),
D14 (track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats
with no flukes but pathology in trial 1. Gels were run under either reducing (a)




Western blots of ES products of adult F. hepatica probed with DO (track 1), D14
(track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats with




Western blots of complete culture medium probed with DO (track 1), D14
(track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats with
flukes and pathology in trial 2. Gels were run under either reducing (a) or non-
reducing (b) conditions.
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DO, D14 and D28 sera from rats that had flukes and liver pathology did not
recognise any antigens in the ES0 or ESj run under reducing conditions. An antigen
of about 191kDa was identified by D42 and D56 sera (Figures 4.28 and 4.29).
DO, D14 and D28 sera did not recognise any antigens in the ES14 whether
gels were run under reducing or non-reducing conditions. A 25 kDa doublet was
detected by D42 and D56 sera (Figure 4.30).
DO, D14 and D28 sera from rats that had flukes and pathology did not
recognise any specific antigen in ESA run under reducing or non-reducing
conditions. A 25 kDa doublet was recognised in the reduced form of the ES by D42
and D56 sera. Sera collected on these days also detected a major antigen of about 26
kDa and a minor antigen of about 27 kDa in the non-reduced form of the extract
(Figure 4.31).
Pooled sera obtained from sequential and final bleeds of rats that had neither
fluke nor pathology in this trial did not detect any antigens in ESA (Figure 4.32).
Somatic (PBS) Extract of Adult Fluke
DO sera did not react with any components in somatic extract run under
reducing conditions. However, D14 and D28 sera faintly recognised a 38 kDa
antigen while D42 and D56 (I2) sera recognised three additional antigens of <15, 23
and 24 kDa. When the extract was run under non-reducing conditions, again DO sera
did not react with any components while D14 and D28 sera faintly recognised a
singlet of about 23 kDa and two doublets of about 43 and 48 kDa. D42 sera did not
recognise the 48 kDa doublet but the 23 kDa antigen was more strongly recognised.
D56 sera (I2) recognised the same antigens that were detected by D42 sera but two
additional antigens (<15 and 63 kDa) were also recognised (Figure 4.33).
Surface NoG Extract of Adult Flukes
No antigens were recognised by DO sera but D14 and D28 sera both faintly
recognised five antigens with apparent weights of <15, 25, 38, 48 and 62 kDa in this






Western blots of ES products of DO F. hepatica collected over 0-24h (a) and
24-48h (b) and probed with DO (track 1), D14 (track 2), D28 (track 3), D42
(track 4) and D56 (track 5) sera from rats with flukes and pathology in trial 2.
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Figure 4.29.
Western blots of ES products of D1 F. hepatica probed with DO (track 1), D14
(track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats with
flukes and pathology in trial 2. Gel was run under reducing conditions
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Figure 4 30.
Western blots of HS of D14 F. hepatica probed with DO (track 1), D14 (track 2),
D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats with flukes and







Western blots of ES products of adult F. hepatica probed with DO (track 1), D14
(track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats with flukes






Western blots of ES products of adult F. hepatica probed with DO (track 1), D14
(track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats with neither


















Western blots of PBS-PI extracts of adult F. hepatica probed with DO (track
1), D14 (track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats
with flukes and pathology in trial 2. Gels were run under either reducing (a) or
non-reducing (b) conditions.
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25 kDa was more strongly recognised and the 62 kDa was recognised as a doublet.
Apart from all the antigens detected by sera collected earlier in the infection, D56
sera faintly detected a doublet of about 75 kDa (Figure 4.34).
Surface CTAB Extract of Adult Flukes
DO and D14 sera did not react with any components in CTAB extract run
under reducing conditions but D28, D42 and D56 sera recognised an antigen of
about 25 kDa. When the extract was run under non-reducing conditions, DO and
D14 sera detected no antigens but D28 sera faintly recognised a doublet of about
48 kDa while D42 and D56 sera recognised an additional antigen of about 25 kDa.
In addition, D56 sera also faintly recognised an antigen of about <15 kDa (Figure
4.35 and Table 4.6).
4.6.4.3 Probing parasite extracts with sera from rats that received
antiserum in passive protection trial 2
Pooled sera obtained from sequential and final bleeds of rats that were
injected with antiserum in passive protection trial 2 were used to probe ES14 and
ESa as well as NoG detergent extracts of adult flukes in order to check for transfer
of potentially protective antibodies and to monitor the pattern of antibody
development in these rats. Pooled sera from rats injected with antiserum but which
had no flukes and no apparent liver lesions were also used to probe these ES
preparations and extracts as well as ES0. The ES products of D1 flukes were not
used for probing because the amount available was too little.
ES Extracts of Flukes
Pooled sera collected from rats given immune serum I2 1 and 3 days after
infection recognised a 25 kDa doublet in ESi4 run under reducing conditions. These
antigens were also faintly recognised by D14 sera but not by D28 sera. However,
the antigens were again detected by D42 and D56. A similar pattern was observed
when the sera was used to probe the non-reduced form of this ES (Figure 4.36).
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Figure 4,34,
Western blots ofNoG surface detergent extracts of adult F. hepatica probed
with DO (track 1), D14 (track 2), D28 (track 3), D42 (track 4) and D56




Western blots ofCTAB detergent surface extracts of adult F. hepatica probed with
DO (track 1), D14 (track 2), D28 (track 3) D42 (track 4) and D56 (track 5) sera
from rats with flukes and pathology in trial 2. Gels were run under either reducing
(a) or non-reducing conditions (b)
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Table 4.6 Antigens recognised in ES and extracts of flukes by sera obtained
from sequential bleeds of rats with flukes and pathology in trial 2
Extract Day after infection at which sera was collected
0 14 28 42 56
R NR R NR R NR R NR R NR
MED -ve -ve -ve -ve -ve -ve -ve -ve -ve -ve
es0 -ve ND -ve ND -ve ND 191 ND 191 ND
es] -ve ND -ve ND -ve ND 191 ND 191 ND
es14 -ve -ve -ve -ve -ve -ve 25 25 25 25
esa -ve -ve -ve -ve -ve -ve 25 27 25 27
26 26
63
pbs-pi -ve -ve 38 48 38 48 38 - 38 -
43 43 24 43 24 43
- - 23 24 23 24
23 23 <15 23 <15 23
<15




62 * 62 * 62 * 62 *
NoG 48 48 48 48
38 38 38 38
25 25 25 25
<15 <15 <15 <15 <15
<15




Western blots of ES products of D14 F. hepatica probed with DO (track 1), D1
(track 2), D3 (track 3), D14 (track 4), D28 (track 5), D42 (track 6) and D56 (track 7)
sera from rats injected with antiserum in passive protection trial 2. Gels were run
under either reducing (a) or non-reducing (b) conditions.
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Pooled sera collected from rats given immune serum I2 1 and 3 days after
infection recognised a 25 kDa doublet in ESA run under reducing conditions. D14
and D28 sera still recognised these antigens but this recognition was very faint.
These antigens were again strongly recognised by D42 and D56 sera. When the
same serum was used to probe the non-reduced ESA, one major antigen of about
26 kDa and a minor one with apparent weights of about 27 kDa were revealed. D14
and D28 sera recognised both antigens but this recogntion was very faint. The
antigens were again strongly recognised by D42 and D56 sera (Figure 4.37).
NoG Extract of Adult Fluke
Five antigens with apparent weights of <15, 25, 38, 48 and 63 kDa were
recognised in the reduced form of this extract by D1 and D3 sera. The 25 kDa was
recognised as a major antigen. D14 sera did not recognise the 48 and 38 kDa
antigens and only weakly recognised the other three antigens. D28 sera recognised
only the <15 kDa antigen while D42 and D56 sera both strongly recognised the 25
and <15 kDa antigens (Figure 4.38 and Table 4.7).
Probing Parasite Extracts With Sera From Rats Injected With Antiserum But
Which Had No Flukes Or Pathology At Necropsy In Passive Protection Trial 2
Pooled D1 and D3 sera from these rats strongly recognised the 191 kDa
antigen in ES0 run under reducing conditions. Although D14 and D28 sera still
recognised this antigen, the recognition was progressively weaker. D42 and D56
sera did not recognise this antigen (Figure 4.39).
The doublet with an apparent weight of about 25 kDa was detected by
pooled D1 and D3 sera in ES14 run under reducing conditions but notably, sera
collected subsequently did not recognise these antigens at all. A similar pattern was
observed following probing of the non-reduced form of this ES (Figure 4.40).
D1 and D3 sera recognised the 25 kDa doublet and a minor antigen with
molecular weight of <15 kDa in ESA run under reducing conditions. Notably, the





Western blots of ES products of adult F. hepatica probed with D0(track 1), D1
(track 2), D3 (track 3), D14 (track 4), D28 (track 5), D42 (track 6) and D56 (track 7)
sera from rats injected with antiserum in passive protection trial 2. Gels were run




Western blots of NoG extracts of adult F. hepatica probed with DO (track
1), D1 (track 2), D3 (track 3), D14 (track 4). D28 (track 5), D42 (track 6)
and D56 (track 7) sera from rats injected with antiserum in passive
protection trial 2. Gel was run under reducing conditions.
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Table 4.7 Antigens recognised in ES14, ESA and NoG extract of adult fluke
by sera obtained from rats injected with antiserum in passive
protection trial 2
Extract Day after infection at which sera was collected
1 3 14 28 42 56
R NR R NR R NR R NR R NR R NR




































Western blots of ES products of DO F.hepatica probed with DO (track 1), D1
(track 2), D3 (track 3), D14 (track 4), D28 (track 5), D42 (track 6) and D56 (track
7) sera from rats injected with antiserum but which had neither flukes nor
pathology in passive protection trial 2. Gel was run under reducing conditions.
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Figure 4.40.
Western blots of ES products of D14 F. hepatica probed with DO (track 1), D1
(track 2), D3 (track 3), D14 (track 4), D28 (track 5) D42 (track 6) and D56 (track
7) sera from rats injected with antiserum but which had neither fluke nor
pathology in passive protection trial 2. Gels were run under either reducing (a) or
non-reducing (b) conditions.
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obtained by D56 of infection did not recognise these antigens. A similar pattern was
observed when the sera were used to probe the non-reduced form of ESA. Pooled
D1 and D3 sera also recognised antigens with apparent weights of 26 and 27 kDa in
this extract. The recognition of these antigens again notably decreased as the
infection progressed, such that by D56 the 27 kDa antigen was only very weakly
recognised (Figure 4.41).
D1 and D3 sera recognised antigens with apparent weights of 63, 48, 38, 25
and <15 kDa in the reduced form of NoG extract. The 25 kDa was a major antigen.
D14 and D28 sera did not recognise the 63, 48 and 38 kDa antigens. However, D28
sera faintly recognised the 25 and <15 kDa antigens. Neither D42 nor D56 sera
recognised the 25 kDa antigen (Figure 4.42).
4.6.4.4 Probing ESA with sera collected from rats used in passive
protection trial 1
ESa was probed with sera obtained from rats given antiserum in the first
passive protection trial in order to monitor the pattern of antibody development in
these rats.
The 25 kDa doublet in ESA (reducing conditions) was recognised by D14
sera. The recognition of these antigens was weaker when the ES was probed with
D28 sera. D42 and D56 sera both strongly recognised these antigens again. A
similar pattern was observed with ES that was run under non-reducing conditions
(Figure 4.43).
4.6.4.5 Probing adult fluke extract with sera from rats used in trial 3 to
produce antiserum
Sera (I3) collected following exsanguination of the rats used in this trial
significantly protected recipient rats against oral challenge. This serum, as well as
sera collected earlier in the infection, were used to probe ES and the somatic extract
of adult flukes in order to monitor the pattern of antibody development.
D14 and D28 sera recognised two antigens (25 kDa doublet and <15 kDa) in





Western blots of ES products of adult F. hepatica probed with DO (track 1), D1
(track 2), D3 (track 3), D14 (track 4), D28 (track 5), D42 (track 6) and D56
(track 7) sera from rats injected with antiserum but which had neither flukes
nor pathology in passive protection trial 2. Gels were run under either reducing
(a) or non-reducing (b) conditions.
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Figure 4.42.
Western blots of surface NoG extracts of adult F. hepatica probed with DO
(track 1). D1 (track 2), D3 (track 3), D14 (track 4). D28 (track 5), D42
(track 6) and D56 (track 7) sera from rats injected with antiserum but which
had neither flukes nor pathology in passive protection trial 2. Gel was run
under reducing conditions.
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Table 4.8 Antigens recognised in ES0, ES14, esa and NoG extract of adult
fluke by sera obtained from rats injected with antiserum but
which had neither flukes nor pathology in passive protection trial
2
Extract Day after infection at which sera was collected
1 3 14 28 42 56
R NR R NR R NR R NR R NR R NR
ES0 191 25 191 ND 191 ND 191 ND -ve ND -ve ND
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Figure 4.43.
Western blots of ES products of adult F. hepatica probed with DO (track 1),
D14 (track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats
injected with antiserum in passive protection trial 1. Gels were run under
either reducing (a) or non-reducing (b) conditions.
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Sera also recognised these antigens. An additional antigen (68 kDa) was recognised
by this serum in ESA (non-reduced). D56 serum detected three additional antigens
of 20, 17 and <15 kDa in the non-reduced ESA (Figure 4.44 and Table 4.9).
D14 sera recognised a 53 kDa doublet in reduced adult PBS-PI somatic
extract. An additional 25 kDa doublet antigen was faintly recognised by D28 serum.
D42 and D56 sera both recognised two additional antigens, a doublet of <15 kDa
and an antigen of about 62 kDa. When this extract was run under non-reducing
conditions, a 53 kDa antigen was recognised by D14 and D28 sera. Two additional
antigens of about 43 and 24 kDa were recognised by D42 sera, while D56 sera
detected yet an additional <15 kDa doublet antigen (Figure 4.45 and Table 4.9).
4.6.4.6 Probing western blots of ESA with pooled total sera obtainedfrom
sequential bleeds of rats injected with antiserum in passive
protection trial 3
Pooled D1 and D3 sera specifically recognised a doublet of about 25 kDa in
ESa run under reducing conditions. These antigens were still detected, though
weakly, by D14 and D28 sera but very strongly by D42 and D56 sera. An additional
antigen with an apparent weight of <15 Da was also detected by D56 serum.
D1 and D3 sera detected antigens of about 75, 27, 26, 20 and 17 kDa in the
non-reduced ESA. These antigens were also detected by D14 and D28 sera but D42
and D56 sera only faintly detected the 17 and 20 kDa antigens. (Figure 4.46).
Probing Western Blots of ESA With Sera From Rats With Pathology But No
Flukes
Gel profiles using reduced extracts were very similar to that described when
total pooled sera was used. Some differences were noticed when this sera was used
to probe ESA run under non-reducing conditions. D42 serum only recognised the 27
and 26 kDa antigens. While D56 serum also recognised these two antigens and
faintly recognised the 20 kDa antigen (Figure 4.47).
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Figure 4,44.
Western blots of ES products of adult F. hepatica probed with DO (track 1),
D14 (track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from rats
with flukes and pathology in trial 3. Gels were run under either reducing (a) or
non-reducing (b) conditions.
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Table 4.9 Antigens specifically recognised in ES and somatic (PBS-PI)
extract of adult fluke by sera obtained from rats with flukes and
pathology in trial 3
Extract Day after infection at which sera was collected
0 14 28 42 56
R NR R NR R NR R NR R NR
esa -ve -ve 25 25 25 68 25 68
<15 26 <15 26 <15 26 <15 26
25 25 25 25
- - - 20
- - - 17
- - " <15
PBS-PI 62
-ve -ve 53 53 53 53 53 53 53 53
- - 25 - 25 43 25 43
- - - <15
Figure 4,45,
Western blots of PBS-PI extracts of F. hepatica probed with DO (track 1),
D14 (track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera from
rats with flukes and pathology in trial 3. Gels were run under either













Western blots of ES products of adult F. hepatica probed with DO (track 1), D1
(track 2), D3 (track 3), D14 (track 4), D28 (track 5), D42 (track 6) and D56
(track 7) sera from rats injected with antiserum in passive protection trial 3.




Wetern blots of ES products of adult F. hepatica probed with DO (track 1),
D1 (track 2), D3 (track 3), D14 (track 4) D28 (track 5), D42 (track 6) and D56
(track 7) sera from rats injected with antiserum but which had neither flukes
nor pathology in passive protection trial 3. Gels were run under either
reducing (a) or non-reducing (b) conditions.
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4.7 STUDIES ON ES AND SOMATIC PROTEINS OF FLUKES
BIOSYNTHETICALLY LABELLED WITH 35S-METHIONINE
Excretory/secretory proteins of various developmental and adult stages of F.
hepatica were biosynthetically radio-label led, the labelling being repeated twice for
all expect D28 and D42 flukes. Somatic extracts of biosynthetically radio-labelled
D28, D42 and adult flukes were prepared in PBS-PI-NP40.
4.7.1 Total Biosynthetically Radio-labelled Proteins in ES Products of
Flukes
The total radio-labelled ES proteins of the various stages were compared,
and their profiles are presented in Figure 4.48 (a and b) and Table 4.10 (a and b)
summarises the sizes of the main components.
The biosynthetically radiolabeled ES of various ages of flukes showed
noticeable similarities and differences. In the reduced state, DO flukes had the
simplest profile, with only three minor components. In contrast, the ES of D1 flukes
(ES]) contained an array of components. All the components of DO ES (ES0) were
present in ES] but there were nine new components. A component of about 39 kDa
in ES14 was possibly an analogue of the 36 kDa component in ESi. The component
of about 30 kDa in ES, was expressed as a major component with an apparent
molecular weight of about 26-30 kDa in ES]4. All the remaining new components
that were detected in ES] as well as another component of about 27 kDa were not
detectable in ES14. ESI4 was quite similar to the ES products of D28 flukes (ES28)
but few differences were apparent. One new, moderately strong, component of
about 16 kDa was expressed in ES28. ES42 was again similar to ES28. However, a
new component of 119 kDa was expressed by D42 flukes. Another new component
of about 14 kDa may be the same as the 16 kDa component in ES28. Slight
differences could be noticed in the ES of D42 and adult flukes (ESA). A moderately
expressed component of about 40 kDa as well as a minor component of about 119
kDa in the former were not present in the latter. Conversely, minor components of
about 87, 93 and 107 kDa detected in the latter were absent in the former.
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Figure 4.48a.
Total biosynthetically radio-labelled ES proteins of DO (track 1), D1 (track 2), D14 (track
3), D28 (track 4), D42 (track 5) and D56 (track 6) F. hepatica. Gels were run under either




Total biosynithetically radiolabeled proteins in PBS-PI-NP40 extracts of D28
(track 1), D42 (track 2) and D56 (track 3) F hepatica. Gels were run under either
reducing (a) or non-reducing (b) conditions
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Tabic 4.10a Apparent molecular weights of proteins detected in
biosynthctically (35S-mcthioninc) radio-labelled ES products of
flukes run under reducing conditions
Age of fluke in days





































Tabic 4.10b Apparent molecular weights of proteins detected in
biosynthetically (35S-methioninc) radio-labelled ES products of
flukes run under non-reducing conditions
Age of fluke in days
0 1 14 28 42 56
>200
- - - - 119 -
- 92 - - - 92
- 82 - - - -
- - - - 79 -
- 77 - - - -
69 69 69 69 69 -
- - - - - 62
- 55 - - - -
- 46 46 46 46 46
- 40 - - - -
- - 36 36 36 -
30 - - - - -
- 28 - - - -
- - - 26-30 26-30 26-30
- - 23-30 - - -
21 21 - - 21 21
<14
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When the ES were run under non-reducing conditions, variations and
similarities were still apparent. Again, ES0 had the simplest profile, consisting of
one major (69 kDa) and two minor (30 and 21 kDa) components. The minor
components were both detected in ES( and the 69 kDa component may be an
analogue of a major component of about 69 kDa in ESj. Apart from these
similarities, five new components were seen in ESj. That of >200 kDa was a major
component. The ESI4 did not contain the 21, 55, 75 and >200 kDa components but
it contained all other components detected in ESj, although the molecular weights
were not always exactly the same. The component with an apparent weight of 23-30
in ESj4 was expressed as a major component while the 46 and 69 kDa components
were moderately well represented. There were only slight differences between ES14
and ES28. The 69 kDa component was more strongly expressed in ESI4, while the
46 kDa component was more strongly expressed in ES28. ES28 was again quite
similar to ES42 although there were minor differences. A new component of about
119 kDa was detected in ES42. This component (119 kDa) and another of about 36
kDa were not detected in ESA.
4.7.2 Total Biosynthetically Radio-labelled Proteins in Somatic (PBS-
PI-NP40) Extracts of Flukes
The profiles of PBS-PI-NP40 extracts of biosynthetically radio-labelled D28
and D42 flukes were quite similar. When run in the reduced state, the only apparent
differences were two components of about 46 kDa in the extract of D42 flukes,
which were absent in the D28 extract. Fewer components were detected in the
extract of adult fluke. Similar sized components were detected in the extracts of the
other two ages of fluke.
In the non-reduced state, there were still similarities in the profiles of D28
and D42 fluke extracts. However, two moderately expressed components (146 and
134 kDa) as well as four minor components within the <14 to 21 kDa range in the
extract of D28 fluke were not present D42 fluke extract. A major component of 28-
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30 kDa detected in the extract of adult fluke was close in size to the 31-35 kDa
component in the extracts of D28 and D42 fluke. A second component of about 72
kDa in the non-reduced adult fluke extract was not present in the extract of D42
fluke but could be similar to a faintly expressed minor component of about 70 kDa
in the extract of D28 fluke.
The apparent weight of all components detected in these extracts are
presented in Table 4.11.
4.7.3 Immuno-coprecipitation Studies Using Sera Obtained From
Trial 1
Sera obtained from sequential and final bleeds of rats that had flukes and
liver pathology or liver pathology without flukes in trial 1 (rats used to produce
transferred serum in trial 1) was was used to probe the biosynthetically labelled ES
proteins of adult flukes.
D14 serum from rats with flukes and pathology in trial 1 faintly detected an
antigen of about 39 kDa as did sera obtained subsequently. The antigen was not
detected in ES that was run under non-reducing conditions but an antigen of about
68 kDa was detected by D56 serum (Figure 4.49).
Sera obtained at D28 and subsequently from rats with liver pathology but no
flukes faintly recognised an antigen of about 37 kDa in ES that was run under
reducing but not under non-reducing conditions. This recognition was again very
faint (Figure 4.50).
Sera obtained from rats that had neither flukes nor pathology did not
specifically recognise any antigen in ESA run under either reducing or non-reducing
conditions.
4.7.4 Probing ES Products With Sera Obtained From Trial 2
The sera obtained from sequential and final bleeds of rats that had flukes and
pathology in trial 2 (I2) were used to probe the ES of DO. D14, D28, D42 and
140
Table 4.11 Apparent molecular weights of proteins in saline somatic extracts
of flukes run under reducing and non-reducing conditions
Reducing Non-reducing
Age of flukes in days
28 42 56 28 42 56
43 146
41 - - 134 - -
- 36-39 - 92 92 -
30-36 - 30 - 69 -
- 24 - 66-76 - 67
- 23 - 55 55 -
21 - 21 46 46 -
20 20 - 43 43 -
18 - - 39 39 -
- 16 - 31-35 31-35 -
- - 14 - - 28-30







Immune-coprecipitation of biosynthetically radio-labelled ES proteins of adult F.
hepatica probed with DO (track 1), D14 (track 2), D28 (track 3), D42 (track 4) and
D56 (track 5) sera from rats with flukes and pathology in trial 1. Gels were run




Immune-coprecipitation of biosynthetically radio-labelled ES proteins of adult F.
hepatica probed with DO (track 1), D14 (track 2), D28 (track 3), D42 (track 4) and
D56 (track 5) sera from rats with no flukes but pathology in trial 1. Gels were ran
under either reducing (a) or non-reducing (b) conditions.
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adult flukes. In addition, sera from rats that had liver pathology but no flukes and
those that had neither liver pathology nor flukes were used to probe ES,4.
4.7.4.1 Probing with sera from rats with flukes and pathology
D14 and D28 sera from these rats recognised an antigen with apparent
weight of about 26 kDa in ES0 run under reducing conditions. This antigen was
hardly recognised by sera obtained at day 56. (Figure 4.51). The non-reduced form
of this ES was not probed due to limited availability of the ES.
DO and D14 sera did not recognise any antigens in ES14. A major antigen of
about 35 kDa was recognised in the reduced form of this ES by D28, D42, and D56
sera (12). This antigen was not recognised in the non-reduced form of the ES (Figure
4.52).
An antigen of about 35 kDa was recognised in the reduced form of ES28 by
D14, D28, D42 and D56 sera. These sera did not recognise any antigens in the non-
reduced form of this ES (Figure 4.53).
DO sera did not recognise any antigens in ES42 but D14 sera detected an
antigen of about 38 kDa in this ES run under reducing conditions. This antigen was
also recognised by D28, D42 and D56 sera. The antigen was recognised as a major
antigen by these sera. (Figure 4.54).
An antigen with apparent weight of about 38 kDa was recognised in the
reduced form of ESA by D14, D28, D42 and D56 sera. The recognition of this
antigen was very faint. No antigens were detected in the non-reduced form of this
ES. (Figure 4.55).
4.7.4.2 Probing with seraJrom rats with pathology but noJlukes
DO, D14 and D28 sera from these rats did not specifically recognise any
antigens in ESi4 run under reducing conditions that were not recognised by DO
serum but D42 sera very faintly recognised an antigen of about 35 kDa in the ES.




Biosynthetically radio-labelled ES proteins of DO F. hepatica probed with
DO (track 1), D14 (track 2), D28 (track 3) and D56 (track 4) sera from rats
with flukes and pathology in trial 2. Gel was run under reducing conditions.
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Figure 4,52.
Biosynthetically radio-labelled ES proteins of D14 F. hepatica probed with DO
(track 1), D14 (track 2), D28 (track 3), D42 (track 4) and D56 (track 5) sera
from rats with flukes and pathology in trial 2. Gels were run under either
reducing (a) or non-reducing (b) conditions.
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Figure 53.
Biosynthetically radiolabelled ES proteins of D28 F. hepatica probed with PBS
(track 1) and DO (track 2), D14 (track 3), D28 (track 4), D42 (track 5) and D56
(track 6) sera from rats with flukes and pathology in trial 2. Gels were run under
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Figure 4 54.
Immune coprecipitation of biosynthetically radio-labelled ES proteins
of D42 F. hepatica probed with PBS (track 1). and DO (track 2), D14
(track 3), D28 (track 4). D42 (track 5) and D56 (track 6) sera from rats





Immune co-precipitation of biosynthetically radio-labelled ES proteins of
adult F. hepatica probed with DO (track 1), D14 (track 2), D28 (track 3),
D42 (track 4) and D56 (track 5) sera from rats with flukes and pathology
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Figure 4,56.
Immune-coprecipitation of biosynthetically radio-labelled ES proteins of D14 F.
hepatica probed with DO (track 1), D14 (track 2), D28 (track 3), D42 (track 4) and
D56 (track 5) sera from rats with no flukes but pathology in trial 2, Gels were run
under either reducing (a) or non-reducing (b) conditions.
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4.7.4.3 Probing with serafrom rats with neitherfluke norpathology
Neither preinfection nor any sequential post-infection sera obtained from rats
with neither flukes nor pathology in trial 2 recognised any antigens in ESU run




The rat (Thorpe, 1965; Hayes et al., 1972, 1974c) and cattle (Ross, 1967;
Doyle, 1971) unlike sheep (Sinclair, 1962; Boray, 1967; Rushton, 1977), are known
to be capable of developing protective immunity against F. hepatica following a
primary infection. The ability of mice (Lang, 1967; 1968; Harness, et al., 1977a; b)
and rabbits (Healy, 1955; Ross, 1966; Kendall et al., 1967; Kendall and Sinclair,
1971; Fortmeyer, 1973; Bolbol, 1975) to develop protective immunity appears
controversial. In the rat this immunity is effective against oral challenge with
metacercariae or parenteral challenge with newly excysted (Goose and MacGregor,
1973; Doy et al., 1978), juvenile or adult flukes (Goose and MacGregor, 1973;
Hughes, Anderson and Harness, 1976). Sera from infected rats and cattle is able to
confer resistance against challenge in naive recipients, indicating the involvement,
direct or otherwise, of antibody (Rajasekariah and Howell, 1979; Pfister et al.,
1984/85; Corba et al., 1971; Haroun et al., 1981).
The rat is often used, as in this study, as a laboratory model for cattle and for
studying host-parasite interactions in fasciolosis due to its similarity to the cattle.
Interestingly, sera from hosts such as rabbits and sheep which are known to
be incapable of mounting resistance after a primary exposure have also been shown
to be capable of conferring protection when transferred to naive heterologous
recipients (Haroun, 1979, Haroun et al., 1981).
The successful establishment of the fluke infection supports earlier views
(Lammler, 1959; Thorpe, 1965) on the suitability of outbred albino rats, the strain
selected for this study, as laboratory hosts for F. hepatica.
In this study rats were infected at 5-6 weeks of age, a time at which they are
fully susceptible to infection with F. hepatica (Goose and MacGregor, 1974;
Rajasekariah and Howell, 1977). A slight unintentional mortality occurred in rats
given an oral dose of 10-20 metacercariae, however, this dose rate was generally
suitable for the production of a chronic infection.
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Variation was observed in the percentage establishment of flukes in the three
trials. Rats in the first trial each received a dose of 10 metacercariae while rats in
trials 2 and 3 each received a dose of 20 metacercariae but the percentage of
establishment varied widely with more flukes becoming established in primary
infection for trials 1 and 3 than trial 2. It is therefore possible that the metacercariae
used in the two former trials were more infective than those used in trial 2.
The metacercariae used in the three trials were obtained from different
sources and this might be a source of variation (Dawes, 1962). Even batches of
metacercariae of similar morphology derived from the same source on different
occasions have been shown to differ in infectivity (Thorpe, 1965). Individual
differences in the immune responsiveness of the rats to F. hepatica could well be
expected in outbred rats and may also have been responsible for such variation
(Thorpe, 1965; Pfister et al., 1984\85) but variation may be expected to be evened
out when using groups of experimental hosts. Urquhart (1954), after giving a
standard dose of metacercariae observed differences in the number of flukes
developing in rabbits but attributed this to differences in technique for dosing
individual animals. In the present trials, the technique of dosing could not be ruled
out as a factor since rats infected by direct stomach tubing in trial 3 had, on the
average, more flukes per rat than rats infected by oesophageal intubation in trial 1.
It was interesting that in some rats no flukes were recovered but liver
pathology was evident. In such rats the infection must have established initially as
evidenced by the immune response measured by ELISA but was thereafter
eliminated. The mechanism for this elimination is not exactly known. In those rats
with neither flukes nor pathology, it is probable that the infection was eliminated at
a very early stage. These two groups might be inherent high responder groups of
rats.
The distribution pattern of the fluke recovered at post mortem in trials 1 and
2 were similar and both appeared to have a Poisson distribution. Thus the majority
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of infected rats had only a light infection, a pattern of distribution similar to what
might be expected in a natural infection. Even though the pattern of distribution was
slightly different in trial 3 in that the rats generally had a heavier fluke burden, the
majority of the infected rats still haboured comparatively low burdens.
The degree of protection afforded by the passive transfer of antiserum was
poorer in trial 1 than trials 2 and 3, in which the degree of protection was
statistically significant. However, the protection conferred by immune serum in all
the three trials was comparable to that reported by previous workers (Hayes et al.,
1974a; Haroun et al., 1981). The results of the present trials as well as those of
previous workers point to the fact that antibody does not confer complete (100%)
protection in fasciolosis. This might be expected since natural infection does not
stimulate sterile immunity (Hayes et al., 1974a; Hughes, Anderson and Harness,
1976; Boray, 1967). Moreover, cellular responses are known to play a role in
immunity to fasciolosis (Lang et al., 1967; Corba et al., 1971; Rajasekariah and
Howell, 1979; Armour and Dargie, 1974). The inability of antibody as well as
active immunization with synthesized or purified antigens (Balloul, Grzych, Pierce
and Capron, 1987; Wolowczuk, Auriault, Grass-Masse, Vendeville, Balloul, Tartar
and Capron, 1989; Wolowczuk, Auriault, Bossus, Boulanger, Grass-Masse,
Mazingue, Pierce, Grezel, Reid, Tartar and Capron, 1991) to confer complete
protection upon recipients has also been observed in S. mansoni, a closely related
trematode. Non-the-less, the present study confirms that antibody plays a significant
role in protection against infection with Fasciola spp.
It is difficult to explain why a significant protection was not achieved in the
first trial. The fact that serum used for this trial was obtained from rats that had a
primary infection of 10 metacercariae (compared to dose of 20 received by rats used
to raise antiserum in trials 2 and 3) might have contributed to this. However, the
aggregate number of flukes of all rats from which the antiserum (Ij) was pooled was
67. This is not markedly different from the aggregate number of flukes (69) of all
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rats used to produce antiserum (I2) transferred in the second passive protection trial.
The number of fluke per rat were similar, at 2.23 and 2.225 respectively.
Rajasekariah and Howell (1979) reported that serum from rats that had experienced
a primary infection of 5 metacercariae conferred a significant protection against oral
challenge in homologous recipients. Thus a dose of 10-20 metacercariae used in this
trial would have been expected to be enough. Although all metacercariae used were
apparently viable as assessed visually, it is possible that they varied in infectivity
and this might affect the number of flukes recovered at post mortem examination. It
is noteworthy that the design of the passive protection trials does not represent what
happens in the natural situation. Under natural conditions the sensitized intestine of
infected animals acts as the initial barrier to the invading newly excysted flukes
(Hayes and Mitrovic, 1977; Rajasekariah and Howell, 1977), apart from the fact that
all tissues of the host are permeated by immunoglobulin. It is quite probable that in
the present trials the immunoglobulin in the injected antiserum might not have
permeated the intestinal and other tissues well enough before the penetration of
intestinal walls by the invading flukes. If the antiserum had been injected about 24h
before challenge there might have been better protection than was observed.
Rats that received normal rat serum before infection with metacercariae in
the three trials consistently had a lower fluke burden than challenge control rats.
This apparent 'protection' afforded by normal rat serum was also noted by Hayes et
al., (1974b); Haroun et a/.,(1981); Mitchell et al.,(1981) and Chapman and Mitchell
(1982a) and emphasises the importance of including this control in such studies. The
protection is generally considered to be due to non-specific deleterious effects of the
serum on the fragile newly excysted flukes in the abdominal cavity (Mitchell et al.,
1981).
Rats that received antiserum from infected rats from trials 2 and 3 habouring
flukes and liver pathology at post mortem had less liver damage than the normal
serum or challenge control rats. This is a good indication that in the first group of
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rats most of the challenge flukes did not reach the liver, but must have been
destroyed in the abdominal cavity. A similar observation was made by Rajasekariah
and Howell (1977). Haroun et al. (1981) found that the serum glutamic
dehydrogenase levels in rats that received protective antiserum at challenge were
lower than those of normal serum and challenge control rats, which supports the
present observation relating to liver damage. The relative failure of passive
protection in trial 1 was reflected in the comparatively greater amount of liver
pathology in rats that received antiserum to F. hepatica in trial 1 as compared to
trials 2 and 3.
The sizes of flukes recovered from rats that received antiserum in the three
trials were similar to those recovered from normal rat serum and challenge control
rats. This confirms the results of previous workers and suggests that immune serum
has an "all or non effect" and those flukes that survive the effect of the immune
serum were able to develop normally (Haroun, 1979).
The pattern of antibody response (as monitored by ELISA using ES and
somatic extracts of adult fluke as antigens) of rats following a primary infection
with F. hepatica was similar in the three trials. The early antibody response
observed in infected rats by two weeks post infection against both parasite extracts
used suggests the existence of common antigens between the juvenile and adult
stages. By 14 days post infection, when serum was first collected the young
migrating juvenile flukes are already in the liver parenchyma. The steady increase in
antibody response suggests that the growth of the fluke in the liver parenchyma is
associated with continued stimulation of the host's immune responses. This is
probably because as the fluke grows its ability to produce metabolic products
increases. The migration of the young adult flukes into the bile ducts after D42 of
infection coincided with a decline in serum antibody. A similar pattern has been
described in rabbits (Lehner and Sewell, 1980) and rats (Oldham, 1985; Poitou,
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et al., 1992) infected with F. hepatica. However, the latter authors obtained a
second antibody peak at 10 weeks after infection.
Rats given immune serum in trial 1 had an elevated antibody level on day 14
(blood samples were not taken on days 1 and 3 from these rats). This initial
elevation was probably in part the result of the injected antiserum but, as the rats
were not significantly protected this initial elevation will have been maintained by
the response stimulated by the flukes resulting from the infection. In contrast, in
trials 2 and 3 this group of rats showed elevated antibody levels on days 1 and 3 but,
as most of the flukes appear to have been killed by the injected antiserum, the
antibody level declined thereafter. The slight elevation in antibody response seen in
trial 3 may be attributed to the fact that most of these rats had flukes even though
there was an overall significant reduction in their fluke burden.
The pattern of eosinophilia observed in rats during primary infection in the
present study was similar to available reports (see literature review). As total cell
counts were not done, it is impossible to know if this was an absolute or relative
eosinophilia. Non-the-less, the eosinophilia increased relative to preinfection levels
in the passive protection groups of rats at D28 post infection and rats that received
antiserum had lower eosinophil levels than rats given normal rat serum or challenge
control rats.
From the report of Milbourne and Howell (1990) that rats and mice infected
with F. hepatica or injected with ES products of adult fluke showed a rapid increase
in peripheral eosinophils, it could be suggested that the eosinophilia observed in the
present study was at least in part a response to ES products from the flukes. Thus, in
rats that received antiserum and which had significantly fewer flukes than the
normal serum and challenge control rats, there might have been less ES from the
flukes and hence, a lesser eosinophilia.
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Immunochemical Studies
In the immunochemical studies the total ES products of various ages of
flukes as well as detergent extracts of adult fluke were analysed by western blotting.
This is a powerful analytical tool that has been employed in studying various
parasites (Harrison, Parkhouse and Sewell, 1984; Gottstein, 1985; Janssen, Wit,
Rycke, De-Wit and De-Rycke, 1990; Homan, Derksen, Knapen and Van-Knapen,
1992). A disadvantage of this technique is the possibility of low molecular weight
proteins failing to bind or binding weakly to the support matrix (Hames and
Rickwood, 1990).
Biosynthetic labelling, which was also employed in the present study, has
the advantage that it affords the opportunity to study ES components which are
actively excreted and or secreted by a parasite, thus excluding waste and breakdown
products that could be present in total protein recovered from parasite cultures
(Joshua et al., 1988). Biosynthetic labelling has been employed by many
investigators (Parkhouse and Clark, 1983; Harnett, Meghji, Worms and Parkhouse,
1986; Sugane, Howell and Nichola, 1985; Wiest, Tisdale, Roberts, Rosenberry,
Mahmoud, and Tartakoff, 1988). The main disadvantage of this technique is the fact
that some of the proteins being synthesized by a parasite might be utilising amino
acids, other than the one being used in the labelling, as precursors. In addition, the
extent of incorporation is influenced by factors such as the amount of a particular
amino acid in a protein molecule (Colligan, Kruisbeek, Margulies, Shevach and
Strober, 1992) and the rate of metabolism of the parasite at any particular point in
its development (Harrison, personal communication).
Analysis of Fluke Extracts
PBS-PI-NP40 extracts of biosynthetically radio-labelled D28, D42 and adult
flukes as well as PBS-PI and surface detergent strips of adult flukes were studied to
a limited extent.
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The somatic (PBS-PI-NP40) extracts of 35S-methionine labelled D28, D42
and adult flukes did not contain many components. Compared to the extracts of D28
and D42, the adult fluke extract contained even fewer components. This may simply
have been because the autoradiographs, especially that of the adult fluke extract,
were not allowed to develop for a sufficiently long time.
The NoG extract apparently contained more components than the CTAB
extract. This seems to suggest that the two detergent extracts vary in the degree to
which they stripped the surface coats of the flukes. The former detergent has been
shown to be efficient for stripping the surface coats of Nematospiroides dubius
(Pritchard, Crawford, Duce and Behnke, 1985).
Apart from a singlet of about 25 kDa which appeared to be common to the
two extracts, there were no other similarities in antigens recognised by antiserum in
the extracts.
In western blot studies antigens of about <15, 25, 38, 48 and 62 kDa were
recognised in the NoG extract by D14 and subsequent sera from rats with flukes and
pathology in trial 2. This indicates that these components may be common to the
juvenile and adult flukes. These as well as other antigens (25 and 48 kDa) identified
in CTAB may be useful in early diagnosis of infection. Since the surface
compartment is a target for immune attack some of the components recognised in
these particular extracts could be of significance in protection.
Antigens recognised in the somatic extract are unlikely to be of diagnostic or
protective significance. This is because the host is only exposed to components of
this compartment after the death and disintegration of the parasite. However,
exposure to these components at this time may provoke a pathological reaction
(Parkhouse and Harrison, 1989).
Fewer antigenic components were detected in the PBS-PI extract examined
in this present study than were reported by Sloan et al. (1991) who probed
homogenates of adult flukes with sera from infected rats as well as monoclonal
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antibodies produced from rats that had been infected with F. hepatica. These
authors had made their adult fluke homogenates in SDS-buffer without any protease
inhibitors.
The 53kDa antigen recognised in the present study may be similar to a 53
kDa component reported by Keegan and Trudgett (1992) who used sera from
infected rats to probe western blots of adult fluke homogenate. However, several
other components (78, 95, 133 and 193 kDa) reported by these authors were not
recognised in the present study. Similarly, antigens of about <15, 22, 25, and 43
kDa recognised in the present study were not detected by the authors. These authors
did not state the method used to prepare their homogenates. Secondly, the authors
used sera diluted at 1:50 while in the present study sera was used at a dilution of
1:200.
The <15 kDa antigenic component detected in this study has about the same
size as the <14 kDa component detected by sera from infected rabbits in Western
blots of fractions (14-45 kDa) obtained from gel filtration of a homogenate of adult
flukes (Santiago and Hillyer, 1986). Other antigenic components detected by rabbit
antiserum were not detected in the present study, while components of 22 and 53
kDa detected in the present study were not detected by these authors. As discussed
earlier, the rat, unlike the rabbit, is similar to cattle (the appropriate host) in its
response to infection with Fasciola spp. The observed differences in antibody
response may well be a reflection of differences in antibody response of an
appropriate (rat) and inappropriate (rabbit) host. Such differences have been
demonstrated in infection of mice and cattle with Taenia saginata metacestodes
(Harrison, Parkhouse and Sewell, 1984). These differences may also have resulted
from the fact that these authors prepared their homogenates in PBS without the
inclusion of protease inhibitors.
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Analysis of ES Products of Flukes Maintained in Culture
The silver stained protein profile of DO and D1 ES were relatively simple in
contrast to those of D14 and adult flukes, which contained numerous components.
This could either mean that DO and D1 flukes synthesized very few components
over the 24h culture period or that they produced much less material than the larger
older flukes. The simple profile of DO and D1 fluke might also be related to the low
protein concentration of their ES products, which meant that about 15 times less
protein (0.03 ng and 0.08 ng of DO and D1 ES/mm2 of gel as opposed to 0.5 ng of
D14 and adult ES/mm2 of gel) was loaded into the gels and minor components
could not be detected.
Although the complete culture medium was run at the same concentration as
the D14 and adult ES, and about 15 times more protein than the DO and D1 ES, it
only revealed one component of about 67 kDa in the reduced state. This component
is likely to be bovine serum albumin from the foetal calf serum used in the medium.
This component might be or be part of the 63-77, 54-76, 67 and 60-75 kDa
components found in the reduced DO, Dl, D14 and adult fluke ES respectively.
Similarly, the component with apparent weight of 69 kDa in the non-reduced form
of medium is likely to be part of the components of about 56-66 kDa in DO and Dl
ES and components with apparent weight of 62 kDa and 69 kDa in D14 and adult
fluke ES respectively. It is apparent, therefore, that the other components detected in
ES of various ages of flukes were of parasite origin.
The similarity between ES of DO and Dl flukes on one hand and D14 and
adult flukes on the other hand may be related to maturation. It might also mirror the
similarity of the secretory granules of flukes of these two ages. Newly excysted
juveniles and young invading flukes (Dl) are known to possess TO granules which
are secreted onto the tegument, while the T1 granules are responsible for secretions
in the young and adult flukes (Hanna, 1980b).
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A comparison of the profiles of the biosynthetically radio-labelled ES
proteins with those of silver stained ES reveals that the former generally contained
fewer components than the latter, especially so for D14 and adult flukes. This may
be because biosynthetically radio-labelled components represent only those
components being actively synthesized during the culture period while the total ES
obtained from culture also includes parasite breakdown and waste products. As
already discussed, the amount of biosynthetically radio-labelled components
revealed is also influenced by the rate of metabolism of the flukes as well as the
composition of the proteins.
The major protein detected in the non-reduced ES of DO fluke is likely to be
passively labelled bovine serum albumin. Such passively labelled bovine serum
albumin was observed by Parkhouse, Clark, Maizels and Denham (1985) in
biosynthetic labelling of Brugia pahangi. As the passively labelled molecule was
precipitated by rat-anti-bovine serum albumin, the authors suggested that 35S-
methionine had complexed via sulphydryl linkage to the BSA in FCS during culture
period. This phenomenon does not seem to occur consistently. It was not observed
in biosynthetic labelling of T. spiralis (Parkhouse and Ortega-Pierres, 1984) but has
been observed in Litomosomoisoides carinii (Harnett, Meghji, Worms and
Parkhouse, 1986) and in T. saginata (Joshua et al., 1988). In this study the passive
labelling did not occur during biosynthetic labelling of D14 and D28 flukes. As yet
there is no clear explanation for the occurence of this phenomenon.
The differences in composition of biosynthetically radio-labelled ES of
various ages of flukes might be a reflection of the differences in functions of these
various ages.
The biosynthetically radio-labelled DO ES contained relatively less
components than its unlabelled form and also less components than the
biosynthetically radio-labelled D1 ES. This may mean that the D1 flukes are
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metabolically more active than the DO or that the DO has preformed pools ofmost of
the proteins it needs.
The main role of the DO fluke is the penetration of the intestinal wall and
entry into the abdominal cavity. Thus, it is possible that the components it excretes
or synthesized might be important for this activity. Also, at this stage of
development the parasite has to radically change its environment from the gut to the
abdominal cavity.
The D1 fluke stays in the abdominal cavity and the developing flukes
penetrate the liver by D2 or D3 (Dawes, 1964). Thus biosynthetically radio-labelled
components specific to D1 (36, 78, 82, 103, 155 and 168kDa in reduced form and
28, 40, 55 and >200 in the non-reduced form) could have enzymatic functions
necessary to digest the liver tissue. Enzymatic functions have been detected in the
ES of many heliminth parasites (Chapbell and Dresden, 1986; McKerrow, Pino-
Heiss, Lindquist and Werb, 1985; Hotez and Cerami, 1983; Hotez, Le Trang,
McKerrow and Cerami, 1985; Petralanda, Yarzabal and Piessens, 1986; Lindquist,
Senft, Petit and McKerrow, 1986; Robertson, Bianco, McKerrow and Maizels,
1989).
There were many apparent similarities in the biosynthetically radio-labelled
ES of D14, D28 and D42 flukes. In reduced form new components of about 39kDa
(40 kDa in ES of D42) and 26-30 kDa were common to the three stages while new
components of 36 and 46 kDa were detected in the non-reduced ES. These three
ages of flukes are all parenchymal flukes, and apparently they are the stage most
responsible for the host's immune response. It is therefore also probable that
components specific to the ES of these flukes could play an important role in the
evasion of the host's immune response. These components could be suppressive to
lymphocyte's functions or toxic to lymphocytes as has been demonstrated in Taenia
taeniaformis and adult F. hepatica respectively (Burger et al., 1986; Goose, 1978).
These ES components could also cause the alteration of functions of host
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macrophages, mast cells and granulocytes as been shown in infections with S.
mansnni (Butterworth, Remold, Houba, David, Franks, David and Sturrock, 1977;
Capron, Torpier and Capron, 1979; Mazingue, Camus, Dessaint, Capron and
Capron, 1980). Since these flukes, like the younger ones, also feed on blood and
liver tissue it is not unlikely that components in their ES might have proteolytic
functions.
ES of D42 fluke contained a new component of about 119kDa. This stage of
fluke must penetrate the bile ducts at about D50 (Dawes, 1964) and since this
component appears to be specific to this stage, it might be relevant to this
penetration. Similarly, the two new components (87 and 107 kDa) detected in ES of
adult flukes might be useful for adaptation of the fluke in its new bile duct
environment.
Western Blotting of ES Products
The ability of anti-F. hepatica antibodies to confer some degree of
protection against challenge infection (see literature review) was confirmed in the
passive protection trials described in this study. These antisera containing the
protective antibodies and also antisera from rats in the passive protection trials were
therefore used in western blotting studies to probe the ES of various ages of flukes
in order to identify components that might have a role in protection or be of
diagnostic significance.
No antigens were detected if the antiserum was used to probe the complete
medium run under either reducing or non-reducing conditions. This clearly indicates
that all the antigens detected in the various ES products were of parasite origin.
In this study, an antigen of about 191kDa was recognised in the ES products
of DO and D1 flukes. Although this antigen was not recognised by sera collected
earlier than D42, the 191 kDa component must obviously have been present in the
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flukes before D42 but antibodies could not be detected due to assay sensitivity and
the small amounts of parasite ES obtained from DO and D1 flukes. The fact that the
antigen was recognised by D42 and D56 sera suggests that the antibody to this
antigen persists in the serum for a long time. Earlier workers (Bennett, 1978;
Sandeman and Howell, 1981; Yoshihara et al., 1981) demonstrated that
metacercarial extracts (that is, DO) and newly excysted juvenile (Dl) flukes formed
precipitin lines in immunodiffusion reactions with antisera raised in rabbits against a
soluble extract of adult fluke, and antisera from infected rats and rabbits
respectively. The present study has extended this knowledge by characterizing the
antigen (191 kDa) that might be involved in this reaction at the molecular level.
Being produced by both the infective (DO) and invasive (Dl) stages of F. hepatica,
this antigen revealed in the present study is likely to be useful in immunodiagnostic
assays designed to detect antiparasite antibody in infected animals especially since
the antibody persists in the serum until the flukes are mature. In addition, as DO and
Dl flukes are those that are first exposed to the host's immune system, antigens
recognised in their ES might have a protective significance for the invading flukes
of a secondary challenge. That this antigen might be involved in protection is
supported by comparing the pattern of its recognition by pooled sera from rats
injected with antiserum in passive protection trial 2 with that of pooled serum from
rats in this group which had neither flukes nor pathology at post mortem. The fact
that in the latter group of rats this antigen was strongly recognised by pooled Dl and
D3 sera after which the recognition decreased with time suggests the involvement of
antibodies to this antigen in either direct antibody-mediated or eosinophil-mediated
destruction or mediating eosinophil destruction of invading juvenile flukes. The
later mechanism has been hypothesized for the destruction of larvae of Toxocara
canis (Badley, Grieve, Rockey and Glickman. 1987).
Similarly, the 25 kDa doublet recognised in the ES of D14 flukes might be
useful in host protection. This is especially so considering the fact that this antigen
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was recognised by protective antiserum and that a significant protection against oral
(Lang, 1974) and intraperitoneal (Lang and Dronen, 1972) challenge have been
obtained in mice implanted with this age of fluke prior to challenge. This antigen
has the same apparent weight as the 25 kDa singlet detected in the saline and
detergent extracts of adult flukes, but it might not be the same as these singlets. It is
apparent from the result of the second passive protection trial that the antibodies
produced against the 25 kDa doublet might have been involved in the destruction of
the juvenile flukes. Thus the antigen was strongly recognised by pooled Dl, D3 as
well as D42 and D56 sera from rats injected with antiserum. By contrast, only
pooled Dl and D3 sera from rats injected with antiserum but which had no flukes
and pathology at post mortem recognised this antigen. This implies that this
component might be present in the ES or surface compartment of invasive flukes so
that the antibodies which were produced by the host against an analogous
component in D14 ES was able to kill or mediate the killing of the juveniles. This
argument seems to be supported by the fact that immuno-coprecipitation of
biosynthetically radio-labelled ES of DO fluke detected an antigen of about 26 kDa,
implying that this component is actively secreted by DO flukes.
A doublet of about 25 kDa was recognised in the reduced form of adult ES.
This doublet might be analogous to the 25 kDa doublet in D14 ES. It might likely
be the reduced form of one of the two antigens (27 and 26 kDa) detected in the non-
reduced form of the ES. These antigens were recognised by sera from rats used to
raise antiserum in all three trials. The possible involvement of these components in
the destruction direct or otherwise of invading flukes is suggested by the result of
the second passive protection trial as discussed above. The fact that these
components were apparently more strongly recognised by antiserum I2 (compared to
their recognition by antisera I, and I3) might probably explain why antiserum I2
conferred the highest level of protection and this in turn argues for the possible
involvement of these antigens in promoting a protective response in the host.
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The spectacular pattern of antigen recognition by sera from rats used in
passive protection trial 2 was not obtained in the two other passive protection trials.
In the first passive protection trial rats were not significantly protected and hence
there was no noticeable decrease in recognition of the antigens. This means that
before the injected antibody was cleared from circulation the flukes from the
challenge infection had already started stimulating the production of antibody by the
rats. Of the rats that received antiserum in passive protection trial 3 only two had no
flukes at post mortem but they did have liver pathology. It is probable that in these
two rats the challenge flukes were not completely eliminated by the antiserum in the
abdominal cavity but were probably destroyed by the rat's immune system during
the course of infection, in which case the rats would have been exposed to products
from the flukes for some time.
The 25kDa antigen identified in reduced form of adult ES in this study was
of similar size to a 22.5 kDa antigen identified by Poitou et al. (1992) in western
blots of adult fluke ES by sera collected from rats from week 2 of infection with F.
hepatica. However, the authors also reported the identification of several other
components (see literature review) which were not identified in the present study.
These differences could be due to a variety of reasons. Firstly, the authors obtained
their sera from rats that were infected at 17-18 weeks of age. Secondly, the flukes
were cultured in ordinary saline whereas throughout this study we maintained flukes
in complete culture medium, a far richer medium, in order to protect the flukes from
tegumental disintegration caused by a hostile culture environment. Thirdly they used
sera diluted at 1:5 in skimmed milk, unlike in the present study when serum was
diluted at 1:200. Unfortunately, the authors did not support their result with pictures
of the western blots.
The 25 kDa antigen also falls within ranges (23-28 kDa) of proteins
identified by Santiago et al. (1986) by sera of infected rabbits in western blots of
adult fluke ES. However, other components reported by these authors (see literature
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review) were not detected in the present study. These authors had collected ES from
flukes that were maintained in ordinary PBS for 3h. In making this comparison it is
assumed that these authors ran their proteins under reducing conditions since they
did not state this in their papers.
The 25 kDa is also of similar size to components of 23 and 25-30 kDa
detected by sera from infected rabbits in western blots of 'reactive' fractions
obtained from gel filtration of adult fluke ES (Rivera-Marrero et al., 1988). Again
several other components (66, 95, 150-160) identified by these authors were not
revealed in the present study. These differences might have arisen due to differences
in host response. Apart from this, there were differences in culture conditions. These
authors maintained their flukes in PBS and, in the case of Rivera-Marrero et al.
(1988), with the addition of a protease inhibitor (PMSF) to the medium.
Of all the antigens recognised in western blots of adult fluke ES by
monoclonal antibodies purified from ascites fluid of mice that had been immunized
with ES of adult fluke (Solano et al., 1991) only the 29 kDa appears close to the 25
kDa detected in the present study. Apart from differences in host response discussed
earlier, the authors had maintained their flukes in Earle's salt solution without serum
or any essential amino acids, a condition which may well have affected the
composition of the ES.
Sera from rats with liver pathology but no flukes in rats that were infected
for production of antiserum in trial 1 moderately recognised a doublet of about 19
kDa. This might be an important component worthy of further investigation since
sera from rats with liver pathology and flukes in the three trials did not recognise
such a component.
Sera from rats that had neither flukes nor pathology among rats infected for
the production of antiserum in trials 1 and 2 did not detect any antigens in adult
fluke ES. However, the ELISA response of this group suggests their exposure, at
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least for a short time, to flukes. The lack of detection of antibody by these sera may
therefore be related to assay sensitivity.
It is noteworthy that when sera from rats injected with antiserum in passive
protection trial 2 was used to probe NoG surface extract, the 25 kDa singlet in the
extract was recognised in a similar pattern as described for D14 and adult ES.
Although it might not be the same protein as the 25 kDa doublet in D14 and adult
ES, it does appear to be important in protection in view of the pattern of its
recognition by sera from rats injected with antiserum but which had neither flukes
nor pathology. It is probable that this antigen is present on the surface of D1 fluke,
so that antibodies produced against the surface antigen of adult fluke was also
effective against the surface of invading D1 fluke. Indeed, Lammas and Duffus
(1985) identified a component of similar size (26 kDa) on surface of D1 flukes.
Immune-coprecipitation
An antigen of about 26 kDa was identified by D14 and D28 sera in
biosynthetically radio-labelled DO ES but not the equivalent of the 191 kDa
identified in the unlabelled form of this ES. This might be an indication that while
the former antigen utilises methionine as its precursor, the latter does not. It is
possible that the 26 kDa component was present in the unlabelled ES of DO and D1
flukes but in so small quantities as not to be detected by silver stained and western
blot preparations. The fact that the 26 kDa antigen was identified by D14 sera
means that it must have been produced by the flukes earlier than D14 of infection,
and could therefore be useful for diagnosis. The detection of this antigen by D14
and D28 sera may suggest that the antibodies to this antigen persist for a long time
in the circulation.
An antigen of about 38 kDa was recognised in biosynthetically radio-
labelled ES of D14, D28 and D42 flukes by D14, D28, D42 and D56 sera from rats
that were infected to produce the antiserum in trial 2. A component of about the
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same molecular weight was recognised in the total biosynthetically radio-labelled
D1 ES, suggesting that this component is produced by D1 fluke and as such might
be of relevance to diagnosis and or protection. The fact that this 38 kDa antigen was
recognised by a protective antiserum may indicate that it plays some role in parasite
protection, in which case antibodies against it may be useful in host protection. It is
probable that this antigen may have shared epitopes with the 25 kDa doublet
detected in western blots of D14 ES.
This result of this immune-coprecipitation is at variance with that of Irving
and Howell (1982) who reported that antiserum from rabbits that had been
vaccinated with soluble extracts of adult fluke recognised components of 24, 26 and
27 kDa in biosynthetically (35S-methionine) labelled ES of 3-week-old F. hepatica.
There could be many reasons for these variations. The authors obtained their ES
from flukes that had been maintained for 7 days in culture. The antisera they used
was not from an oral infection but had been produced by vaccination and they were
using a different host from that used in the present study.
An antigen of about 38 kDa was faintly recognised in biosynthetically radio-
labelled adult fluke ES by sera obtained from rats used to produce antiserum in
trials 1 and 2. A component of same size was detected in the biosynthetically radio-
labelled D1 ES, suggesting that this component was produced by D1 flukes and
might therefore be a useful diagnostic component. Since this antigen was recognised
by protective antiserum (I2) it may be useful for protection. The fact that it was only
faintly recognised might mean that this antigen is not abundant or immunodominant.
The 38 kDa antigen appears to be of similar size as one of the antigens (40
kDa) detected in immunoprecipitation of antiserum from infected rabbits with radio-
labelled adult fluke ES (Santiago et al., 1986). However, several other antigens (28,
33, 44 and 62 kDa) detected by these authors were not recognised in the present
study. These differences might be due to differences in host response as well as
differences in culture conditions used in the two investigations. These authors
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maintained their flukes for 3h in PBS without addition of serum or any of the
essential amino acids, both of which could affect the composition of ES (Lehner,
1977; Kwan-Lim, Gregory, Selkirk, Partono and Maizels, 1989).
The results of the present study also differs from that of Sexton et al. (1991)
who identified a major antigen of about 30 kDa in biosynthetically radio-labelled
adult fluke ES. Apart from the fact that these authors used antiserum from a
different host (sheep), their flukes were maintained in serum-free MEM, a condition
that again might affect the composition of the ES.
None of the antigens (12.5, 13.5, 14.4, 26.5, 27 and 70 kDa) recognised by
immunoprecipitation of mRNA in vitro translation products of adult flukes by
antisera produced in rabbits against homogenates of F. hepatica (Hillyer and Taylor,
1988) were detected in the present study. Again the difference may be due to
differences in host response and the fact that the two studies were probing different
parasite preparations.
The results of this immuno-coprecipitations suggest that most of the
biosynthetically radio-labelled ES components were apparently non-immunogenic.
These non-immunogenic components could be very useful in diagnostic assays
designed to detect parasite products in the circulation (Joshua et al., 1988) by using
monoclonal antibodies directed against such components. (Maizels, Denham and
Sutanto, 1985). Moreover, some of these components are specific to some ages of
flukes and monoclonal antibodies produced against such components could be of
use in epidemiological studies aimed at determining the temporal distribution of the
disease. Very immunogenic components are not very suitable for such assays
(Parkhouse, Almond, Cabrera and Harnett, 1987) as they form complexes with host
antibody resulting in reduced assay sensitivity (Forsyth, Spark, Kazura, Brown,
Peters, Heywood, Dissanayake and Mitchell, 1985).
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Conclusions
This study concentrated on the molecular characterization of the
excretory/secretory products of F. hepatica as it develops in the rat and to a lesser
extent, somatic (saline) and detergent surface extracts of adult fluke. It did
demonstrate that changes occur in the ES products of the fluke in the course of its
development in the rat and that certain components are specific to some ages of
flukes. The study demonstrated that there are differences in protein profiles of total
ES products and total biosynthetically radio-labelled ES proteins of all ages of
flukes examined.
It has extended the study of Yoshihara et al. (1981); Sandeman and Howell
(1981) and Benette et al. (1982) who used immunodiffusion to study antigenicity of
metacercarial extracts by characterizing at molecular level a 191kDa antigen
involved in immune reactions with the host.
It has identified molecules that are apparently immunogenic in unlabelled
D14 and adult fluke ES. The differences of this result with those of earlier workers
highlighted two points. First, that the method of collection of the ES product could
affect its composition and hence antigenicity. Second, that there is considerable
variation in different host responses to fluke ES.
The study also identified immunogenic and non-immunogenic components
in biosynthetically radio-labelled ES of invasive (Dl), parenchymal (D14, D28 and
D42) and adult fluke. It is suggested that the immunogenic components might be
important in diagnosis and or protection while monoclonal antibodies produced
against the non-immunogenic components might be important in diagnostic assays
aimed at detecting parasite products.
Finally, the study characterized components that appear to be involved in
antibody-mediated protection. This includes antigens of 191, a 25 kDa doublet, 26
and 27 kDa; in Dl; D14 and adult ES respectively as well as a 25 kDa antigen in
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NoG detergent surface extracts of adult flukes. It is suggested that these antigens
play an important role in host-parasite relationship in fasciolosis.
Suggested Studies
Only a few biosynthetically radio-labelled components were immunogenic
as revealed by the results of immune-coprecipitation in this study. In the event that
some ES components might not be utilising methionine as their precursor, future
biosynthetic labelling studies could use other amino acids such as leucine, isoleucine
or cysteine. Unlabelled ES of flukes could be radioiodinated and used in
immunecoprecipitation. The results of this study could then be compared with the
results obtained from immunecoprecipitation of biosynthetically radio-labelled ES.
Any antigens detected in the radioiodinated ES but not in the biosynthetically radio-
labelled ES might either be utilising other amino acids as their precursors or might
be surface components released into the ES.
It would be useful to probe unlabelled and biosynthetically radio-labelled ES
of various ages of flukes with sera from infected resistant (cattle) and infected
susceptible (sheep and rabbits) hosts, and compare similarities and differences. This
may shed further light as to components that are likely to be important in protection.
A major problem encountered in this study was the non-specific
precipitation of a major component (about 30 kDa) by normal rat serum. This means
that the goat anti-rat gammaglobulin is reacting with components in the normal rat
serum. Further immuno-coprecipitation studies should be tried using protein G as
the precipitating second antibody.
Most of the immunogenic components identified in this trial (i.e 25 kDa
doublet in western blots of D14 ES; 25, 26 and 27 kDa in western blots of adult ES;
26 and 38 kDa respectively in biosynthetically radio-labelled D1 and parenchymal
ES (D14, D28 and D42) had low molecular weight. It is therefore suggested that
future studies should be done on lower gel gradients (e.g 5-10%). For instance, the
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38 kDa recognised in biosynthetically radio-labelled ES of parenchymal flukes as
well as the 26 and 27 kDa antigens recognised in western blots of non-reduced adult
ES may possibly contain more than one component and separation on a low gradient
gel might reveal more information on the make-up of the antigens. In addition,
separation of unlabelled ES for western blots as well as immuneprecipitates on 2D
eletrophoresis will shed further light on composition of the antigens identified in
this study.
Monoclonal antibodies produced against non-immunogenic components
detected in biosynthetically radio-labelled ES of flukes may be useful in diagnostic
assays designed to detect parasite products. These components are detectable in
Table 4.10 but the prominent ones among them includes components of 103, 155
and 168 kDa in D1 ES; 46 kDa in ES of D14 and D28 flukes and 119 kDa in ES of
D42 flukes. The antigens (25, 38, 48 and 62 kDa) detected in surface detergent
(NoG) strips of adult fluke could be of diagnostic value. As discussed already, the
recognition of these antigens by sera collected earlier in infection might indicate that
such components may also be present on the surfaces of younger flukes.
Monoclonal antibodies against them could therefore be useful in early diagnosis of
infection.
The antigens revealed in passive protection trial 2 as apparently being
involved in protection merit further investigation. These include the 191 kDa
antigen in DO and D1 ES, 25 kDa doublet antigen in D14 ES, and 25 kDa, 27 and
26 kDa in reduced and non-reduced adult ES respectively. These antigens could be
isolated, purified, possibly cloned and used in laboratory immunization trials.
Similarly, antigens recognised in biosynthetically radio-labelled ES of D1 (26 kDa)
and parenchymal (38 kDa) flukes could be purified and their cDNA cloned, and
tested in immunization trials.
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APPENDIX ONE: TABLES OF VALUES
Table A4.2 Fluke burdens of rats in trials to produce antiserum




1 15 13 3
2 5 8 5
3 3 5 9
4 3 2 10
5 3 2 2






Table A4.3 Fluke burdens of individual rats in the three passive protection
trials
Number of flukes in rats
Trials
Treatment
Dose 1 2 3
Antiserum 20 0,6,4,5, 0,0,0,0,0, 0,0,1,1,1
(10 ml) at Days 6,3,2 3 0,0,1,1,2 1,1,1,1,2
0 and 2
Normal rat 20 1,2,2,6, 1,1,1,2,2 1,1,1,2 3
serum Days 0 8,11,7 2,2,3,3 5,5,5,6
and 2
No serum 20 1,3,3,5, 0,0,0,1,2 1,3,3 3 4
8,9,11,6 2,2,4,6,8 4,5,4,5,6
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L B L B L B
12 5 9 5 16 8
12 6 12 6 14 8
13 7 15 8 15 7
16 8 13 7 12 6
8 4 9 6 13 7
16 9 12 6 10 5
12 6 13 6 13 6
10 5 12 7 10 5
13 6 10 5 10 5
11 6 14 7 13 7
14 7 17 8 13 6
15 7 18 9 16 8
9 5 13 7 6 3
12 6 8 5 10 5
17 8.5 9 5 9 5






L B L B L B
12 7 10 5 14 7
12 6 12 6 13 6
14 7 14 7 13 7
15 8 12 6 10 6
8 5 11 5
13 7 20 10
11 6 19 10
10 5 18 9
14 8 10 5
20 9 9 4
13 7 10 6
13 7 8 4
17 8 15 7
9 5 12 6
11 6 11 5
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Table A4.3.1(c) Measurements (mm) of flukes recovered from rats in





L B L B L B
20 9 14 5 8 3
18 8 12 5 16 8
13 6 20 10 18 9
18 9 13 5 15 7
17 8 12 5 19 9
11 6 17 8 10 4
16 8 16 6 8 4
20 9.5 14 7 12 6
14 6.5 15 7 18 8
20 9 12 5.5
16 9 12 5
15 7 9 4.5
19 8 17 9
20 10 14 6.5
18 9 17 9
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Table A4.4.1(a) OD values of obtained from titration of somatic extract of
F. hepatica against 1:200 dilution of sera from rats with 1-





1-3 F 4-6F Control
(positive) (positive) (negative)
50 1.545 1.713 1.043
10 1.571 1.702 0.720
5 1.044 1.041 0.212
2 0.688 0.749 0.092
1 0.517 0.548 0.065
0.5 0.185 0.208 0.026
0.25 0.104 0.104 0.032
0.125 0.065 0.063 0.030
Table A4.4.1(b) OD values following titration of known positive antisera







1 50 0.513 0.438 0.189
1 100 0.375 0.304 0.115
1 200 0.315 0.268 0.090
1 400 0.257 0.176 0.091
1 800 0.231 0.144 0.050
1 1600 0.173 0.130 0.056
1 3200 0.113 0.098 0.050
1 6400 0.110 0.091 0.053
1 12800 0.111 0.075 0.045
1 25600 0.075 0.067 0.067
1 51200 0.070 0.065 0.051
1 102400 0.093 0.063 0.052
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Table A4.4.1(c) OD values following Titration of enzyme conjugate






500 0.728 0.697 0.092
1000 0.619 0.581 0.068
2000 0.454 0.404 0.048
4000 0.277 0.218 0.031
8000 0.163 0.127 0.025
16000 0.093 0.079 0.027
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Table A4.4.2(la) ELISA response (mean OD) of trial 1 rats to adult ES
Correction Negative
Group DO D14 D28 D42 D56 factor control
0.078 0.478 0.554 0.547 0.614
0.094 0.487 0.495 0.539 0.477
0.086 0.448 0.433 0.568 0.639
0.083 0.465 0.532 0.642 0.577 0.961 .074
0.094 0.404 0.469 0.557 0.562
0.079 0.512 0.616 0.767 0.657
0.089 0.505 0.617 0.724 0.561
0.089 0.581 0.727 0.739 0.729
0.115 0.507 0.631 0.669 0.586
0.100 0.518 0.613 0.707 0.594
1-3 F 0.091 0.538 0.606 0.698 0.658
0.093 0.538 0.593 0.685 0.654 0.964 .088
0.090 0.420 0.472 0.631 0.482
0.094 0.548 0.569 0.641 0.548
0.097 0.567 0.567 0.660 0.624
0.096 0.520 0.610 0.622 0.543
0.087 0.474 0.537 0.621 0.552
0.088 0.419 0.510 0.563 0.511
0.090 0.547 0.615 0.671 0.671
0.093 0.510 0.591 0.690 0.714 0.897 .085
0.094 0.521 0.574 0.682 0.709
0.095 0.512 0.577 0.691 0.629
0.093 0.514 0.607 0.665 0.647
0.065 0.515 0.748 0.762 0.708 0.897 .085
4-7 F 0.098 0.669 0.735 0.856 0.637 0.680 .095
0.103 0.607 0.652 0.751 0.630
0.103 0.660 0.763 0.749 0.722
0.099 0.741 0.851 0.937 0.763
0.098 0.770 0.867 0.914 0.728
0.106 0.716 0.898 0.974 0.870
0.098 0.190 0.268 0.320 0.210
0.099 0.702 0.723 0.863 0.817 0.680 .095
0F+P 0.074 0.566 0.783 0.841 0.600
0.069 0.323 0.682 0.714 0.565
0.109 0.549 0.563 0.486 0.328 0.745 .064
nr „ 0.097 0.192 0.197 0.165 0.115U P
0.087 0.573 0.581 0.693 0.716
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Table A4.4.2(lb) Uninfected control rats
Correct Negative Correction Negative
DO D56 factor control DO D56 factor control









































Table A4.4.2(l.la) ELISA response (mean OD) of trial 1 rats to somatic




DO D14 D28 D42 D56 Factor control
0.088 0.515 0.637 0.815 0.651
0.115 0.397 0.305 0.462 0.784
0.091 0.504 0.531 0.676 0.660
0.087 0.540 0.540 0.563 0.423 1.00 0.085
0.088 0.494 0.605 0.662 0.571
0.099 0.532 0.676 0.825 0.664
0.094 0.558 0.683 0.717 0.658
0.101 0.576 0.516 0.541 0.500
0.088 0.707 0.783 0.835 0.781
0.095 0.666 0.708 0.766 0.832
0.093 0.682 0.691 0.809 0.826
0.095 0.717 0.674 0.874 0.826 0.772 0.084
0.086 0.520 0.601 0.706 0.718
0.086 0.552 0.611 0.645 0.590
0.090 0.592 0.675 0.623 0.619
0.094 0.493 0.493 0.742 0.542
0.074 0.758 0.751 0.796 0.909
0.064 0.712 0.770 0.835 0.480
0.074 0.401 0.509 0.738 0.588
0.060 0.645 0.632 0.667 0.766
0.067 0.537 0.544 0.571 0.645
0.057 0.469 0.473 0.658 0.545
0.063 0.562 0.554 0.530 0.618
0.932 0.056
0.083 0.556 0.634 0.768 0.743 0.932 0.056
0.110 0.344 0.575 0.746 0.346
0.090 0.502 0.505 0.732 0.643
0.110 0.453 0.529 0.667 0.514
0.111 0.369 0.570 0.737 0.626
0.111 0.262 0.311 0.675 0.554
0.108 0.360 0.414 0.615 0.729
1.055 0.108
0.109 0.152 0.176 0.191 0.153






























Table A4.4.2(l.lb) Uninfected control rats
Correction Negative Correction Negative

























































































Table A4.4.2(2a) ELISA response (mean OD) of trial 2 rats to ES of adult
fluke
Correction Negative
DO D14 D28 D42 D56 Factor control
0.097 0.524 0.703 0.643 0.541
0.086 0.509 0.607 0.655 0.624
0.084 0.623 0.710 0.748 0.798
0.085 0.556 0.563 0.696 0.728 0.721 0.095
0.096 0.617 0.672 0.811 0.893
0.097 0.515 0.503 0.587 0.683
0.104 0.507 0.643 0.661 0.755
0.105 0.537 0.607 0.684 0.511
0.126 0.486 0.621 0.854 0.925
0.109 0.404 0.525 0.776 0.752
0.106 0.258 0.562 0.478 0.571
0.102 0.402 0.508 0.601 0.409 0.790 0.090
0.087 0.423 0.603 0.622 0.591
0.093 0.270 0.640 0.496 0.567
0.107 0.443 0.621 0.706 0.794
0.093 0.514 0.603 0.671 0.606
0.091 0.357 0.343 0.471 0.434
0.091 0.316 0.392 0.449 0.408
0.093 0.348 0.411 0.499 0.298
0.094 0.372 0.423 0.491 0.425 1.042 0.089
0.090 0.515 0.539 0.621 0.705
0.094 0.388 0.448 0.548 0.440
0.100 0.379 0.473 0.510 0.544
0.103 0.457 0.463 0.505 0.554
0.094 0.339 0.519 0.633 0.642
0.102 0.367 0.515 0.588 0.613 1.087 0.098
0.097 0.343 0.435 0.534 0.541
0.091 0.357 0.402 0.558 0.591
4-6 F 0.091 0.291 0.382 0.609 0.631 1.087 0.098
0.092 0.407 0.485 0.609 0.707
0.110 0.366 0.459 0.619 0.727
0.097 0.183 0.357 0.353 0.330
0F+P 0.100 0.189 0.199 0.434 0.367 1.251 0.085
0.100 0.335 0.363 0.350 0.295
0.099 0.187 0.309 0.260 0.282
0.106 0.190 0.234 0.188 0.200 1.251 0.085
0F-P 0.092 0.131 0.199 0.171 0.174
0.105 0.221 0.412 0.423 0.399
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Table A4.4.2(2b) Uninfected control rats
Correction Negative Correction Negative



















































































Table A4.4.2(2.la) ELISA response (mean OD) of trial 2 rats to somatic
extract of adult fluke
Correction Negative
Group DO D14 D28 D42 D56 Factor control
0.083 0.316 0.460 0.465 0.472
0.070 0.344 0.460 0.479 0.510
0.096 0.308 0.397 0.460 0.490
0.070 0.410 0.489 0.520 0.479 1.180 0.067
0.070 0.347 0.445 0.476 0.485
0.071 0.278 0.380 0.473 0.412
0.076 0.500 0.530 0.555 0.496
0.082 0.306 0.414 0.429 0.453
0.090 0.351 0.466 0.471 0.487
0.090 0.373 0.435 0.477 0.488
0.082 0.290 0.476 0.478 0.486
0.081 0.346 0.467 0.473 0.486 1.255 0.076
0.088 0.296 0.400 0.425 0.455
0.086 0.306 0.477 0.506 0.518
0.087 0.346 0.473 0.467 0.483
0.080 0.350 0.486 0.477 0.481
1-3 F
0.085 0.247 0.314 0.442 0.465
0.093 0.285 0.320 0.371 0.435
0.086 0.348 0.460 0.489 0.483
0.087 0.315 0.471 0.466 0.491 1.200 0.062
0.088 0.346 0.458 0.476 0.486
0.095 0.381 0.460 0.489 0.499
0.088 0.342 0.461 0.469 0.472
0.094 0.255 0.335 0.380 0.411
0.079 0.311 0.371 0.412 0.460
0.078 0.295 0.415 0.455 0.478 0.987 0.075
0.065 0.184 0.308 0.533 0.409
0.067 0.227 0.305 0.421 0.382
4-6 F 0.073 0.190 0.269 0.518 0.507 1.320 0.062
0.073 0.294 0.366 0.578 0.511
0.068 0.289 0.358 0.619 0.467
0.080 0.213 0.224 0.334 0.284
OF+P 0.080 0.204 0.237 0.278 0.258 1.260 0.078
0.088 0.177 0.200 0.327 0.291
0.090 0.158 0.307 0.279 0.254
0.080 0.261 0.306 0.229 0.241 1.260 0.078
OF-P 0.082 0.130 0.203 0.198 0.197
0.101 0.187 0.280 0.296 0.310
204
Tabic A4.4.2(2.1b) Uninfected control rats
Correction Negative Correction Negative














































Table A4.4.2(3a) ELISA response (mean OD) of rats in trial 3 rats ES of
adult fluke
Correction Negative










































0.048 0.135 0.155 0.196 0.171
0.045 0.090 0.164 0.138 0.144
0.046 0.091 0.142 0.142 0.150
0.048 0.097 0.122 0.126 0.200 4.500 .088
0.045 0.070 0.110 0.171 0.189
0.048 0.067 0.120 0.196 0.212
0.046 0.077 0.129 0.115 0.123
0.094 0.083 0.121 0.106 0.123
0.047 0.143 0.210 0.320 0.365
0.059 0.108 0.166 0.202 0.270
0.061 0.132 0.164 0.232 0.247
0.058 0.098 0.173 0.205 0.226 4.037 .085
0.058 0.091 0.130 0.229 0.205
0.061 0.087 0.146 0.291 0.235
0.064 0.121 0.143 0.252 0.265
0.084 0.091 0.166 0.230 0.257
0.081 0.179 0.235 0.290 0.285
0.077 0.109 0.166 0.295 0.282
0.082 0.088 0.192 0.207 0.255
0.078 0.218 0.213 0.303 0.278
0.114 0.139 0.159 0.302 0.176 2.590 0.095
0.150 0.141 0.158 0.244 0.165
0.095 0.141 0.195 0.234 0.193
0.076 0.170 0.239 0.307 0.234
0.104 0.144 0.160 0.247 0.179 2.3 0.073
0.078 0.172 0.240 0.307 0.234
206
Tabic 4.4.2(3b) Uninfected control rats
Correction Negative Correction Negative
DO D56 factor control DO D56 factor control
0.074 0.072 0.709 0.075 0.066 0.080 1.018 0.073
0.071 0.066 0.078 0.073
0.082 0.084 0.082 0.064
0.068 0.078 0.069 0.073
0.080 0.068 0.072 0.077
0.076 0.066 0.068 0.070
0.100 0.090 0.067 0.065
0.101 0.071 0.817 0.065 0.071 0.075
0.097 0.092 0.070 0.072
0.073 0.065 0.070 0.080
0.081 0.083 0.081 0.082
0.078 0.074 0.066 0.069
0.088 0.082 0.050 0.059
0.084 0.078 1.018 0.073 0.060 0.073
0.077 0.075 0.072 0.077
0.078 0.088 0.067 0.065
0.075 0.069 0.064 0.065
0.089 0.075 0.073 0.081
0.078 0.084 0.072 0.082
0.079 0.090 0.067 0.068
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Table A4.4.2(3.1a) ELISA response (mean OD) of trial 3 rats to somatic
extract of adult fluke
Correction Negative
Group DO D14 D28 D42 D56 factor control
0 079 0.228 0.313 0.365 0.644
0.104 0.275 0.293 0.385 0.351
0.101 0.292 0.344 0.459 0.398
0.074 0.261 0.395 0.548 0.426
0.098 0.244 0.257 0.343 0.264
0.109 0.163 0.313 0.315 0.370
0.078 0.127 0.197 0.288 0.298
0.086 0.188 0.274 0.330 0.379
0.098 0.196 0.384 0.568 0.383
0.097 0.189 0.361 0.307 0.372
0.101 0.139 0.280 0.309 0.368
0.098 0.129 0.232 0.213 0.184 2.900 .088
0.097 0.150 0.211 0.369 0.228
0.098 0.176 0.275 0.390 0.355
0.097 0.138 0.195 0.255 0.170
0.106 0.119 0.190 0.257 0.207
0.092 0.183 0.300 0.376 0.213
0.093 0.168 0.296 0.313 0.306
0.100 0.209 0.295 0.393 0.342
0.104 0.242 0.270 0.391 0.329 2.800 .085
0.104 0.210 0.247 0.335 0.300
0.098 0.197 0.280 0.425 0.322
0.100 0.164 0.268 0.447 0.331
0.097 0.134 0.294 0.367 0.252
0.093 0.213 0.380 0.310 0.483
0.095 0.124 0.229 0.313 0.400
0.088 0.103 0.291 0.430 0.252
0.090 0.220 0.336 0.578 0.417
0.089 0.129 0.201 0.514 0.435 2.560 0.095
0.090 0.136 0.120 0.250 0.220
0.090 0.136 0.227 0.344 0.270
0.100 0.196 0.197 0.307 0.399
0.101 0.136 0.095 0.251 0.229
0.088 0.197 0.197 0.312 0.299
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Tabic A4.4.2(3.1b) Unifectcd control rats
Correction Negative Correction (Negative
DO D56 factor control DO D56 factor control
0.084 0.076 0.917 0.075 0.084 0.101
0.067 0.101 0.078 0.080
0.078 0.085 0.079 0.089
0.067 0.078 0.075 0.076
0.078 0.088 0.084 0.081
0.087 0.087 0.088 0.090
0.084 0.083 0.071 0.080
0.078 0.074 0.067 0.076
0.078 0.084 0.087 0.088
0.100 0.101 0.068 0.066
0.095 0.087 0.069 0.095
0.094 0.093 0.086 0.081
0.094 0.092 0.097 0.077
0.083 0.074 0.084 0.106
0.073 0.082 0.063 0.091
0.082 0.074 0.084 0.092
0.074 0.090 0.073 0.075
0.075 0.086 0.080 0.081
0.078 0.067 0.094 0.083
0.065 0.067 0.072 0.084
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Table A4.4.3(la) ELISA response (mean OD) of passive protection trial 1
rats to ES of adult fluke
Correction Negative
Group DO D14 D28 D42 D56 Factor control
0.072 0.573 0.385 0.234 0.120
0.082 0.570 0.658 0.639 0.332
0.095 0.561 0.526 0.595 0.517
+IRS 0.077 0.504 0.602 0.715 0.531 1.134 0.075
0.084 0.506 0.606 0.645 0.741
0.080 0.470 0.504 0.669 0.480
0.081 0.432 0.504 0.405 0.341
0.083 0.432 0.466 0.643 0.394
0.079 0.157 0.204 0.246 0.158
0.80 0.146 0.170 0.209 0.190
0.082 0.247 0.335 0.316 0.345
+NRS 0.089 0.229 0.307 0.457 0.283 1.611 0.078
0.085 0.305 0.328 0.434 0.414
0.084 0.291 0.407 0.410 0.422
0.084 0.250 0.301 0.330 0.329
0.081 0.182 0.241 0.548 0.424
0.073 0.183 0.241 0.457 0.284
0.077 0.202 0.252 0.398 0.344
NS 0.083 0.237 0.246 0.457 0.376 1.604 0.069
0.089 0.229 0.296 0.482 0.379
0.074 0.232 0.262 0.399 0.380
0.081 0.245 0.328 0.448 0.414
0.070 0.261 0.323 0.518 0.431
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Table A4.4.3(lb) ELISA response (mean OD) of passive protection trial 1
rats to somatic extract of adult fluke
Correction Negative
Group DO D14 D28 D42 D56 Factor control
0.109 0.365 0.280 0.202 0.189
0.085 0.600 0.590 0.649 0.574
0.075 0.551 0.564 0.674 0.568
+IRS 0.083 0.574 0.670 0.768 0.638 1.070 0.069
0.109 0.546 0.550 0.618 0.600
0.101 0.603 0.672 0.803 0.556
0.117 0.469 0.508 0.648 0.500
0.072 0.484 0.540 0.678 0.546
0.076 0.269 0.386 0.602 0.574
0.084 0.366 0.551 0.668 0.575
0.096 0.293 0.421 0.587 0.546
+NRS 0.087 0.316 0.408 0.552 0.500 1.020 0.065
0.071 0.293 0.446 0.616 0.551
0.078 0.337 0.43 0.588 0.543
0.101 0.213 0.196 0.185 0.175
0.092 0.306 0.438 0.774 0.700
0.096 0.393 0.548 0.838 0.708
0.098 0.316 0.396 0.628 0.610
NS 0.103 0.494 0.623 0.888 0.698 1.040 0.088
0.089 0.268 0.348 0.538 0.518
0.092 0.288 0.401 0.653 0.550
0.098 0.290 0.425 0.601 0.549
0.090 0.286 0.334 0.605 0.538
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Table A4.4.3(2a) ELISA response (mean OD) of passive protection trial
rats to ES of adult fluke
Correction
Group DO D1 D3 D14 D28 D42 D56 Factor
0.095 0.551 0.563 0.465 0.293 0.195 0.100
0.099 0.439 0.536 0.422 0.428 0.379 0.335 .884
0.091 0.517 0.577 0.482 0.309 0.133 0.095
0.103 0.607 0.599 0.588 0.431 0.258 0.219
0.095 0.523 0.592 0.429 0.431 0.201 0.206
0.092 0.590 0.643 0.465 0.244 0.209 0.095 .898
0.096 0.511 0.577 0.358 0.345 0.154 0.166
0.091 0.555 0.607 0.391 0.431 0.257 0.363
0.101 0.628 0.670 0.477 0.263 0.159 0.116 .872
0.090 0.660 0.694 0.521 0.277 0.218 0.184
0.096 0.092 0.130 0.475 0.476 0.502 0.339
0.095 0.155 0.172 0.466 0.455 0.597 0.540 .872
0.100 0.130 0.183 0.415 0.485 0.589 0.474
+NRS 0.097 0.138 0.160 0.385 0.451 0.481 0.397 .919
0.101 0.105 0.154 0.170 0.194 0.216 0.230
0.098 0.144 0.145 0.462 0.503 0.618 0.680
0.106 0.152 0.212 0.340 0.434 0.483 0.485
0.103 0.099 0.127 0.459 0.506 0.592 0.580 1.04
0.099 0.149 0.158 0.367 0.373 0.490 0.533
0.104 0.097 0.100 0.467 0.563 0.515 0.575
0.172 0.112 0.099 0.272 0.258 0.344 0.293 1.05
0.090 0.089 0.101 0.525 0.634 0.650 0.640
0.090 0.096 0.102 0.324 0.441 0.448 0.435
0.094 0.100 0.095 0.384 0.432 0.428 0.398
0.095 0.078 0.094 0.355 0.432 0.431 0.378 1.05
0.094 0.069 0.088 0.376 0.459 0.530 0.486
0.099 0.090 0.089 0.333 0.429 0.570 0.530
0.097 0.088 0.065 0.417 0.465 0.555 0.565 1.05
0.099 0.069 0.077 0.145 0.164 0.117 0.102
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Table A4.4.3(2b) ELISA response (mean OD) of passive protection trial 2
rats to somatic extracts of adult fluke
Correction






































































































































0.090 0.113 0.105 0.309 0.391 0.578 0.302 1.30
NS
0.096 0.103 0.095 0.296 0.280 0.230 0.200
0.089 0.093 0.088 0.545 0.630 0.710 0.840 1.25
0.101 0.077 0.096 0.530 0.608 0.696 0.769
0.096 0.113 0.098 0.501 0.602 0.789 0.820
0.097 0.099 0.116 0.496 0.585 0.660 0.740
0.098 0.097 0.101 0.037 0.240 0.210 0.190 1.04
0.094 0.088 0.078 0.486 0.545 0.630 0.680
0.099 0.108 0.110 0.487 0.570 0.664 0.700
0.112 0.099 0.103 0.360 0.190 0.185 0.180 1.02
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Table A4.4.3(3a) ELISA response (mean OD) of passive protection trial 3
rats to to ES product adult fluke
Correction
Group DO D1 D3 D14 D28 D42 D56 Factor
0.090 0.145 0.168 0.073 0.093 0.093 0.071
0.109 0.118 0.126 0.068 0.073 0.092 0.095 3.5
0.099 0.160 0.182 0.100 0.106 0.150 0.127
0.104 0.180 0.190 0.098 0.108 0.148 0.130
+IRS
0.105 0.190 0.210 0.131 0.135 0.180 0.159
0.107 0.210 0.250 0.150 0.135 0.191 0.160 3.56
0.100 0.201 0.205 0.160 0.136 0.200 0.159
0.102 0.203 0.208 0.132 0.122 0.174 0.131
0.074 0.200 0.220 0.118 0.115 0.113 0.115 3.88
0.086 0.182 0.209 0.077 0.110 0.036 0.046
0.093 0.100 0.094 0.093 0.122 0.208 0.229
0.102 0.099 0.102 0.107 0.154 0.176 0.142 3.88
0.093 0.087 0.110 0.089 0.100 0.183 0.133
+NRS 0.093 0.095 0.096 0.107 0.117 0.190 0.138 4.1
0.099 0.097 0.101 0.115 0.136 0.200 0.112
0.094 0.095 0.095 0.132 0.174 0.215 0.145
0.097 0.100 0.099 0.106 0.151 0.215 0.241
0.095 0.093 0.092 0.139 0.178 0.206 0.200 3.94
0.094 0.097 0.100 0.095 0.110 0.152 0.132
0.101 0.099 0.096 0.209 0.269 0.221 0.214
0.097 0.097 0.101 0.240 0.296 0.320 0.259 3.9
0.080 0.085 0.088 0.215 0.197 0.230 0.210
0.099 0.096 0.095 0.136 0.140 0.212 0.211
NS
0.098 0.093 0.099 0.076 0.081 0.101 0.101
0.086 0.088 0.098 0.142 0.184 0.224 0.210 4.05
0.102 0.098 0.092 0.145 0.223 0.213 0.215
0.094 0.088 0.099 0.141 0.148 0.219 0.205
0.083 0.090 0.099 0.145 0.223 0.213 0.215 4.10
214
Table A4.4.3(3b) ELISA response (mean OD) of passive protection trial 3
rats to somatic extract of adult fluke
Group DO D1 D3 D14 D28 D42 D56
Correction
Factor
0.093 0.366 0.279 0.157 0.156 0.123 0.112
0.088 0.325 0.272 0.136 0.148 0.153 0.168
0.089 0.354 0.297 0.202 0.166 0.210 0.149
































































0.088 0.101 0.107 0.138 0.273 0.226
0.088 0.092 0.115 0.145 0.303 0.219
0.089 0.094 0.120 0.145 0.24 0.352
0.090 0.091 0.128 0.181 0.42 0.270
2.9
0.086 0.090 0.090 0.111 0.221 0.374 0.439
0.071 0.092 0.087 0.136 0.192 0.422 0.278
































0.101 0.094 0.095 0.075 0.081 0.158 0.082
0.101 0.094 0.080 0.135 0.217 0.315 0.315
0.093 0.089 0.092 0.154 0.242 0.345 0.342
0.097 0.089 0.095 0.163 0.289 0.570 0.548
2.80






























Mean percentage eosinophil in trial 3 rats
Day after infection


























































Table A4.5.1(b) Mean PCV of rats from trial 3
Day after infection
Group 0 14 28 42 56
40 51 55 50 50
48 60 54 62 55
40 59 57 50 53
52 54 53 45 56
+IRS 46 55 50 49 58
42 52 47 50 47
47 50 50 45 42
46 51 53 49 50
49 45 54 48 56
49 57 40 45 48
40 44 53 42 43
45 54 55 59 52
50 55 52 50 52
43 59 56 59 55
+NRS 44 46 46 44 46
50 60 49 52 52
44 52 58 50 50
51 55 54 64 50
46 50 50 52 45
40 52 50 46 48
50 52 52 44 38
44 52 52 42 48
46 50 52 48 52
NS 56 59 54 55 56
58 56 58 54 48
45 56 50 44 40
44 48 55 60 58
40 50 58 54 56
217
Table A4.5.1(c) Mean percentage of neutrophils of rats from trial 3
Day after infection
Group 0 14 28 42 56
30 30 31 29 25
35 28 25 23 19
38 16 10 25 63
40 22 6 39 29
+IRS 40 38 14 40 14
30 35 26 28 20
30 20 29 44 22
24 28 31 35 30
27 19 20 30 23
18 24 25 38 18
40 34 35 51 17
26 68 34 44 37
28 35 35 50 15
40 40 30 39 32
+NRS 21 64 52 41 15
30 50 39 37 30
22 29 32 45 20
24 50 49 49 48
27 40 45 55 27
30 40 46 38 36
32 47 49 34 36
18 29 35 45 24
27 25 42 43 19
25 31 18 18 14
24 33 24 65 23
n ->
J J 36 29 51 19
41 41 33 43 27
28 37 40 52 21
218
Table A4.5.1(d) Mean percentage lymphocytes in rats from trial 3
Day after infection
Group 0 14 28 42 56
70 83 54 35 74
67 76 73 76 66
65 76 71 57 33
66 74 78 35 66
+IRS 64 55 56 40 83
60 57 49 38 71
69 73 56 46 70
77 69 65 66 74
63 55 59 32 74
75 74 44 72 64
76 70 55 53 79
74 56 37 34 70
73 28 54 42 48
60 54 38 33 48
+NRS 65 51 40 24 82
68 32 23 43 50
72 43 35 37 74
77 68 52 38 61
50 42 26 39 54
62 55 48 42 59
68 40 20 41 48
75 61 43 49 71
77 58 30 46 71
69 54 72 75 83
66 55 39 19 68
76 48 46 39 73
58 47 46 48 59
60 47 27 40 59
219
Table A4.5.1(e) Mean percentage of monocytes in rats from trial 3
Day after infection
Group 0 14 28 42 56
8 4 3 7 6
13 8 2 1 14
12 10 13 12 1
11 4 9 12 3
+IRS 7 9 9 4 4
15 8 10 5 4
13 5 7 9 7
11 6 10 15 0
7 3 1 4 0
6 12 8 7 1
13 8 12 7 5
7 4 9 11 8
6 9 6 8 1
15 8 9 19 6
+NRS 14 4 7 7 7
8 6 6 14 12
14 3 6 7 5
13 4 17 6 5
10 5 13 14 7
8 8 12 8 2
7 7 9 18
13 6 17 6 ->J
14 13 12 9 2
15 13 8 6 3
8 7 18 8 4
14 14 7 4 6
10 9 7 nJ) 10
4 3 8 7 9
220


















Calcium chloride 5.5g/l 00 ml
To 250 ml of solution A add 900 ml of distilled water followed by 1.0 ml of










34.8 mg in 1 ml
ethanol.
COMPLETE CULTURE MEDIUM




I mM L-Glutamine 2 ml
B-Mecarptoehanol 0.761 pg
Foetal Calf serum (sterile) 20 ml
Fungizone (no filtration) 100 pg
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COMPLETE MEDIUM FOR BIOSYNTHETIC LABELLING
1. Dispense 250 ml of RPMI 1640 (Selectamine, Gibco) into a flask containing
250 ml of sterile, deionized distilled water.
2. Reconstitute each amino acid, (excepting the one to be used for labelling)
with 10 ml of sterile, deionized distilled water and add to the medium.
3. Reconstitute the vitamin mixture with 10 ml of sterile deionized water and
add to the medium.
4. Add 20 ml of 10% glucose and 10 ml of 0.05% phenol.
5. Add 27 ml of 7.5% NaCC>3 to the medium.
6. Adjust pH to 7.0 with IN HC1 or NaOH.
7. Bring volume to 1 L.
8 Aliquot and store in 20ml volumes at -70°C.
FINAL PREPARATION OF MEDIUM FOR BIOSYNTHETIC LABELLING
1. Defrost 20 ml ofmedium, and pipette off 600 pi.
2. Add through millipore filtration.
penicillin 200 units
Streptomycin 200 pg
1 mM L-Glutamine 200 pi
Foetal Calf Serum 600 pi
Fungizone 20 pg
SOLUTIONS FOR ELISA
Borate buffered saline (pH 8.2)
Boric acid 6.18 g
Di-sodium tetraborate 9.54 g
Sodium chloride 4.38 g
Distilled water to 1 L
Washing solution
Nacl 72 g
Tween 20 4 g
Distilled water to 8 L
Sodium acetate/citrate buffer
Solution A: 49.2 g of sodium acetate (anhydrous) made up to 1 L with distilled
water (0.6 M). Solution B: 52.5 g of citric acid made up to 500 ml with distilled
water (0.5 M). x% stock was prepared by adding 100 ml of solution B to 50 ml of
solution A and adjusting pH to 6.0. Stock was diluted 5x for use.
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TMB substrate
3,3',5,5'-Tetramethylbenzidine (TMB) 5 mg
(Dissolved in 0.5 ml DMSO [analar])
0.1 M Sodium acetate/citric acid buffer
(pH 6.0) 50 pi
Hydrogen peroxide (30% w/v) 7.5 pi
SDS-PAGE SOLUTIONS
Solution A
1 M HCL 96 ml
Tris 73.2g
TEMED 92 pi




Made up to 500 ml with distilled water.




1 M HCL 144 ml
Bring up to 300 ml with distilled water (pH 6.7)
Preparation of 10-20% gradient solutions for large gels
10% 20%
Solution A 3.12 ml 3.12 ml
Solution B 8.32 ml 16.64 ml
Distilled water 2.48
10% SDS 250 pi 250 pi
Solution D 10.79 ml** 4.95 ml*
**
= 50 mg ammonium persulphate in 100 ml H20.
= 74.94 mg ammonium persulphate in 100 ml H20.
Stacking gel
Stacking buffer 5 ml
Solution B 4 ml
TEMED 50 pi
10% SDS 400 pi
Distilled water 33.55 ml
10% ammonium persulphate 250 pi
Preparation of 12% separating solution for mini gels
1.5 M Tris-HCL 3.35 ml
10% SDS 2.5 ml
Solution B 4 ml




Distilled water 6.1 ml
0.5 M Tris-HCL 2.5 ml
10% SDS 100 f^l
Solution B 1.3 ml
10% ammonium persulphate 50 pi
TEMED 10 pi
WESTERN BLOTTING





NP 40 1 ml
Distilled water to 2 L





Adjust volume to 2 L with double distilled water
CO-PRECIPITATION DILUENT
Buffers
1. 2.0M Tris/HCl (i.e, 121 g Tris in 500 ml of
distilled H20, pH 8)
2. 10% NP40
3. 0.5 M NaCL
Diluent
1. 2.0M Tris/Hcl pH 8 10 ml
2. 0.5M NaCl 100 ml
3. 10% NP 40 20 ml
Make up to 1L, pEl 8.0.
SOLUBILIZING BUFFERS
Solution 1
Trisma base 45 mg
EDTA 223 mg












Made up to 10 ml in distilled water. Add pouceau-S to colour
Reducing buffer and non-reducing buffers
Add equal volumes of solution 1 and 2 to prepare reducing buffer and equal
volumes of solutions 1 and 3 to rpepare non-reducing buffer.
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APPENDIX THREE MANUFACTURERS' NAMES AND ADDRESSES
BDH Ltd Sterilin Ltd.






















Lincoln Place Green End
Aylesbury Buckinghamshire
HP20 2TP






























Bantin and Kingsman Ltd
The Field Station
Grimston Aldborough
Hull, Northumberside
HUW1 4QE
England
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